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An	  Investigation	  into	  the	  Role	  of	  Subliminal	  Inputs	  in	  Placebo	  
Response	  	  
SALLY	  ANNE	  FRANCES	  PEARCE	  	  According	  to	  the	  network	  theory	  of	  psychoneuroimmunology,	  (Hyland,	  2011a),	  the	  placebo	  response	  is	  a	  short-­‐term,	  problem	  solving	  response	  to	  a	  variety	  of	  inputs	  processed	  via	  the	  ‘infornet’.	  However,	  within	  the	  current	  infornet	  model	  of	  placebo	  response,	  these	  inputs	  are	  categorized	  as	  either	  conscious	  verbal	  inputs,	  or	  inputs	  learnt	  via	  traditional	  conditioning	  mechanisms.	  This	  thesis	  investigates	  the	  extent	  to	  which	  other	  ‘higher-­‐order’	  subliminal	  inputs	  may	  also	  play	  a	  part	  in	  determining	  placebo	   response.	   The	   findings	   presented	   here	   found	   no	   reliable	   effect	   of	  subliminal	   priming	   information	   on	   placebo	   response	   in	   a	   short-­‐term	   placebo	  context.	   Further	   research	   is	   needed	   to	   determine	   if	   subliminally	   presented	  information	  is	  more	  likely	  to	  be	  used	  within	  a	  long-­‐term	  placebo	  context.	  The	  lack	  of	   consistency	   in	   findings	   across	   this	   set	   of	   experiments	   supports	   replication	  criticisms	  leveled	  at	  the	  subliminal	  priming	  field,	  and	  the	  claim	  that	  differences	  in	  trivial	   contextual	   details	   may	   be	   the	   underlying	   cause	   of	   these	   inconsistencies.	  Theoretical	  and	  practical	  implications	  of	  these	  findings	  are	  also	  discussed.	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Chapter	  1	  	  Introduction	  
	  1.1 	  	  	  	  	  Definition	  	  The	  introduction	  to	  a	  body	  of	  research	  traditionally	  commences	  with	  a	  definition	  of	   the	  phenomenon	  under	   investigation.	  The	  need	  to	  give	  a	  definition	  sometimes	  reflects	   the	   fact	   that	   a	   term	   is	   used	   in	   a	   variety	   of	  ways,	   and	   this	   is	   reflected	   in	  definitions	   of	   placebo.	   Numerous	   definitions	   of	   both	   the	   placebo	   itself	   and	   the	  placebo	   response	   currently	   exist,	   (Kirsch,	   1999;	   Moerman	   &	   Jonas,	   2002).	   For	  example,	  Vase	  et	  al.,	  (2002),	  refer	  to	  the	  placebo	  response	  as,	  	  	   “…	   the	   reduction	   in	   a	   symptom	   as	   a	   result	   of	   the	   subject’s	   /	   patient’s	  perception	  of	  therapeutic	  intervention”,	  (p.	  451),	  	  	  whilst	  others	  refer	  to	  a	  placebo	  as,	  	  	  “the	   physiological	   or	   psychological	   response	   to	   an	   inert	   substance	   or	  procedure”,	  (Stewart-­‐Williams	  &	  Podd,	  2004b,	  p.199).	  	  	  In	   comparison	   to	   more	   historical	   elucidations,	   these	   definitions	   are	  advantageous	   in	   that	   they	   are	   not	   limited	   to	   particular	   individuals,	   types	   of	  treatment	   or	   dependent	   variables,	   (Geers	   et	   al.,	   2005a).	   However,	   inherent	  difficulties	  remain.	  For	  example,	  how	  can	  a	  substance	  be	  truly	  inert	  if	  it	  reduces	  a	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subject’s	   /	   patient’s	   symptoms?	   In	   order	   to	   understand	   the	   term	   ‘placebo’	  properly,	  we	  must	  examine	  not	  only	  when	  it	  is	  being	  used,	  but	  also	  by	  whom.	  
	  1.2 	  	  	  	  	  Historical	  Context	  
	  1.2.1	  	  	  	  	  An	  Inert	  Prop	  –	  Pre	  Modern	  Medicine	  
	  The	  origins	  of	  the	  word	  ‘placebo’	  can	  be	  traced	  back	  to	  a	  Latin	  phrase	  used	  in	  the	  “office	  of	  the	  dead”	  ritual	   in	  Western	  Churches	  in	  the	  Middle	  Ages,	  (Finniss	  et	  al.,	  2010).	  At	  the	  end	  of	  each	  recited	  passage,	  mourners	  would	  respond	  by	  reciting	  the	  9th	   line	  of	  Psalm	  116,	   “placebo	  Domino	   in	   regione	  vivorum”	  or	   “I	  will	   please	   the	  Lord	   in	   the	   Land	   of	   the	   Living”.	   (This	   phrase	   was	   actually	   mistranslated	   from	  Hebrew	  into	  the	  Latin	  Vulgate	  version	  of	  the	  Bible	  by	  St.	  Jerome.	  Strictly	  translated,	  the	  original	  Hebrew	  meant,	  “I	  will	  walk	  before	  the	  Lord”.	  Later	  translators	  of	   the	  Bible	  rejected	  St.	   Jerome’s	  version	  and	  his	   rendering	   is	  not	   found	   in	  any	  modern	  English	  version).	  	  The	  most	   passionate	   ‘placebo’	   responders	   were	   the	   grieving	   close	   family	  and	   friends	   of	   the	   deceased.	   As	   the	   ritual	   became	   an	   integral	   part	   of	   medieval	  society,	   bogus	  mourners	  would	   appear	   at	   the	   funerals	   held	   by	  wealthy	   families,	  claiming	  a	  relationship	  with	  the	  dead	  in	  order	  to	  partake	  of	  food	  and	  other	  benefits	  handed	  out	  at	  the	  end	  of	  the	  ceremony.	  Some	  families	  were	  even	  reputed	  to	  hire	  “professional”	   mourners	   in	   order	   to	   increase	   the	   perceived	   popularity	   of	   the	  deceased.	   In	   this	  way,	   the	  word	   ‘placebo’	  became	  associated	  with	   insincerity	  and	  deception,	  (Kaptchuk	  et	  al.,	  2009).	  	  The	  use	  of	   the	  word	  placebo	   to	   reflect	   these	   characteristics	  also	   found	   its	  way	   into	   the	   literature	   of	   the	   late	   14th	   century	  when	   Chaucer	   used	   the	  word	   to	  
CHAPTER	  1.	  INTRODUCTION	  
	  13	  
name	   a	   sycophantic	   character	   in	   ‘The	   Merchant’s	   Tale’.	   The	   main	   character	   is	  struck	   blind	   after	   only	   paying	   attention	   to	   his	   brother	   Placebo’s	   flattery	   and	  ignoring	  the	  cautionary	  advice	  of	  his	  other	  brother.	  	  	   Later,	  the	  use	  of	  a	  prop	  to	  distinguish	  ‘real’	  phenomena	  from	  the	  effects	  of	  the	  imagination	  was	  demonstrated	  in	  the	  Catholic	  Church	  in	  the	  16th	  century.	  The	  Catholic	  clergy	  attempted	  to	  discredit	  right-­‐wing	  exorcisms	  by	  administering	  fake	  procedures.	   Individuals	   claiming	   to	  be	   ‘possessed’	  by	   the	  Devil	  would	  be	  given	  a	  fake	   holy	   object.	   If	   they	   reacted	   with	   convulsions,	   it	   was	   concluded	   that	   the	  possession	  was	  ‘in	  their	  imagination’,	  (Kaptchuk	  et	  al.,	  2009).	  	  	   This	  historical	  combination	   led	  to	   the	  appearance	  of	   the	  word	   ‘placebo’	   in	  the	  medical	  profession,	  (de	  Craen	  et	  al.,	  1999).	  In	  the	  1700’s,	  the	  Oxford	  Dictionary	  defined	  a	  placebo	  as,	  	  	   “a	   pill,	   medicine,	   procedure	   etc.	   prescribed	   more	   for	   the	   psychological	  benefit	  of	  the	  patient	  being	  given	  a	  prescription	  than	  for	  any	  physiological	  effect,”	  (Oxford,	  1993).	  	  	  By	  the	  18th	  century	  physicians	  regularly	  prescribed	  placebo	  medication	  for	  the	  “satisfaction	  of	  the	  patient’s	  mind”	  and	  not	  with	  a	  view	  to	  producing	  any	  direct	  remedial	  effects,	  and	  during	  the	  17th,	  18th	  and	  19th	  centuries,	  the	  use	  of	  substances	  known	  to	  be	  inert	  by	  physicians	  remained	  commonplace,	  (Pepper,	  1945;	  Shpairo,	  1959).	   However,	   it	   wasn’t	   until	   1870,	   when	   leading	   neurologist	   Jean	   Martin	  Charcot	   turned	  his	   attention	   to	   a	   common	  disorder	   of	   the	   time	  named	   ‘hysteria’	  that	   the	   use	   of	   a	   placebo	   began	   to	   reflect	   negative	   beliefs	   about	   the	   patient.	  Physical	   symptoms	   of	   hysteria	   included	   paralyses,	   coughing	   and	   choking,	  blindness	  and	  convulsions.	  After	  investigation,	  Charcot	  announced	  he	  had	  found	  a	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neurological	  basis	  for	  the	  collection	  of	  symptoms,	  claiming	  the	  disease	  progressed	  in	   four	   stages	  with	   the	   ‘regularity	  of	   a	  mechanism’,	   (Charcot	  &	  Siegerson,	  1879).	  However,	   a	   rival	   named	   Bernheim	   used	   hypnosis	   to	   demonstrate	   the	   symptoms	  were	   not	   due	   to	   a	   neurological	   mechanism,	   but	   a	   result	   of	   the	   process	   of	  ‘suggestion’,	  (Bernheim,	  1890).	  	  Charcot’s	   reputation	   was	   left	   in	   tatters,	   with	   many	   believing	   his	   own	  patients	  had	  ‘hoodwinked’	  him.	  The	  controversy	  lead	  to	  the	  widespread	  belief	  that	  such	  bodily	  symptoms	  were	  a	  physiological	  ‘lie’	  and	  a	  tendency	  to	  dismiss	  a	  patient	  suffering	  from	  them	  as	  ‘neurotic’	  or	  ‘hypochondriacal’.	  Ironically,	  Bernheim	  offered	  his	  research	  as	  a	  foundation	  for	  a	  new	  kind	  of	  medicine	  that	  he	  called,	  ‘suggestive	  therapeutics’,	   including	   the	   emphasis	   that	   the	   effects	   of	   suggestion	   may	   have	  power	   in	   ‘real’	   disease	   as	  well	   as	   hysteria.	   However,	   this	  was	   overlooked	   in	   the	  furore	   surrounding	   Charcot’s	   debunking	   and	   the	   association	   of	   psychological	  based	  disease	  with	  hypochondria	  and	  sham	  ‘placebo’	  medicine	  was	  born.	  	  
	  1.2.2	   	  	  Medical	  Community	  and	  the	  Placebo	  –	  An	  Inert	  Tool	  
	  Until	   the	   1900’s	   only	   a	   handful	   of	   specific	   drugs	   were	   available	   in	   the	   medical	  profession.	  Even	  though	  psychological	   illness	  was	  believed	  to	  be	  a	  sham,	  doctors	  still	   had	   patients	   coming	   to	   them	   expecting	   to	   be	   treated.	   These	   patients	   were	  therefore	   given	   a	   ‘sham’	   pill	   to	   placate	   them.	   As	   a	   result,	   there	   are	   reports	   that	  placebo	  use	  was	  commonplace	  until	  the	  20th	  century,	  (Shapiro,	  1959).	  However,	  as	  biological	  knowledge	  grew	  during	  this	  century,	  the	  use	  of	  placebos	  as	  a	  comforter	  diminished	  and	  with	  the	  simultaneous	  advent	  of	  scientific	  method,	   the	  use	  of	   the	  placebo	  altered	  once	  more.	  In	  1937,	  the	  U.S.	  Food,	  Drug	  and	  Cosmetic	  Act	  required	  rigorous	  evidence	  of	  not	  only	  drug	  safety,	  but	  also	  drug	  efficacy,	  and	  therefore	  the	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clinical	  trial	  design	  needed	  to	  be	  improved.	  The	  result	  was	  the	  development	  of	  the	  Randomised	  Controlled	  Trial.	  	  The	  first	  time	  the	  word	  ‘placebo’	  was	  used	  in	  a	  randomised	  controlled	  trial	  was	   in	   1938,	   (Diehl	   et	   al.,	   1938),	   when	   it	   was	   used	   to	   distinguish	   the	   ‘genuine’	  effects	  of	  a	  drug	  from	  a	  ‘psychological’	  effect.	  Placebo	  effects	  were	  viewed	  as	  ‘noise’	  to	  be	   filtered	  out	  along	  with	  biases	  and	   judgement	  errors,	  statistical	  phenomena,	  spontaneous	   remission	   and	   other	   incidences	   of	   no	   medical	   interest.	   Playing	   a	  pivotal	   role	   in	   establishing	   the	   use	   of	   placebos	   in	   this	   way	  was	   a	  medic	   named	  Henry	  Beecher.	  Towards	  the	  end	  of	  World	  War	  II,	  morphine	  supplies	  were	  running	  low	  and	   in	  desperation	  Beecher	  administered	  a	  saline	  solution	   to	   injured	   troops.	  He	  noticed	   the	  soldiers	  appeared	   to	  genuinely	   feel	   less	  pain	  and	  upon	  his	   return	  began	  studying	  the	  phenomena.	  	  In	   1955,	   “The	   Powerful	   Placebo”	   was	   published	   in	   the	   Journal	   of	   the	  American	   Medical	   Association,	   (Beecher,	   1955).	   The	   article	   undertook	   a	   meta-­‐analysis	  to	  estimate	  the	  proportion	  of	  patients	  who	  demonstrated	  placebo	  effects	  in	  15	  controlled	  trials.	  The	  paper	  claimed	  placebo	  effects	  were	  real,	  physiological	  phenomenon	  and	  medicine	  had	  to	  protect	   itself	  against	   the	  placebos	   ‘obfuscating	  effects’.	   The	   paper	   has	   since	   been	   the	   target	   of	   heavy	   criticism,	   (de	   Craen	   et	   al.,	  1999).	   For	   example,	   critiques	   included	   the	   failure	   to	   take	   natural	   deterioration	  rates	  into	  account	  and	  the	  lack	  of	  control	  conditions.	  It	   is	  doubtful	  that	  the	  paper	  would	  be	  published	  today,	  however,	  at	   the	  time	  it	   ignited	  a	  raft	  of	   interest	   in	  the	  topic	   and	   was	   highly	   influential	   in	   establishing	   the	   clinical	   significance	   of	   the	  placebo	  effect	  within	  the	  medical	  community.	  During	   the	   1960’s	   and	   1970’s	   comparison	   against	   placebo	   in	   clinical	   trial	  became	   the	   gold	   standard	   for	   any	   new	   drug.	   In	   1970,	   the	   U.S.	   Food	   and	   Drug	  Administration	   cited	   that	   new	   drugs	   had	   to	   undergo	   clinical	   trials	   before	   being	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licensed,	   and	   over	   the	   next	   decade	   other	   countries	   and	   scientific	   journals	  made	  similar	  requirements.	  As	  a	  result,	  placebos	  were	  used	  in	  thousands	  of	  clinical	  trials	  and	  the	  data	  mounted	  up.	  However,	  due	  to	  ethical	  considerations	  and	  disinterest	  in	   the	   placebo	   itself,	   the	   trials	   rarely	   contained	   a	   no	   treatment	   control	   group	  thereby	  no	  direct	  evidence	  of	  the	  placebo	  effect	  was	  obtained.	  During	   this	   time,	   the	   medical	   world	   also	   saw	   an	   increasing	   regard	   for	  ethical	   considerations	   in	   general	   practice.	   By	   1990,	   General	   Practitioners	   were	  being	   encouraged	   to	  prescribe	  medicines	   that	   had	   a	   good	   clinical	   evidence	  base,	  (Jacobson	  et	  al,	  1997;	  Rosenburg	  &	  Donald,	  1995),	  and	  patients	  now	  had	  a	  right	  to	  informed	  consent	  and	  active	  participation	  in	  their	  treatment	  decisions.	  Placebos	  in	  medical	  practice	  were	  now	  publically	  viewed	  as	  a	  nuisance	  in	  clinical	  trials	  whilst	  being	  deceptive,	  unethical	  and	  out	  of	  place	  in	  clinical	  practice	  among	  the	  medical	  profession,	  (Wall,	  1992).	  As	  hostility	  towards	  placebos	  grew,	  so	  did	  claims	  that	  the	  placebo	   effect	   was	   simply	   an	   illusion	   and	   a	   result	   of	   methodological	   bias,	   (e.g.	  Kienle	  &	  Kiene,	  1997),	  and	  authors	  argued	  that	  a	  placebo	  is	  simply	  an	  inert	  prop	  into	  the	  current	  century,	  (Hrobjärtsson	  et	  al.,	  2001,	  2004).	  	  Although	   use	   of	   evidence	   based	   medicine	   is	   surprisingly	   low	   in	   practice,	  (Hardern	   et	   al.,	   2003;	  Prasad	  et	   al,	   2013),	   due	   to	   this	  part	   of	   its	   history,	  when	  a	  medic	  refers	  to	  a	  ‘placebo’	  they	  are	  generally	  referring	  to	  an	  effect	  observed	  in	  the	  control	   arm	  of	   a	   clinical	   trial,	   or	   a	  physical,	   inert	  prop	  used	   to	  placate	   a	  difficult	  patient.	  The	   ‘placebo	   response’,	   however,	   refers	   to	   something	  different.	  This	   is	   a	  phrase	  used	  by	  the	  academic	  community	  and	  encompasses	  the	  words	  and	  rituals,	  symbols	  and	  meanings	  used	  by	  the	  patient	  to	  interpret	  the	  world	  around	  them	  and	  to	   assess	   most	   their	   appropriate	   response,	   (Carlino	   &	   Benedetti,	   2014).	   The	  development	  of	  this	  interpretation	  followed	  a	  different	  historical	  route.	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  1.2.3	   Academic	  Research	  –	  An	  Active	  Human	  Response	  
	  Whilst	   the	  medical	  profession	  established	   the	  placebo	  as	  a	  useful	   tool	  within	   the	  context	   of	   the	   clinical	   trial,	   the	   academic	   research	   community	   focussed	  more	   on	  the	   actual	   response	   a	   placebo	   prop	   could	   elicit	   from	   a	   human	   being.	   In	   1950,	  Stewart	  Wolf	  questioned	  the	  ecological	  validity	  of	  biomedical	  research,	  suggesting	  the	   beginnings	   of	   a	   split	   from	   the	   medical	   standpoint	   regarding	   placebo	   use.	  Although	  working	  in	  the	  medical	  community,	  instead	  of	  viewing	  the	  placebo	  as	  an	  inert	   prop,	  Wolf	   concentrated	   on	   the	   process	   occurring	   in	   the	   placebo	   recipient,	  describing	  how,	  
	  	   “The	  mechanisms	   of	   the	   human	   body	   are	   capable	   of	   reacting	   not	   only	   to	  direct	  physical	   and	  chemical	   stimulation	  but	  also	   to	   symbolic	   stimuli,	  words	  and	  events	  which	  have	  somehow	  acquired	  special	  meaning	   for	   the	   individual,”	   (Wolf,	  1950,	  p.	  108)	  
	  This	  definition	  is	  important	  as	  an	  understanding	  of	  the	  term	  ‘inert’	  substance	  is	  not	  required.	  Instead,	  psychological	  influences	  form	  just	  one	  of	  a	  number	  of	  influences	  on	  “the	  end	  state	  of	  the	  organ”.	  The	  resulting	  shift	  in	  focus	  away	  from	  the	  placebo	  ‘prop’	  towards	  the	  psychologically	  active	  process	  in	  a	  human	  being	  implies	  that,	  in	  reality,	   placebo	  mechanisms	  have	   a	   role	   in	   all	   clinical	   contexts,	   not	   just	  where	   a	  placebo	  ‘prop’	   is	  used	  in	  a	  clinical	  trial	  group.	  As	  humans	  are	  not	  “tissue	  on	  a	  lab	  slide”	  it	  is	  impossible	  to	  eradicate	  these	  processes	  in	  any	  given	  context.	  	  	   A	   few	  years	   later,	   the	   interest	   ignited	  by	  Beecher’s,	   (1955),	   “The	  Powerful	  Placebo”	  not	  only	  contributed	  to	  the	  development	  of	  the	  placebo	  controlled	  clinical	  trial,	   but	   also	   prompted	   further	   academic	   research	   into	   the	   human	  mechanisms	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behind	   the	  placebo	   response.	   Large	  numbers	  of	   clinical	   trials	  meant	   there	  was	   a	  growing	  amount	  of	  data	  demonstrating	  a	  placebo	  response,	  but	  the	  infrequent	  use	  of	   a	   control	   group	  meant	   it	  was	   impossible	   to	   separate	   actual	   placebo	   response	  from	  other	  phenomena	  such	  as	  regression	  to	  mean,	  natural	  history	  etc.	  Academic	  researchers	   therefore	   had	   to	   collect	   their	   own	   empirical	   evidence	   in	   order	   to	  separate	   the	   result	   of	   psychological	   mechanisms	   from	   other	   statistical	   noise,	  (Fields	  &	  Levine,	  1981).	  	  	   In	   1962,	   Liberman	   gave	   one	   of	   the	   first	   formal	   definitions	   of	   the	   placebo	  response.	  This	  definition	  focussed	  on	  the	  psychological	  complexity	  of	  the	  response	  rather	  than	  the	  prop	  itself	  by	  suggesting	  that,	  
	  	   “Any	   change	   in	   a	   patient’s	   signs	   or	   symptoms	   which	   is	   the	   result	   of	   the	  therapeutic	   intent,	   and	   not	   the	   specific	   physio-­‐chemical	   nature	   of	   a	   medical	  procedure	   can	   be	   called	   a	   placebo	   effect…………	  The	   effects	   of	   a	   placebo	  may	   be	  quite	  physical	  and	  objective,	  like	  the	  action	  of	  the	  adrenal	  gland	  or	  the	  secretion	  of	  gastral	  juice,	  however,	  these	  effects	  are	  mediated	  by	  the	  brain	  and	  are	  dependent	  on	   the	   individual’s	   ability	   to	   comprehend	   the	   cultural	   symbols,	   (such	   as	   pills,	  hospitals,	   injections	   and	   so	   forth),	   which	   give	   meaning	   to	   the	   patient-­‐doctor	  relationship,”	  (Liberman,	  1962,	  pg	  761).	  	  
	   This	  definition	  is	  important	  as,	  further	  to	  Stewart	  Wolf’s,	  (1950),	  definition,	  it	   also	   states	   that	   the	   placebo	   doesn’t	   have	   to	   be	   an	   inert	   prop.	   Instead,	   it	  emphasises	   the	   psychological	   mediation	   of	   the	   placebo	   response	   and	   how	   it	   is	  meaning	  orientated.	  Within	  academic	  circles,	  the	  placebo	  effect	  began	  to	  be	  seen	  as	  an	  active	  human	  response	  rather	  than	  ‘noise’	  to	  be	  filtered	  out	  of	  a	  clinical	  trial	  and	  research	   programs	   designed	   specifically	   to	   investigate	   this	   phenomenon	   were	  commenced.	  
CHAPTER	  1.	  INTRODUCTION	  
	  19	  
The	  early	  pioneers	  of	  placebo	  research	   largely	   focussed	  exclusively	  on	  the	  effect	  of	  a	  placebo	  on	  the	  perception	  of	  pain,	  and	  placebo	  analgesia	  remains	  one	  of	  the	   most	   well	   documented	   placebo	   phenomena	   in	   both	   academic	   and	   clinical	  environments,	   (Montgomery	   &	   Kirsch,	   1997;	   Colloca	   &	   Benedetti,	   2006;	   Tracey,	  2010).	  American	  gastroenterologist,	  Howard	  Spiro	  wrote,	  	  
	   “To	  talk	  about	  placebos	  is	  to	  talk	  in	  large	  part	  about	  pain”,	  (Spiro,	  1997,	  p.	  37).	  	  
	  However,	   a	   variety	   of	   other	   conditions	   that	   are	   susceptible	   to	   a	   placebo	  response	   have	   also	   been	   identified.	   These	   range	   from	   nausea,	   headaches	   and	  changes	   in	   blood	   pressure,	   (Geers	   et	   al.,	   2005a,	   2006),	   through	   to	   medical	  complaints	   such	   as	   anxiety	   and	   depression,	   (Schapira	   et	   al.,	   1970;	   Kirsch	   &	  Sapirstein	   1998),	   asthma,	   (Kemeny	   et	   al.,	   2007)	   and	   Parkinson’s	   disease,	   (de	   la	  Fuente-­‐Fernández	  et	  al.,	  2001;	  Benedetti	  et	  al.,	  2004).	  More	  recently,	  other	  human	  functions	   such	   as	   sense	   of	   taste,	   (Nitschke	   et	   al.,	   2013)	   and	   implicit	   learning,	  (Colaguiri	  et	  al.,	  2011)	  have	  also	  been	  found	  to	  be	  potentially	  placebo	  responsive.	  	  As	  well	  as	  perceptual	  changes,	  chemical	  changes	  in	  the	  body	  in	  response	  to	  a	  placebo	  have	  also	  been	  identified.	  For	  example,	  Benedetti	  et	  al.,	  (2014),	  showed	  chemical	  changes	  to	  PGE2	  levels	  in	  the	  blood	  at	  high	  altitude	  when	  participants	  are	  given	   placebo	   oxygen,	   and	  Wager	   et	   al.,	   (2004),	   demonstrated	   changes	   in	   brain	  activity	  shown	  on	  an	  fMRI	  scan	  when	  participants	  are	  given	  a	  placebo	  analgesic.	  	  In	  the	  early	  years	  of	  academic	  research,	  there	  was	  also	  a	  lot	  of	  focus	  on	  the	  search	   to	   identify	   a	   ‘placebo	   responder’.	   Liberman	   (1962)	   describes	   a	   placebo	  responder	  as	  someone	  who	  should,	  “respond	  to	  a	  placebo	  regardless	  of	  where	  he	  was	   or	   who	   was	   administering	   it,”	   (p.	   772).	   The	   search	   was	   on	   for	   a	   trait	  characteristic	  within	  a	  person	  that	  would	  be	  able	  to	  predict	  a	  placebo	  response.	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   Some	   later	   studies	  have	   found	  evidence	   for	   individual	   characteristics	   that	  can	   lead	   to	   greater	   placebo	   response.	   For	   example,	   Geers	   et	   al.,	   (2005b),	   found	  optimists	   showed	   greater	   placebo	   response	   but	   not	   nocebo	   response,	   (in	   which	  negative	   instead	   of	   positive	   symptoms	   are	   experienced	   as	   a	   result	   of	   a	   placebo	  administration).	   In	   an	   extensive	   review	   of	   placebo	   personality	   literature,	   Fisher	  and	  Greenberg,	  (1997),	  also	  found	  acquiescence	  was	  an	  empirically	  consistent	  trait	  in	  placebo	  response.	  However,	  overall	  inconsistencies	  in	  the	  data	  over	  a	  number	  of	  years	   led	   to	   the	   conclusion	   that	   the	   ‘placebo	   responder’	   doesn’t	   exist,	   (Brody,	  2000;	  Kaptchuk	   et	   al.,	   2008).	   Instead	  of	   internal,	   stable	   traits	   predicting	  placebo	  response,	   it	   was	   thought	   more	   likely	   that	   external,	   situational	   determinants	  predicted	  response,	  (Horing	  et	  al.,	  2014).	  	  During	   the	   course	   of	   the	   1960’s	   and	   1970’s,	   ranges	   of	   such	   contextual	  variables	   were	   identified.	   For	   example,	   coloured	   pills	   were	   more	   effective	   than	  white,	   (Blackwell	   et	   al.,	   1972),	   injections	   were	   found	   to	   be	   more	   effective	   than	  tablets,	  (Grenfell	  et	  al.,	  1961),	  the	  branding	  written	  on	  the	  placebo,	  (Branthwaite	  &	  Cooper,	   1981),	   and	   even	   ‘sham’	   surgery	   was	   shown	   to	   produce	   a	   response,	  (Dimond	  et	  al.,	  1960).	  More	  recently,	  even	  factors	  such	  as	  viewed	  facial	  expression	  have	  been	  shown	  to	  alter	  placebo	  response,	  (Valentini	  et	  al.,	  2014).	  Moerman	   and	   Jonas	   (2002)	   used	   this	   evidence	   to	   argue	   that	   it	   is	   the	  meaning	   a	   human	   being	   derives	   from	   contextual	   factors	   based	   on	   cultural	   and	  environmental	  factors	  that	  elicit	  a	  placebo	  response.	  They	  argued	  that	  the	  placebo	  effect	  should	  be	  reconceptualised	  in	  terms	  of	  a	  ‘meaning	  response’,	  and	  proposed	  the	  placebo	  effect	  should	  be	  defined	  as,	  
	  	   “	   the	   physiologic	   or	   psychological	   effects	   of	   meaning	   in	   the	   origins	   or	  treatment	  of	  illness,”	  (p.	  472).	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   This	   proposal	   is	   important	   as	   Moerman	   argues	   human	   beings	   can	   never	  avoid	  contextual	  meaning	  completely,	  even	  in	  a	  medical	  or	  laboratory	  setting.	  Even	  slight	   differences	   in	   context	   in	   the	   administration	   of	   medication	   or	   laboratory	  placebos	  can	  produce	  differences	   in	  response	   if	  a	  different	  meaning	   is	  associated	  with	   them	   by	   the	   recipient.	   More	   recent	   experiments	   have	   also	   supported	   the	  notion	   that	   the	   placebo	   response	   comprises	   of	   a	   ‘state’	   rather	   than	   trait	  characteristics.	   For	   example,	   in	   a	   study	   comparing	   different	   types	   of	   placebo	  effects,	   Kong	   et	   al.,	   (2013),	   concluded	   that	   individuals	   may	   respond	   to	   unique	  healing	  rituals	  in	  different	  ways.	  Building	  on	  this,	  other	  research	  has	  proposed	  an	   integration	  of	   the	  role	  of	  personality	   traits	   and	   environmental	   factors,	   proposing	   placebo	   response	   is	   a	  result	  of	  an	  interaction	  between	  a	  person	  and	  their	  environment,	  with	  personality	  and	  situational	  factors	  interacting	  to	  produce	  a	  response,	  (Geers	  et	  al.,	  2005b).	  For	  example,	   optimism	   may	   be	   moderated	   by	   goal	   prioritisation	   and	   the	   personal	  relevance	  of	   cognitive	   information,	   (Geers	   et	   al.,	   2003).	  Other	  personal	   variables	  that	  can	  moderate	  the	  placebo	  effect	  have	  also	  been	  identified.	  For	  example,	  choice	  of	  placebo	  treatment,	  (Geers	  &	  Rose,	  2011),	  and	  increasing	  somatic	  focus,	  (Geers	  et	  al.,	  2006),	  have	  been	  shown	  to	  increase	  placebo	  responding.	  Conversely,	  increasing	  awareness	  by	  informing	  the	  participant	  that	  there	  is	  a	  possibility	  they	  may	  receive	  a	   placebo,	   (Geers	   et	   al.,	   2006),	   and	   ‘naturally-­‐derived’	   experience	   with	   the	  experimental	  stimulus,	  (Geers	  et	  al.,	  2014),	  have	  been	  shown	  to	  decrease	  placebo	  response.	  In	  addition,	  gender	  has	  also	  been	  shown	  to	  moderate	  placebo	  effects.	  For	  example,	   Aslaksen	   et	   al.,	   (2011),	   and	   Flaten	   et	   al.,	   (2006),	   found	   an	   analgesic	  placebo	   response	   in	   males,	   but	   not	   in	   females.	   More	   recently,	   the	   search	   for	   a	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genetic	   marker	   indicating	   predisposition	   to	   placebo	   effects	   has	   also	   just	   begun,	  (Hall	  et	  al.,	  2015).	  Viewing	   the	   placebo	   response	   as	   a	   psychologically	   mediated	   event	   as	  opposed	  to	  an	  inert	  prop	  led	  researchers	  to	  identify	  and	  isolate	  a	  specific	  placebo	  response,	   and	   to	   then	   identify	   a	   large	   number	   of	   factors	   that	   can	   influence	   this	  response.	  Research	  has	  identified	  that	  a	  placebo	  may	  elicit	  a	  response	  in	  a	  human	  being	   in	  a	  number	  of	  different	  ways,	   and	  be	   influenced	  by	  a	  number	  of	  different	  variables,	   but	   how	   does	   this	   work?	   A	   number	   of	   alternative	   psychological	  mechanisms	  were	  put	  forward	  to	  explain	  this	  phenomenon.	  	  
	  1.3 Traditional	  Psychological	  Mechanisms	  
	  1.3.1 Conditioning	  Theory	  	  A	  number	  of	  early	  psychological	  theories	  of	  placebo	  responding	  were	  put	  forward,	  for	   example,	   perceptual	   filtering	   in	   Attribution	   Theory,	   (Zanna	   &	   Cooper,	   1974;	  Storms	  &	  Nisbett,	  1970)	  and	  Self-­‐Efficacy	  Theory,	  (Bandura,	  1977).	  However,	  two	  predominant	   theories	   led	   research	   efforts	   in	   the	   1980’s	   and	   1990’s.	   These	  were	  conditioning	   theory,	   (Wickramasekera,	   1980;	   Voudouris	   et	   al.,	   1985),	   and	  response	  expectancy	  theory,	  (Kirsch,	  1985).	  Conditioning	   accounts	   of	   the	   placebo	   response	   involve	   a	   form	   of	   non-­‐conscious,	   automated	   learning,	   and	   suggest	   that	   neutral	   places,	   persons,	  procedures	   and	   objects,	   (the	   conditioned	   stimulus),	   become	   associated	   with	   an	  active	   stimuli	   such	   as	  medication,	   (the	   active	   stimulus).	   The	   conditioned	   stimuli	  then	   acquires	   similar	   therapeutic	   properties	   to	   those	   associated	  with	   the	   active	  treatment,	   resulting	   in	   the	  placebo	  effect	  as	  a	  conditioned	  response.	  The	  method	  by	   which	   associations	   between	   stimuli	   are	   formed	   is	   via	   the	   non-­‐conscious	  
CHAPTER	  1.	  INTRODUCTION	  
	  23	  
activation	  of	  automatic	   links	  between	  stimuli.	  This	  method	  of	   learning	   is	   seen	  as	  requiring	  only	  automatic,	  low-­‐level	  processing.	  	   The	   first	   documented	   conditioned	   placebo	   response,	   (although	   not	  explained	   as	   such),	  was	   found	  by	  Glaser	   and	  Whittow,	   (1953,	   1954).	   In	   subjects	  given	   a	   drug	   with	   an	   unpleasant	   side	   effect,	   the	   subsequent	   application	   of	   a	  placebo	  with	  identical	  physical	  features	  produced	  a	  similar	  response.	  	   	  In	   1980,	   Wickramasekera	   put	   forward	   a	   two-­‐stage	   model	   and	   made	  predictions	  based	  on	  the	  use	  of	  conditioned	  stimuli.	  Voudouris	  et	  al.	  (1985,	  1989)	  then	   developed	   this	   model	   by	   demonstrating	   that	   both	   analgesic	   and	   algesic	  responses	   could	   be	   produced	   by	   use	   of	   placebo	   creams.	   Voudouris	   and	   his	  colleagues	  utilised	  a	  highly	  controllable	  method	  of	  pain	  application,	  which	  used	  an	  electrical	  current	  to	  drive	  potassium	  ions	  into	  the	  skin.	  Subjects	  were	  exposed	  to	  a	  series	  of	  learning	  trials	  within	  the	  experiment	  whereby	  when	  a	  placebo	  cream	  was	  applied,	   unbeknown	   to	   the	   participants,	   the	   pain	   stimulus	   was	   turned	   down.	   In	  later	  trials	  when	  a	  placebo	  cream	  was	  applied	  but	  the	  pain	  stimulus	  remained	  at	  its	  original	  level,	  participants	  still	  reported	  a	  reduction	  in	  pain	  levels.	  	   Although	   relatively	   rare	   in	   humans,	   (Kirsch,	   2004),	   other	   examples	   of	  conditioned	   placebos	   can	   be	   found	   in	   the	   literature.	   For	   example,	   Flaten	   et	   al.,	  (2004),	   found	  a	   conditioned	  placebo	  muscle	   relaxant	   altered	  eye	  blink	   response,	  and	   Colloca	   and	   Benedetti,	   (2006),	   reviewed	   evidence	   demonstrating	   a	  conditioned	   respiratory	   suppression	   response	   to	   the	   hidden	   administration	   of	  opiates.	   A	   small	   number	   of	   other	   such	   studies	  meant	   that	   classical	   conditioning	  was	  argued	  as	  a	  placebo	  mechanism	  in	  its	  own	  right.	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1.3.2 Response	  Expectancy	  Theory	  
	  The	  other	  predominant	  theory	  of	  the	  1980’s	  and	  1990’s	  was	  response	  expectancy	  theory,	   (Kirsch,	  1985).	  Kirsch	  defines	  a	  response	  expectancy	  as	   the,	   “anticipation	  of	  automatic,	  subjective	  and	  behavioural	  responses	  to	  particular	  situational	  cues,”	  (Kirsch,	  1997,	  p.	  69).	  	   Response	   expectancies	   are	   distinguishable	   from	   stimulus	   expectancies	   as	  they	   refer	   to	   the	   expected	   occurrence	   of	   a	   non-­‐volitional	   internal	   event,	   rather	  than	  an	  external	  event.	  These	  internal	  response	  expectancies	  are	  claimed	  by	  Kirsch	  to	  be,	  “directly	  self-­‐confirming”,	  (Kirsch,	  1997,	  p.	  69).	  In	  other	  words,	  they	  directly	  generate	   subjective	   experience.	   Response	   expectancies	   take	   the	   form	   of	   self-­‐fulfilling	  prophecies,	  and	  they	  are	  claimed	  to	  be	  immediate	  and	  unmediated	  causes	  of	  the	  placebo	  response.	  	  	   The	   exact	   details	   of	   how	   the	   cognitive	   experience	  of	   response	   expectancy	  determines	  physiological	  experience	  are	  unspecified,	  however,	  it	  is	  argued	  that	  no	  other	   psychological	   variables	   are	   required	   to	   explain	   behaviour.	   Changes	   in	  experience	   are	   said	   to	   be	   substantiated	   by	   changes	   in	   volitional	   behaviour	   and	  physiological	   function;	  changes	   in	  physiological	  effects	  are	  said	   to	  occur	  due	   to	  a	  singular	  mind-­‐body	  assumption	  whereas	  effects	  on	  volitional	  behaviour	  are	  said	  to	  occur	  due	  to	  the	  positive	  /	  negative	  reinforcement	  of	  non-­‐volitional	  responses.	  	  	   Extensive	  evidence	  has	  demonstrated	  that	  consciously	  accessible	  response	  expectancies	   are	   predictive	   of	   a	   wide	   range	   of	   placebo	   responses,	   (see	   Kirsch,	  1997,	  and	  Kirsch,	  1999,	   for	  a	  review),	  and	  response	  expectancy	  theory	  remained	  the	  dominant	  view	  of	  placebo	  response	  for	  a	  number	  of	  years.	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1.3.3 The	  Conditioning	  verses	  Response	  Expectancy	  Debate	  
	  The	  conditioning	  verses	  cognitive	  accounts	  of	  the	  placebo	  phenomenon	  generated	  a	  ferocious	  debate.	  Voudouris	  et	  al.	  (1989)	  claimed	  that	  conditioning	  effects	  were	  stronger	  than	  cognitive	  expectancy	  effects	  after	  repeating	  their	  initial	  experiment	  but	  increasing	  the	  pain	  stimuli	  at	  the	  first	  placebo	  analgesic	  application	  instead	  of	  decreasing	  it,	  thereby	  producing	  conflicting	  information	  for	  the	  participant.	  Verbal,	  cognitive	   information	   led	   participants	   to	   believe	   they	   would	   experience	   a	  reduction	  in	  pain,	  while	  their	  physiological	  experience	  would	  lead	  to	  an	  increase	  in	  pain.	   Voudouris	   found	   the	   physiological	   experience	   had	   the	   strongest	   effect	   and	  any	   placebo	   effect	   induced	   by	   cognitive	   information	   disappeared	   in	   these	  circumstances.	  	   However,	   Montgomery	   and	   Kirsch,	   (1997),	   also	   repeated	   Voudouris	   and	  colleagues’	   initial	  experiment.	  This	   time	  one	  group	  was	  told	   that	   the	  pain	  stimuli	  was	   being	   turned	   down,	   thus	   cognitively	   attributing	   pain	   reduction	   to	   the	   pain	  machine,	  not	  the	  cream.	  The	  placebo	  response	  disappeared	  in	  this	  group,	   leading	  Montgomery	   and	   Kirsch	   to	   claim	   it	   was	   the	   interpretation	   of	   the	   conditioning	  trials,	   rather	   than	   the	   trials	   themselves,	   that	   affected	  placebo	   responding.	  Kirsch	  (2004)	  went	  on	  to	  suggest	  that	  conditioning	  may	  be	  conceived	  of	  as	  a	  special	  form	  of	   expectancy,	   with	   the	   conditioning	   paradigm	   being	   just	   one	   way	   in	   which	  expectancies	  can	  be	  generated.	  	  	   A	  large	  body	  of	  further	  research	  followed.	  In	  summary,	  it	  found	  consciously	  mediated	   response	   expectancies	   tend	   to	   be	   stronger	   than,	   and	   override,	  conditioning	   effects,	   (for	   example,	   Montgomery	   &	   Kirsch,	   1997).	   Kirsch	   (2004)	  argues	   this	   may	   be	   due	   to	   an	   ecological	   advantage	   of	   the	   cognitive	   function	   of	  expectancies.	  However,	  eliciting	  conditioned	  placebo	  effects	  without	  the	  presence	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of	   conscious	   expectancies	   is	   possible,	   therefore	   response	   expectancies	   cannot	  be	  seen	  as	  a	  complete	  explanation	  of	  the	  placebo	  response,	  (Benedetti	  et	  al.,	  1999).	  In	  addition,	   the	   presence	   of	   a	   response	   expectancy	   doesn’t	   always	   lead	   to	   a	  corresponding	  change	  in	  actual	  response,	  (Walach	  et	  al.,	  2002).	  However,	  there	  is	  evidence	   that	   anything	   that	   increases	   response	   expectancy,	   for	   example,	  situational	  variables,	  (Moerman,	  2002),	  and	  the	  presence	  of	  others,	  (Mazzoni	  et	  al.,	  2010),	  may	  increase	  the	  placebo	  response.	  	  	   In	  2004,	  Stewart-­‐Williams	  and	  Podd	  stated,	  	   “The	   literature	   suggests	   that	   classical	   conditioning	   procedures	   are	   one	  shaping	   factor	   but	   that	   verbal	   information	   can	   also	   shape	   placebo	   effects.	   The	  literature	   also	   suggests	   that	   conditioning	   procedures	   and	   other	   sources	   of	  information	  sometimes	  shape	  conscious	  expectancies	  and	  that	  these	  expectancies	  mediate	   some	   placebo	   effects;	   however,	   in	   other	   cases	   conditioning	   procedures	  appear	   to	   shape	   placebo	   effects	   that	   are	   not	   mediated	   by	   conscious	   cognition,”	  (Stewart-­‐Williams	  and	  Podd,	  2004a,	  p.	  324).	  	  	  Stewart-­‐Williams	   and	   Podd	  went	   on	   to	   suggest	   that	   response	   expectancy	  and	   conditioning	   mechanisms	   need	   not	   be	   mutually	   exclusive,	   (this	   is	   further	  discussed	   in	   section	   1.4).	   Although	   the	   conditioning	   verses	   response	   expectancy	  debate	   dominated	   placebo	   literature	   at	   that	   time,	   other	   accounts	   of	   the	   placebo	  effect	  were	   also	   posited.	   These	   included	  motivational	   and	   biological	   accounts	   of	  the	  placebo	  effect.	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1.3.4 Motivational	  Theories	  	  
	  Motivational	   accounts	   were	   also	   posited	   at	   the	   time	   the	   conditioning	   verses	  response	  expectancy	  debate	  was	  raging,	  yet	  were	  largely	  overlooked,	  (Amanzio	  &	  Benedetti,	  1999).	  However,	  these	  accounts	  are	  now	  experiencing	  renewed	  interest	  in	  the	  placebo	  literature.	  Early	  motivational	  theories	  held	  the	  placebo	  response	  to	  be	  an	  outcome	  of	  one’s	  desire	  to	  experience	  the	  placebo	  effect,	  (for	  example,	  Price	  &	  Fields,	   1997),	   or	   as	   the	   effect	   of	   self-­‐enhancing	  motives,	   (Gibbons	  &	  Gaeddert,	  1984).	  	   Although	  relatively	  scarce,	  data	  investigating	  participant	  motivation	  shows	  some	   support	   for	   this	   viewpoint.	   For	   example,	   Jensen	   and	   Karoly,	   (1991),	   gave	  participants	  sedatory	  placebo	  pills	  whilst	  manipulating	  the	  desire	  to	  feel	  the	  effect	  of	   the	   tablet	   by	   linking	   either	   positive	   or	   negative	   personality	   traits	   to	   the	  response.	   Jensen	  and	  Karoly	  found	  a	  stronger	  placebo	  response	  when	  motivation	  to	   respond	  was	   present.	   	   In	   addition,	   in	   a	   study	   investigating	   placebo	   effects	   in	  patients	   with	   Irritable	   Bowel	   Syndrome,	   Vase	   et	   al.,	   (2003),	   demonstrated	   an	  interaction	  between	  the	  desire	  for	  pain	  relief	  and	  expected	  pain	  relief	  contributed	  to	  the	  amount	  of	  pain	  reported.	  	   In	  1999,	  Price	   and	   colleagues	   also	   attempted	   to	  demonstrate	   the	   effect	   of	  motivation	   on	   placebo	   response.	   They	   manipulated	   the	   amount	   of	   pain	  participants	  were	  told	  they	  would	  be	  experiencing,	  anticipating	  that	  the	  higher	  the	  level	   of	   pain	   a	   participant	   expected,	   the	   more	   motivated	   they	   would	   be	   to	  experience	  the	  benefits	  of	  a	  placebo	  analgesic.	  However,	  this	  study	  found	  no	  effect	  of	   the	   motivation	   manipulation,	   possibly	   due	   to	   confounding	   factors	   such	   as	  altered	  expectation,	  altered	  mood	  and	  helplessness.	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   Geers	  et	  al.	  (2005a)	  also	  conducted	  a	  series	  of	  experiments	  supporting	  the	  hypothesis	  that,	  “to	  predict	  placebo	  responding,	  one	  must	  jointly	  consider	  the	  role	  of	  goals	  and	  expectations,”	  (Geers	  et	  al.,	  2005a,	  p.	  145).	  Here,	  Geers	  proposed	  that	  an	   individual’s	   currently	   active	   goal	   drives	   the	   extent	   to	   which	   expectations	  determine	   the	   placebo	   response.	   A	   broad	   assortment	   of	   goals	   may	   be	   activated	  consciously	  or	  non-­‐consciously.	  It	   is	  hypothesised	  that	  a	  strong	  placebo	  response	  is	  therefore	  the	  combination	  of	  a	  placebo	  expectation	  and	  a	  compatible	  goal.	  	   The	  experiments	  supporting	  this	  claim	  studied	  a	  range	  of	  placebo	  responses	  in	  sleep	  quality,	  feeling	  state	  and	  caffeine	  related	  symptoms	  whereby	  the	  goal	  for	  the	   placebo	   to	   work	   was	   activated	   non-­‐consciously.	   All	   experiments	   not	   only	  supported	  the	  theory	  that	  goals	  moderate	  placebo	  response,	  but	  in	  four	  out	  of	  five	  experiments,	  there	  was	  no	  effect	  of	  placebo	  expectation	  without	  the	  presence	  of	  an	  activated	  goal.	  	  	   Following	   this	   research,	   Motivational	   Concordance	   theory,	   (Hyland	   &	  Whalley,	   2008),	   suggested	   that	   the	   positive	   mood	   resulting	   from	   carrying	   out	  intrinsically	  rewarding	  rituals	  or	  health	  behaviours	  can	  result	  in	  the	  manifestation	  of	   the	   placebo	   response.	   A	   later	   review	   concludes	   that	   whereas	   response	  expectancy	   theory	   explains	   short-­‐term	   laboratory	   based	   responses,	  motivational	  concordance	  theory	  provides	  a	  better	  explanation	  for	  the	  response	  found	  in	  long-­‐term	   clinical	   contexts	  where	   participants	   are	  more	   highly	  motivated	   to	   improve	  their	  health,	  (Hyland,	  2011).	  	   However,	  motivation	  may	  still	  have	  a	  role	  in	  generating	  placebo	  response	  in	  the	  laboratory.	  Aigner	  and	  Svanum	  (2014)	  recently	  put	  forward	  one	  mechanism	  by	  which	  motivation	  may	  moderate	  expectation	  in	  a	  short-­‐term	  laboratory	  context.	  In	   their	  Motivation-­‐Attention	  model	   of	   placebo	   responding,	   the	   authors	   propose	  that	  motivated	   persons	   pay	   greater	   attention	   to	   placebo	   related	   stimuli,	   thereby	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altering	   the	   placebo	   response.	   In	   this	   model,	   attention	   is	   the	   mediating	   factor	  between	  motivation	  and	  response.	  
	  1.3.5 Biological	  Accounts	  
	  Interest	   in	   biological	   mechanisms	   of	   placebo	   response,	   particularly	   placebo	  analgesia,	   began	   in	   the	   1960’s	   and	   1970’s.	   Evidence	   from	   molecular	   imaging	  studies	  using	  positron	  emission	   tomography,	   (PET),	   found	  placebo	  analgesia	   can	  be	  mediated	  by	   the	   release	  of	  endogenous	  neuromodulators	   such	  as	  opioids	  and	  dopamine,	   (for	   example,	   Levine	   et	   al.,	   1978).	   Drugs	   that	   reverse	   the	   effect	   of	  morphine	   have	   also	   been	   found	   to	   reverse	   the	   conditioned	   effect	   of	   placebo	  analgesics,	  (Watkins	  et	  al.,	  1982).	  	  Subsequent	   technological	   developments,	   such	   as	   functional	   Magnetic	  Resonance	  Imaging,	  (fMRI),	  scans	  have	  led	  to	  the	  corroboration	  of	  the	  involvement	  of	  endogenous	  opioid	  and	  cannaboid	  systems,	  (Benedetti	  et	  al.,	  2011).	  A	  review	  by	  Price	   and	   Soerensen,	   (2002),	   leads	   to	   the	   conclusion	   that	   pain	   systems	  may	   be	  activated	  via	  cognitive	  and	  emotional	   input,	  not	   just	  tissue	  damage.	  Colloca	  et	  al.,	  (2013),	  describe	  how,	  
	  “Psychological	   mechanisms	   such	   as	   verbally-­‐induced	   expectations,	   cued	  and	  contextual	  conditioning	  and	  social	  learning	  trigger	  the	  cascade	  of	  endogenous	  opioids	  and	  non-­‐opioids.	  The	  result	  is	  an	  alteration	  of	  the	  pain	  experience	  that,	  at	  least	  in	  part,	  induces	  an	  active	  inhibition	  of	  nociceptive	  activity	  and	  modulation	  of	  brain	  areas	  predicting	  placebo	  response,”	  (p.	  512).	  
	  Another	   physiological	   area	   studied	   in	   relation	   to	   the	   placebo	   response	   is	  Psychoneuroendocrine	   Immunology.	   Eskandari	   and	   Sternberg	   (2002)	   review	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literature	  detailing	  how	   the	  HPA,	   (Hypothalamic-­‐pitutary-­‐adrenal),	   axis	  dampens	  immune	  responses	  via	  secretion	  of	  anti-­‐inflammatory	  glucocorticoids	  from	  adrenal	  glands,	  while	  branches	  of	  the	  autonomic	  nervous	  system	  regulate	  immune	  organs,	  such	  as	  the	  spleen,	  regionally.	  Peripheral	  nerves	  also	   influence	   immune	  response	  at	   sites	   of	   inflammation	   via	   release	   of	   neuropeptides.	   This	   ‘cross-­‐talk’	   among	  neurons,	  endocrine	  and	  immune	  cells	  enables	  fine	  tuning	  of	  immune	  response.	  It	  is	  reasonable	  to	  assume	  that	  signals	  from	  the	  cognitive	  and	  emotional	  centres	  in	  the	  brain	  tap	  into	  these	  systems.	  There	   have	   also	   been	   attempts	   to	   link	   personality	   traits	   with	   biological	  mechanisms.	   For	   example,	   higher	   levels	   of	   endogenous	   opioids	   have	   been	  observed	   in	   participants	   who	   score	   highly	   in	   measures	   of	   agreeableness	   and	  resilience,	  (Petchina	  et	  al.,	  2012).	  Perhaps	   the	   potential	   integration	   of	   biological	   mechanisms	   behind	   the	  placebo	   response	   shouldn’t	   come	   as	   a	   surprise.	   If	   a	  manufactured	   drug,	   such	   as	  morphine,	  works	  on	  the	  human	  body	  then	  there	  must	  be	  a	  biological	  receptor	  site	  for	   it	   in	  the	  brain.	  If	  there	  is	  a	  receptor	  site	  for	   it,	   there	  must	  be	  a	  corresponding	  endogenous	  chemical	  manufactured	  in	  the	  body.	  That	  chemical	  could	  be	  released	  under	  psychologically	  mediated	  conditions.	  Viewed	  in	  this	  way,	  the	  brain	  has	  the	  potential	   to	   release	   a	   large	   range	   of	   naturally	   occurring	   chemicals,	   with	   effects	  ranging	  from	  energy	  and	  sleep	  regulation	  through	  to	  pain	  modulation.	  The	  release	  of	   these	   chemicals	   can	   be	   based	   on	   psychologically	   mediated	   events	   enabling	  humans	   to	   adapt	   to	   internal	   and	   external	   needs	   based	   on	   psychological	  interpretation,	   (Wager,	  2011).	  The	  biological	  models	   largely	   ignore	  psychological	  antecedents	   in	   their	   search	   for	   specificity.	   However,	   it	   is	   important	   to	   find	   the	  psychologically	  mediated	  conditions	  that	  trigger	  these	  biological	  events.	  
	  
CHAPTER	  1.	  INTRODUCTION	  
	  31	  
1.4 A	  Unifying	  Theory	  
	  1.4.1 Early	  Integrative	  Models	  
	  The	   debate	   regarding	   the	   different	   mechanisms	   behind	   the	   placebo	   response	  continued	  for	  a	  number	  of	  years.	  However,	  researchers	  gradually	  began	  to	  realise	  that	   these	  mechanisms	  need	  not	  be	  mutually	  exclusive	  and	  concentrated	   instead	  on	  how	  they	  may	  integrate.	  For	  example,	  Benedetti	  et	  al.,	  (2003),	  proposed	  that	  while	  both	  conditioning	  and	  expectancy	  can	  produce	  effects	  on	  conscious	  physiological	  processes	  such	  as	  pain,	   only	   conditioning	   can	   produce	   effects	   on	   non-­‐conscious	   processes,	   such	   as	  hormone	   secretion.	   Other	   models	   attempt	   to	   provide	   biological	   frameworks	   for	  combining	  conditioning	  and	  expectancy	  effects,	  (Pecina	  et	  al.,	  2013;	  Meissner	  et	  al.,	  2011).	  	   From	   a	   psychological	   perspective,	   Stewart-­‐Williams	   and	   Podd,	   (2004b),	  proposed	   that	   conditioning	   and	   expectancy	  models	   are	   in	   fact	   compatible	   and	   a	  choice	  need	  not	  be	  made	  between	  the	  two.	  They	  proposed	  that	  all	  mammals	  detect	  and	  respond	  to	  contingencies	  in	  the	  environment.	  As	  humans,	  these	  contingencies	  can	  be	  learnt	  in	  two	  different	  ways.	  Not	  only	  can	  we	  learn	  through	  non-­‐conscious	  classical	   conditioning,	   but	   we	   can	   also	   learn	   by	   forming	   conscious	   cognitive	  expectancies.	  	  	   This	   multi-­‐faceted	   nature	   of	   the	   human	   organism	   was	   then	   developed	  further	  in	  the	  current	  integrative	  theory	  of	  human	  response,	  the	  ‘Network	  Theory	  of	   Psychoneuroimmunology’,	   or	   ‘Infornet	   Theory’,	   (Hyland,	   2011a).	   This	   theory	  unifies	   not	   only	   conditioning	   and	   response	   expectancy	   models	   of	   placebo	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response,	   but	   also	   biological,	   motivational	   and	   meaning	   related	   models	   in	   the	  context	  of	  a	  broader	  human	  system.	  
	  1.4.2 Infornet	  Theory	  –	  General	  Response	  
	  In	  summary,	  infornet	  theory	  hypothesises	  that	  human	  beings	  function	  not	  only	  as	  a	  serial	   processing	   system,	   but	   also	   as	   a	   complex	   parallel-­‐processing	   system,	  resulting	  in	  the	  integration	  of	  neurological,	  immune	  and	  endocrine	  systems.	  In	  any	  given	   situation,	   these	   systems	   receive	   inputs,	   derive	   meaning	   from	   them	   and	  combine	  them	  in	  order	  to	  produce	  a	  response	  appropriate	  to	  current	  priority	  and	  future	   anticipation.	   The	   infornet	   is	   hypothesised	   as	   being	   capable	   of	   self-­‐organisation,	   self-­‐healing	   and	   producing	   emergent	   properties.	   Hyland	   (2011a)	  states	  that,	  	   	  “	   The	   infornet	   contains	   information:	   it	   is	   a	  meaning	   system.	   The	   infornet	  controls	   the	   body’s	   control	   loops	   through	   instructions	   that	   alter	   the	   settings	   of	  those	   control	   systems.	   Those	   instructions	   are	   based	   on	   the	   way	   the	   infornet	  interprets	  the	  situation	  	  -­‐	  i.e.,	  the	  internal	  and	  external	  environment,”	  (p.	  97).	  
	  	   The	  human	  infornet	  is	  therefore	  hypothesised	  to	  be	  capable	  of	  both	  short-­‐term	   problem-­‐solving	   responses,	   as	   well	   as	   longer-­‐term	   self-­‐organisational	  responses.	  	   In	  a	  short-­‐term	  response,	  the	  infornet	  receives	  a	  vast	  range	  of	  inputs	  from	  a	  large	  number	  of	  sources.	  These	  inputs	  can	  be	  categorised	  in	  a	  variety	  of	  ways.	  For	  example,	   they	  may	  be	   internal	  or	  external	   to	   the	  body;	   they	  may	  be	  behavioural,	  physiological	  or	  psychological,	  and	  they	  may	  be	  conscious	  or	  non-­‐conscious.	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   The	  infornet	  interprets	  the	  meaning	  associated	  with	  these	  inputs	  according	  to	   previously	   learnt	   information.	   This	   information	   may	   have	   been	   learnt	   in	  different	  ways,	   for	  example,	  via	  conditioned	  associations,	  or	  via	   the	  higher-­‐order	  function	  of	  cognitive	  learning.	  	   The	   interpretation	   of	   these	   inputs	   is	   then	   hypothesised	   to	   lead	   to	   the	  formation	  of	  ‘infornet	  beliefs’.	  These	  are	  not	  conscious	  cognitions	  in	  the	  traditional	  sense	  of	  the	  word,	  but	  a	  representation	  of	  the	  meaning	  encoded	  in	  the	  infornet.	  For	  example,	  ‘the	  external	  situation	  is	  good’.	  	  	   Based	  on	  these	  infornet	  beliefs,	  the	  infornet	  then	  produces	  an	  appropriate	  response.	  This	  response	  may	  also	  be	  categorised	  in	  a	  number	  of	  different	  ways.	  For	  example,	  changes	  in	  mood,	  energy	  levels	  and	  pain	  may	  occur	  in	  order	  to	  provide	  an	  appropriate	  response	  or	  action	  in	  any	  given	  situation.	  Physiological	  processes	  may	  also	   be	   activated.	   For	   example,	   if	   an	   external	   threat	   is	   detected,	   the	   HPA,	  (Hypothalamic	   Pituary-­‐Axis	   or	   ‘Fight	   or	   Flight’	   response),	  may	   be	   invoked.	   If	   an	  internal	   threat	   is	   detected,	   the	   IRA,	   (Inflammatory	   Response	   System),	   may	   be	  activated	   and	   vice	   versa.	   Feedback	   then	   allows	   these	   systems	   to	   reset	   once	  continuing	  inputs	  have	  signalled	  that	  circumstances	  have	  changed.	  Hyland	  (2011a)	  summarises	  as	  follows,	  	   	  	   “The	  infornet	  interprets	  what	  is	  happening	  in	  the	  external	  world,	  using	  any	  information	   that	   is	  available	  –	  direct	  experience,	  verbal	   instructions	   from	  others,	  and	  vicariously	  mediated	  information	  –	  and	  solves	  the	  problem	  of	  what	  to	  do	  next	  based	  on	  that	  meaning,”	  (p.	  252).	  
	  	   In	  addition	  to	  interpreting	  the	  meaning	  of	  individual	  inputs,	  infornet	  theory	  hypothesises	   that	  we	  are	   ‘programmed’	   to	  recognise	  collective	  patterns	  of	   inputs	  and	   likewise	   produce	   an	   appropriate	   pattern	   of	   response	   ‘outputs’.	   These	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‘programs’	   can	   be	   stored	   in	   two	   different	   ways	   –	   as	   a	   specific	   location	   on	   the	  genome,	  or	   in	  a	  more	  distributed	   form	  as	  a	  pattern	  of	  activation	  rules	  across	   the	  infornet.	  	  	   The	   genome	   ‘program’	   occurs	   in	   the	   form	   of	   reference	   criteria,	   which	  trigger	  response	   if	   levels	  of	   corresponding	   feedback	  rise	   too	  high	  or	   fall	   too	   low,	  analogous	   to	   a	   room	   thermostat.	   The	   reference	   criteria	   also	   fall	   into	   different	  categories.	   For	   example,	   they	   may	   be	   biological,	   (e.g.	   body	   temperature	   and	  hydration	   levels),	   psychological,	   (e.g.	   the	   need	   for	   self-­‐determination	   and	   social	  support),	  or	  behavioural,	  (e.g.	  activity	  levels).	  	   As	  well	  as	  the	  reference	  criteria	  held	  on	  the	  genome,	  it	  is	  hypothesised	  that	  programs	   of	   response	   may	   be	   stored	   in	   a	   distributed	   form	   across	   the	   parallel-­‐processing	  network.	   Information	  is	  said	  to	  be	  stored	  via	   ‘Activation	  Rules’,	  which	  govern	   the	   amount	   of	   inhibitory	   or	   excitatory	   effects	   between	   neurons	   and	  receptor	   sensitivity.	   The	   amalgamation	   of	   these	   rules	   is	   an	   ‘Activation	   Pattern’.	  When	   a	   corresponding	   pattern	   of	   inputs	   is	   detected,	   an	   appropriate	   pattern	   of	  response	  is	  therefore	  activated.	  	   In	   addition	   to	   short-­‐term	   problem	   solving	   responses,	   the	   infornet	   is	   also	  hypothesised	   to	   be	   capable	   of	   long-­‐term	   self-­‐organisational	   responses.	   The	  ‘programmed’	  responses	  to	  patterns	  of	  inputs	  are	  not	  fixed	  within	  the	  infornet.	  As	  a	   result	   of	   the	   parallel-­‐processing	   network,	   it	   is	   hypothesised	   we	   are	   self-­‐regulatory	  and	  as	  such,	  in	  the	  long-­‐term	  we	  are	  constantly	  self-­‐organising	  in	  order	  to	   self-­‐regulate	   more	   efficiently.	   This	   self-­‐organisation	   is	   achieved	   through	  application	   of	   network	   learning	   rules.	   One	   proposed	   learning	   rule	   is	   the	  ‘Associative	   Learning	   Rule’	   resulting	   in	   conditioning	   effects.	   Another	   is	   the	  ‘Supervised	   Learning	   Rule’,	   which	   results	   in	   the	   adjustment	   of	   homeodynamic	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reference	   criteria	   located	   on	   the	   genome,	   or	   via	   altering	   activation	   rules	   stored	  across	  the	  network.	  	  
	  1.4.3 Infornet	  and	  the	  Placebo	  Response	  
	  Within	  the	  infornet,	  the	  placebo	  response	  is	  viewed	  as	  just	  one	  example	  of	  a	  short-­‐term	   problem-­‐solving	   response	   in	   action,	   not	   a	   specific	   phenomenon.	   Hyland	  (2011a)	  states,	  
	  	   “the	  mechanism	  underlying	   the	   placebo	   is	   a	   common	  mechanism	  but	   one	  that	  is	  being	  exhibited	  in	  an	  unusual	  way	  in	  placebo	  paradigms,”	  (p.	  253).	  
	  For	   example,	   within	   a	   placebo	   context,	   the	   infornet	   is	   usually	   reacting	   to	  information	  learnt,	  (either	  via	  association	  or	  cognitive	  learning),	  within	  the	  context	  of	  a	  defined	  experimental	  or	  clinical	  setting.	  If	  the	  infornet	  receives	  a	  ‘safety	  signal’	  as	   part	   of	   a	   specific	   contextual	   setting	   it	   will	   respond	   accordingly,	   even	   if	   that	  signal	  is	  learnt	  via	  verbal	  information.	  	  Further,	   infornet	   theory	   therefore	  predicts	   the	  placebo	   response	  will	  only	  occur	   in	  homeodynamic	  responses	   that	  would	  normally	  be	  adjusted	  according	   to	  external	  conditions.	  For	  example	  it	  would	  be	  found	  in	  blood	  pressure	  and	  pain	  but	  not	  in	  blood	  sugar	  levels.	  	  
	  1.4.4 Integrating	  Existing	  Placebo	  Mechanisms	  within	  Infornet	  Theory	  
	  In	   viewing	   the	   placebo	   response	   as	   part	   of	   a	   broader	   system,	   it	   is	   possible	   to	  integrate	  existing	  placebo	  mechanisms	  as	  part	  of	  a	  single,	  unified	  theory.	  	   Conditioning	   theory	   and	   response	   expectancy	   theory	   can	   be	   seen	   as	  alternative	   ways	   of	   learning	   contingencies	   within	   the	   environment.	   The	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information	   provided	   by	   either	   learning	   route	   can	   be	   used	   to	   interpret	   the	  meaning	   of	   inputs	   and	   determine	   response.	   For	   example,	   information	   about	  environmental	  contingencies	  learnt	  via	  conditioned	  associations	  would	  result	  in	  a	  conditioned	  response,	  whereas	  contingencies	  learnt	  via	  a	  cognitive	  learning	  route,	  (such	  as	  verbal	  expectancies),	  would	  also	  be	  used	  to	  interpret	  current	  inputs	  and	  alter	   response.	   In	   this	   way,	   both	   conditioning	   and	   response	   expectancy	  mechanisms	  can	  work	  simultaneously	  within	  one	  system.	  	  Infornet	   theory	  predicts	   that	   time-­‐scales	   are	   an	   important	  determinant	   in	  which	   learning	   route	   may	   have	   a	   greater	   impact.	   	   For	   example,	   response	  expectancy	  would	  generally	  have	  a	  greater	  impact	  on	  short-­‐term	  response	  because	  the	   cognitive	   learning	   route	   is	   a	   stronger	   determinant	   of	   environmental	  contingencies	   in	   this	   context.	  However,	   longer-­‐term	  placebo	   responses	   are	  more	  likely	   to	   be	   as	   a	   result	   of	   motivational	   mechanisms,	   such	   as	   Motivational	  Concordance,	  (Hyland	  &	  Whalley,	  2008).	  	   However,	   it	   is	  not	   just	  conditioning	  and	  response	  expectancy	  mechanisms	  that	   can	   be	   integrated	   under	   infornet	   theory.	   Within	   infornet	   theory,	   biological	  accounts	   of	   the	   placebo	   effect	   are	   viewed	   as	   the	   organic	   response	   to	   the	  psychological	   interpretation	   of	   events	   within	   the	   infornet.	   However,	   due	   to	   the	  intricate	   connection	   between	   neurological,	   immune	   and	   endocrine	   systems	   and	  the	  parallel-­‐processing	  nature	   of	   the	   infornet,	   exact	   biological	   specificity	  may	  be	  difficult	  to	  establish.	  Within	  the	  infornet,	  physiological	  outputs	  are	  viewed	  simply	  as	  part	  of	   the	  same	  system	  as	  psychological	  outputs	  such	  as	  changes	   in	  mood	  or	  attention.	   For	   example,	   consistent	  with	   the	   integrative	   theory	   of	   pain,	   (Loeser	  &	  Melzack,	  1999),	  the	  infornet	  views	  pain	  as	  a	  signal	  from	  a	  network	  system	  that	  has	  multiple	  inputs.	  These	  inputs	  may	  be	  psychological	  as	  well	  as	  physical.	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   Within	   the	   context	   of	   infornet	   theory,	   some	   personality	   traits	   may	   also	  correlate	   with	   placebo	   response	   as	   personality	   is	   viewed	   as	   an	   output	   of	   the	  infornet	   based	   on	   previous	   learning.	   Personality	   traits	   are	   seen	   as	   consistent	  patterns	   of	   behaviour,	   not	   fixed	   responses.	   For	   example,	   the	   personality	   trait	   of	  optimism	   may	   be	   generated	   by	   long-­‐term,	   consistent	   positive	   learning	   and	   the	  infornet	  belief	  that	  the	  ‘external	  situation	  is	  good’.	  This	  longer-­‐term	  learning	  could	  then	   be	   used	   to	   interpret	   short-­‐term	   information	   provided	   within	   the	   placebo	  context,	  but	  would	  also	  be	  used	  in	  context	  of	  other	  inputs	  provided	  in	  the	  placebo	  situation.	   For	   example,	   Geers	   et	   al.,	   (2008)	   found	   that	   presenting	   health	   related	  words	  negated	   the	  effect	  of	  dispositional	  optimism	  on	  perceived	  pain.	  Geers	  and	  colleagues	   hypothesised	   this	   was	   due	   to	   the	   health	   related	   words	   returning	  attention	   to	   health	   concern,	  which	   optimists	   had	   shifted	   attention	   away	   from	   as	  part	  of	  a	  coping	  strategy.	  Moerman’s	  (2002)	  Meaning	  Response	  Theory	  can	  also	  be	  viewed	  within	  the	  context	  of	   infornet	   theory.	  Moerman	  views	  the	  placebo	  response	  as	  a	  reaction	   to	  meaning	   in	   the	   environment.	   This	   has	   obvious	   similarities	   to	   infornet	   theory.	  However,	   infornet	   theory	   hypothesises	   that	   meaning	   need	   not	   be	   consciously	  mediated	  via	  cognition	  as	  Moerman	  proposes.	  	   Infornet	   theory	   can	   provide	   a	   unifying	   framework	   from	   within	   which	   a	  range	   of	   previous	   placebo	   response	   mechanisms	   can	   be	   interpreted,	   offering	   a	  more	  cohesive	  base	  from	  which	  to	  understand	  this	  complicated	  phenomenon.	  
	  1.5 What’s	  Missing?	  
	  1.5.1	   Higher-­‐Level	  Subliminal	  Inputs	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In	  relation	  to	  the	  placebo	  response,	  infornet	  theory	  concentrates	  on	  the	  effects	  of	  inputs	   which	   are	   processed	   via	   associative	   learning,	   (‘lower-­‐level’	   inputs),	   or	  cognitive	   learning,	  (‘higher-­‐level’	   inputs).	  Currently,	   infornet	  theory	  assumes	  that	  cognitive	   learning,	   (for	   example	   via	   verbal	   information),	   is	   a	   conscious	   process,	  whereas	  only	  associative	  learning	  may	  occur	  both	  consciously	  or	  non-­‐consciously.	  However,	  it	  is	  not	  just	  conditioning	  effects	  or	  explicit	  information	  that	  may	  be	  used	  by	  the	  infornet.	  	   The	   role	   of	   non-­‐conscious	   processing	   has	   been	   touched	   upon	   within	   the	  placebo	   literature.	   For	   example,	   Geers	   et	   al.,	   (2005a),	   demonstrated	   that	   goals	  elicited	   via	   non-­‐conscious	   processing	   can	   alter	   reactions	   to	   a	   placebo.	   However,	  the	  focus	  of	  this	  research	  was	  primarily	  on	  the	  specific	  motivational	  effects	  elicited	  by	  the	  input,	  rather	  than	  the	  nature	  of	  the	  processing	  itself.	  	  In	   addition,	   Jensen	   et	   al.,	   (2012),	   also	   investigated	   the	   non-­‐conscious	  activation	  of	  a	  placebo	  analgesic	  response.	  However,	  non-­‐conscious	  activation	  was	  induced	  via	   a	   conditioning	  procedure	   and	  didn’t	   examine	   the	  potential	   effects	   of	  any	   higher-­‐level	   non-­‐conscious	   processing.	   Further,	   in	   2010,	   Colagiuri	   and	  colleagues	  also	  touched	  on	  the	  role	  of	  non-­‐conscious	  processes,	  but	   this	   time	  the	  focus	  was	  on	  the	  non-­‐conscious	  placebo	  response	  of	  implicit	  learning	  rather	  than	  examining	  the	  role	  of	  a	  non-­‐conscious	  input.	  	  While	  these	  studies	  do	  suggest	  that	  non-­‐conscious	  inputs	  can	  have	  an	  effect	  on	   placebo	   response,	   none	   of	   them	   specifically	   investigate	   the	   potential	   role	   of	  ‘higher-­‐order’,	   or	   cognitively	   learnt	   subliminal	   inputs.	   If,	   as	   infornet	   theory	  hypothesises,	   inputs	   can	   originate	   from	   anywhere,	   the	   effects	   of	   subliminally	  processed	   ‘higher-­‐level’	   inputs	   should	   also	   be	   investigated	   within	   the	   infornet	  model.	   The	   area	   of	   psychology	   most	   relevant	   to	   investigating	   this	   is	   that	   of	  subliminal	  priming.	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The	   area	   of	   subliminal	   priming	   has	   been	   extensively	   studied	   within	  psychology,	   and	   has	   demonstrated	   a	   raft	   of	   higher-­‐level,	   subliminal	   inputs	   that	  influence	   a	   range	   of	   human	  behaviour	   and	   emotion,	   yet	   none	  have	  been	   studied	  specifically	  in	  the	  context	  of	  the	  placebo	  response.	  Subliminal	   priming	   involves	   the	   presentation	   of	   non-­‐reportable	   stimuli,	  usually	  masked	  by	  supraliminal	  stimuli.	  	  Its	  effect	  on	  a	  range	  of	  human	  behaviour,	  emotions	  and	  evaluations	   is	   then	  measured.	  The	   term	  subliminal	   is	  used	  here	   to	  refer	  to	  inputs	  that	  are	  physically	  unable	  to	  reach	  consciousness	  due	  to	  the	  speed	  at	   which	   they	   are	   presented.	   The	   term	   ‘non-­‐conscious	   stimuli’,	   (as	   opposed	   to	  subliminal),	   may	   also	   refer	   to	   inputs	   that	   are	   simply	   currently	   unattended	   and	  therefore	   do	   not	   reach	   consciousness.	   This	   body	   of	   research	   focuses	   on	  subliminally	  presented	  inputs.	  	   The	   field	   of	   subliminal	   priming	   has	   had	   a	   mixed	   history.	   Following	   a	  controversial	   incident	   in	   1957,	   when	   James	   Vicary	   erroneously	   claimed	   to	   have	  increased	   sales	   of	   popcorn	   and	   cola	   by	   subliminally	   flashing	   the	   words,	   ‘Eat	  Popcorn’	   and	   ‘Drink	   Cola’	   to	   an	   unsuspecting	   cinema	   audience,	   the	   field	   of	  subliminal	   priming	   has	   been	   veiled	   in	   an	   air	   of	   suspicion.	   Some	   researchers	  claimed	   the	   phenomenon	   was	   a	   myth,	   (Pratkanis,	   1992),	   but	   following	  methodological	  improvements	  and	  more	  convincing	  empirical	  results	  in	  the	  1990’s	  it	  was	  argued	  that	  investigation	  into	  this	  phenomenon	  was	  worthwhile,	  (Dehaene	  et	  al.,	  1998;	  Dikjsterhuis	  et	  al.,	  2005).	  	  	   As	   evidence	   for	   the	   effects	   of	   subliminal	   priming	   accumulated,	   attention	  shifted	   away	   from	   establishing	   the	   existence	   of	   the	   phenomena	   towards	  identifying	  the	  range	  of	  responses	   that	  can	  be	  elicited	  via	  subliminally	  processed	  inputs,	  (Kiesel	  et	  al.,	  2007).	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Research	   revealed	   evidence	   that	   overt	   behaviour	   can	   be	   altered	   via	  subliminal	   processing.	   For	   example,	   activating	   stereotypes	   via	   subliminal	   words	  has	   been	   shown	   to	   bring	   behaviour	   in	   line	   with	   traits	   associated	   with	   that	  stereotype.	   One	   famous	   example	   is	   that	   of	   Bargh	   et	   al.,	   (1996),	   who	   found	  participants	   moved	   more	   slowly	   following	   exposure	   to	   subliminally	   presented	  words	  associated	  with	  the	  elderly,	  (see	  Dikjsterhuis	  &	  Bargh,	  2001,	  for	  a	  review).	  	  Evaluative	   judgements,	   such	  as	   social	  perception,	   (Bargh	  &	  Pietromonaco,	  1982),	  and	  pleasantness	  ratings,	  (Murphy	  &	  Zajonc,	  1993),	  have	  also	  been	  shown	  to	   be	   influenced	   by	   subliminal	   priming.	   In	   categorisation	   tasks,	   both	   response	  times,	  (Barbot	  &	  Kouider,	  2011),	  and	  accuracy	  rates,	  (Draine	  &	  Greenwald,	  1998),	  have	   been	   demonstrated	   to	   be	   improved	   with	   the	   use	   of	   subliminal	   primes.	  Importantly	   for	   placebo	   research,	   subliminally	   presented	   semantic	   primes	   have	  also	  been	  shown	  to	  increase	  pain	  tolerance,	  (Meerman	  et	  al.,	  2010).	  The	   mechanisms	   put	   forward	   to	   explain	   these	   results	   fell	   into	   two	   main	  categories	   –	   automatic	   ‘spreading	   activation’	   type	   effects,	   and	   ‘higher-­‐level’	  semantic	  processing.	  The	  automatic	  spreading	  activation	  explanation	  posited	  that	  the	  subliminal	  prime	   spreads	   neural	   activation	   in	   the	   semantic	   network.	   Response	   is	   increased	  with	  congruent	  primes	  due	  to	  pre-­‐activation	  in	  the	  appropriate	  semantic	  network,	  (Neely,	  1991).	  For	  example,	  Meerman	  et	  al.,	   (2010),	  explain	  the	  effects	  of	   illness-­‐related	  subliminal	  primes	  on	  pain	  tolerance	  as	  due	  to	  the	  automatic	  activation	  of	  illness-­‐related	   memory	   altering	   attention.	   Another	   example	   is	   that	   of	   affective	  priming,	  whereby	  the	  valence	  of	  input	  alters	  response,	  (Winkielman	  et	  al.,	  2005).	  If	  elicited	   outside	   conscious	   awareness,	   the	   transference	   of	   affective	   primes	   to	  targets	  is	  claimed	  to	  be	  ‘diffuse	  and	  nonspecific’,	  (Murphy	  &	  Zajonc,	  1993).	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Alternatively,	   ‘higher-­‐level’	   semantic	   mechanisms	   propose	   that	   the	  subliminal	  stimuli	  are	  processed	  at	  a	  deeper	  analytical	  level	  and	  submitted	  to	  the	  same	   categorisation	   procedures	   as	   consciously	   processed	   stimuli.	   Subliminal	  primes	   influence	   the	   conscious	   processing	   of	   stimuli	   only	   if	   they	   belong	   to	   task-­‐relevant	   response	   category,	   (Keisel	   et	   al.,	   2007;	   Greenwald	   et	   al.,	   2003).	  Demonstrating	   the	   effects	   of	   novel	   primes	  with	   no	   previous	   associations	   largely	  shows	  support	  for	  the	  semantic	  priming	  mechanism,	  (Klauer	  et	  al.,	  2007).	  There	  were	  also	  attempts	  to	  identify	  which	  types	  of	  processing	  may	  be	  used	  under	  different	  circumstances.	  For	  example,	  Murphy	  and	  Zajonc,	  (1993),	  proposed	  affective	   priming	   is	   more	   likely	   when	   evaluative	   or	   speed	   related	   tasks	   are	  measured,	   whereas	   semantic	   mechanisms	   are	   more	   likely	   where	   cognitive	   or	  accuracy	  related	  tasks	  are	  measured.	  More	   recently,	   attempts	   have	   been	   made	   to	   combine	   the	   two	   types	   of	  mechanism.	   For	   example,	   Keisel	   et	   al.,	   (2007),	   proposed	   an	   ‘Action	   Trigger	  Account’	  whereby	  participants	  build	  up	  expectations	  regarding	  imperative	  stimuli	  for	   required	   responses,	   named	   “Action	   Triggers’.	   Stimuli	   that	   then	   match	   these	  triggers	   directly	   activate	   response.	   In	   other	   words,	   only	   subliminal	   primes	   that	  match	   expectancy	   induced	   via	   experience	   and/or	   instruction	   elicit	   a	   primed	  response.	  Elsner	  et	  al.	  (2008)	  also	  suggest	  that	  semantic	  priming	  via	  novel	  primes	  is	  more	  likely	  to	  occur	  if	  the	  identity	  and	  physical	  appearance	  of	  those	  primes	  are	  expected.	  Finkbeiner	  and	  Friedman	  (2011)	  go	  on	  to	  suggest	  that	  it	  is	  possible	  that	  both	  associative	  and	  semantic	  mechanisms	  can	  be	  used,	  even	  within	  the	  same	  task,	  but	  are	  used	  in	  different	  ways.	  	  In	   addition	   to	   the	   mechanisms	   involved	   in	   subliminal	   priming	   effects,	  moderating	   factors	   have	   also	   been	   investigated.	   For	   example,	   motivation	   and	  awareness	   of	   prime	   have	   been	   shown	   to	   be	   important	   contextual	   variables	   in	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determining	   the	   effectiveness	   of	   eliciting	   a	   response,	   (Randolph-­‐Seng	   &	  Mather,	  2009).	  The	  subliminal	  prime	  must	  be	  goal	  relevant	  in	  order	  to	  influence	  response.	  For	   example,	   thirst-­‐related	   stimuli	   will	   only	   affect	   drinking	   behaviour	  when	   the	  participant	   is	   thirsty,	   (Strahan	   et	   al.,	   2002).	   In	   addition,	   if	   participants	   are	  informed	  they	  are	  being	  subliminally	  primed,	  the	  effects	  are	  considerably	  reduced,	  (Verwijmermen	  et	  al.,	  2013).	  This	   raft	   of	   research	   into	   the	   effects	   of	   subliminally	   presented	   inputs	   has	  largely	   been	   omitted	   from	   placebo	   research.	   However,	   there	   is	   also	   a	   range	   of	  other	   literature	   across	   a	   number	   of	   psychology	   disciplines	   that	   suggest	   higher-­‐level	  subliminal	  inputs	  should	  be	  investigated	  in	  the	  context	  of	  placebo	  response.	  	  From	   an	   evolutionary	   perspective,	   Viamontes	   and	   Beitman,	   (2007),	  hypothesise	  that,	  	  
	  “	   Unconscious	   processes	   are	   constantly	   receiving	   sensory	   information,	  predicting	   its	  meaning	   in	   terms	   of	   innate	   or	   learned	   patterns	   and	   preparing	   the	  body	  to	  deal	  with	  the	  situation	  that	  has	  been	  predicted,”	  (p.	  6).	  
	  It	   is	   not	   difficult	   here	   to	   see	   the	   overlap	   with	   Hyland’s,	   (2011),	   infornet	  theory.	   However,	   Viamontes	   and	   Beitman	   suggest	   there	   may	   be	   more	   to	   non-­‐conscious	  processing	  of	  stimuli	  than	  a	  simple	  automatic	  conditioned	  response.	  From	   a	   biological	   perspective,	   Miller	   and	   Colloca,	   (2010),	   apply	   Pierce’s,	  (1940),	   semiotic	   theory	   to	  placebo	   response.	  They	  describe	   the	  placebo	  effect	   as	  ‘the	   body’s	   apprehension	   and	   response	   to	   signs	   in	   the	   environment’.	   They	   claim	  the	  placebo	  device	  or	  procedure	  provides	  the	  body	  with	  a	  set	  of	  signs	  that	  convey	  information	  from	  which	  patients	  or	  participants	  respond	  accordingly.	  Importantly,	  they	   claim	   these	   signs	   can	   provide	   symbolic	  meaning	   plus	   forms	   of	   anticipation	  and	  perception	  that,	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  “may	  fall	  below	  the	  level	  of	  consciously	  accessible	  meaning,”	  (p.	  511).	  	  
	  In	   the	   philosophical	   literature,	   Haug,	   (2011),	   hypothesises	   that	   placebo	  effects	  are	  mediated	  via	   ‘Aliefs’.	  Aliefs	  are	  differentiated	   from	  beliefs	   in	   that	   they	  are	  consciously	  inaccessible	  and	  inferentially	  isolated	  from	  beliefs.	  Aliefs	  are	  said	  to	   be	   associative,	   automatic	   and	   arational,	   (Gendler,	   2008).	   An	   example	   used	   by	  Gendler	   describes	   how,	   when	   standing	   on	   the	   glass	   floor	   of	   the	   Grand	   Canyon	  Skywalk	   4000	   feet	   in	   the	   air,	   you	  may	   rationally	   believe	   you	   are	   safe,	   but	   your	  heart	  may	  still	  race	  and	  your	  hands	  tremble.	  Haug	  argues	  these	  aliefs	  play	  a	  role	  in	  determining	  placebo	  response.	  In	   summary,	   there	   is	   a	   raft	   of	   research	   across	   a	   number	   of	   domains	  suggesting	   that	   subliminal	   ‘higher-­‐level’	   inputs,	   learnt	   outside	   of	   the	   traditional	  conditioning	  paradigm,	  may	  be	  used	  in	  generating	  placebo	  responses,	  and	  should	  therefore	  be	  included	  in	  the	  infornet	  model	  of	  placebo	  response.	  
	  1.5.2	  Integration	  of	  Inputs	  
	  Another	  question	  that	  remains	  to	  be	  addressed	  within	  infornet	  theory	  is	  how	  the	  various	  inputs	  are	  integrated	  to	  form	  a	  response.	  It	  is	  therefore	  unknown,	  not	  only	  if	  higher-­‐level	  subliminal	  inputs	  can	  be	  used	  in	  determining	  placebo	  response,	  but	  also	  whether	  they	  can	  integrate	  with	  conscious,	  propositional	  information.	  	   Integration	  of	  stimuli	  can	  be	  defined	  as,	  ‘the	  generation	  of	  a	  nonperceptual,	  abstract	  representation	  by	  associating	  distinct	  signals	  into	  a	  new	  one’,	  (Mudrik	  et	  al.,	  2014,	  p.488).	  This	   integration	  can	  be	  purely	  additive,	   (for	  example,	  when	   the	  concept	  of	  ‘5’	  is	  produced	  after	  combining	  ‘2’	  and	  ‘3’),	  or	  it	  can	  be	  more	  interactive,	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(for	   example,	  when	   the	   concept	   of	   ‘honeymoon’	   is	   evoked	  when	   the	   concepts	   of	  ‘honey’	  and	  ‘moon’	  are	  combined).	  	   The	   field	   of	   subliminal	   priming	   may	   help	   theorise	   how	   subliminally	  presented	   inputs	   could	   be	   used	   in	   relation	   to	   conscious	   verbal	   information.	  Stafford	   (2014)	   suggested	   that	   subliminal	   inputs	   may	   be	   integrated	   with	   other	  information	   only	   when	   not	   directly	   in	   competition	   with	   consciously	   processed	  information.	  He	  goes	   further	   to	  suggest	   it	   is	  possible	   that	   subliminally	  presented	  information	  may	  require	  the	  presence	  of	  relevant	  conscious	   information	  in	  order	  to	  be	  used	  within	  processing.	  	  In	  addition,	  Mudrik	  et	  al.,	   (2014),	   reviewed	  empirical	  data	  suggesting	   that	  integration	   of	   stimuli	   presented	   at	   a	   non-­‐conscious	   level	   with	   consciously	  presented	  information	  may	  require	  certain	  circumstances	  in	  order	  to	  occur.	  These	  circumstances	  include	  a	  short	  spatio-­‐temporal	  window	  between	  stimuli;	  if	  stimuli	  are	   presented	   via	   the	   same	   sensory	   route	   and	   if	   the	   subliminal	   information	   is	  familiar	  to	  the	  subject	  and	  only	  requires	  processing	  at	  an	  associative	  ‘lower-­‐level’,	  (although	  Mudrik	  suggests	   that	  some	   forms	  of	   ‘higher-­‐level’	   semantic	   integration	  may	  be	  possible	  if	  the	  previous	  associations	  are	  consciously	  acquired).	  	  	   This	  literature	  suggests	  it	  is	  possible	  for	  subliminally	  presented	  inputs	  to	  be	  integrated	   with	   consciously	   processed	   verbal	   information.	   However,	   it	   doesn’t	  specify	  how	  they	  may	  be	  integrated.	  For	  example,	  is	  integration	  of	  subliminal	  and	  consciously	   presented	   information	   more	   likely	   to	   occur	   on	   an	   additive	   or	   an	  interactive	  basis?	   For	   a	  possible	   answer	   to	   this	  question	  we	   can	   look	   to	   another	  area	   of	   psychology	   –	   that	   of	   Dual-­‐Process	   theories	   of	   behaviour.	  Mainly	   used	   as	  explanatory	  models	  within	  cognitive	  and	  social	  psychology,	  these	  theories	  view	  a	  range	  of	  human	  behaviour	  as	  resulting	  from	  two	  distinct	  processing	  ‘systems’.	  One	  system	  is	  unconscious,	  rapid	  and	  automatic,	  and	  the	  other	   is	  conscious,	  slow	  and	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deliberative.	   Within	   Dual-­‐Process	   theories,	   each	   ‘system’	   shares	   clusters	   of	  attributes,	  (see	  Evans,	  2008,	  for	  a	  review).	  If	  subliminal	  stimuli	  are	  assumed	  to	  be	  processed	  via	   ‘system	  1’	   and	  verbal	   expectancy	   information	  via	   ‘system	  2’,	   these	  theories	  may	  suggest	  how	  these	  inputs	  may	  be	  integrated	  within	  a	  placebo	  context.	  Whilst	   varying	   in	   the	   details	   of	   how	   the	   systems	   integrate,	   within	   Dual-­‐Process	   theories	   of	   behaviour,	   integration	   as	   is	   generally	   seen	   as	   an	   additive	  process.	   The	   processing	   in	   each	   ‘system’	   produces	   separate	   outputs,	   which	   are	  then	  added	  together,	  ignored	  or	  ‘allowed’	  in	  order	  to	  determine	  response.	  	   For	  example,	  some	  theories	  claim	  the	  output	  from	  each	  type	  of	  processing	  leads	   to	   two	   distinct	   forms	   of	   knowledge	   which	   then	   compete	   for	   control	   of	  behaviour,	   (Smith	   &	   Decoster,	   2000;	   Sloman,	   1996).	   In	   a	   placebo	   context,	   this	  could	   suggest	   each	   type	   of	   input	   produces	   its	   own	   ‘expectancy’.	   These	  ‘expectancies’	   then	   compete	   to	   provide	   the	   basis	   of	   a	   placebo	   response.	   Toates	  (1997)	  also	  suggests	  how	  the	  output	  priority,	  (and	  therefore	  response	  priority),	  of	  each	   form	  of	   processing	   is	   determined	   as	   a	   function	   of	   development,	   experience	  and	   pathology.	   Other	   theories	   claim	   rapid,	   automatic	   processes	   cue	   default	  behaviour	   that	   more	   conscious,	   deliberative	   processes	   then	   may	   approve	   or	  intervene	  upon,	   (Kahneman,	  2011;	  Evans,	  2006).	  Kahneman	  (2011)	  refers	   to	   the	  ‘law	  of	  least	  effort’,	  whereby	  non-­‐conscious,	  associative	  information	  is	  used	  unless	  there	  is	  sufficient	  reason	  to	  employ	  the	  resource	  needed	  for	  ‘higher-­‐level’	  cognitive	  effort.	  In	  a	  placebo	  context,	  this	  would	  suggest	  that	  any	  stimuli	  would	  be	  used	  at	  an	  associative	   lower-­‐level	   unless	   there	   is	   sufficient	   motivation	   to	   use	   ‘higher-­‐level’	  processes,	  possibly	  including	  integration	  with	  explicit	  cognitive	  information.	  	  	   The	  Dual-­‐Process	  approach	   seems	  an	   intuitive	   fit	   in	   attempting	   to	  predict	  how	  subliminally	  presented	  inputs	  may	  be	  integrated	  with	  cognitive	  expectancies	  within	   a	   placebo	   context,	   suggesting	   processing	   from	   each	   type	   of	   input	  may	   be	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prioritised	  then	  allowed	  /	  ignored,	  or	  added	  together	  to	  form	  a	  response.	  However,	  one	   drawback	   of	   using	   this	   approach	   is	   the	   assumption	   that	   non-­‐conscious	  processing	  is	  always	   ‘fast	  and	  automatic’.	  The	  fundamental	  split	  between	  the	  two	  systems	  described	  by	  Dual-­‐Process	  theories	  may	  be	  flawed.	  	  Evans	  (2008)	  proposes	  the	  two	  systems	  are	  not	  actually	  distinct	  entities,	  as	  not	   all	   the	   attributes	   associated	   with	   each	   process	   can	   be	   mapped	   onto	   an	  individual	  system.	  Indeed,	  there	  may	  be	  multiple	  kinds	  of	   implicit,	  non-­‐conscious	  processes	   involved	   in	   determining	   behaviour,	   (and	   response),	   which	   develop	   at	  different	  points	  in	  our	  lifetime,	  (Evans,	  2011).	  Evans	  argues	  that	  the	  only	  empirical	  evidence	  that	  separates	  the	  two	   ‘systems’	   is	   in	  whether	  working-­‐memory	  is	  used	  within	   the	   processing.	   Therefore,	   in	   trying	   to	   identify	   how	   inputs	   within	   the	  placebo	   context	   interact,	   a	   distinct	   separation	   between	   non-­‐conscious	   and	  conscious	  input	  processing	  may	  be	  arbitrary.	  There	  may	  be	  more	  overlap	  between	  ‘systems’	   than	  we	  believe.	  For	  example,	  Mitchell	   and	  De	  Houwer,	   (2009),	   review	  evidence	  to	  suggest	  that,	  to	  some	  degree,	  automatic	  conditioned	  responses	  actually	  involve	   the	   use	   of	   higher-­‐level	   cognitive	   functioning.	   In	   other	   words,	   the	   link	  between	   whether	   it	   is	   possible	   to	   be	   conscious	   of	   an	   input	   doesn’t	   necessarily	  dictate	  the	  way	  in	  which	  it	  is	  processed,	  or	  integrated,	  with	  other	  information.	  In	   summary,	   infornet	   theory	   has	   provided	   a	   significant	   step	   forward	   in	  understanding	   the	  placebo	   response.	  However,	  non-­‐conscious	  priming	   literature,	  and	  literature	  from	  other	  areas	  of	  psychology	  suggest	  that	  subliminally	  presented,	  higher-­‐level	   inputs	  also	  need	  to	  be	  included	  within	  the	  infornet	  model	  of	  placebo	  response.	   Literature	   investigating	   the	   role	   of	   consciousness	   in	   information	  integration	   suggests	   it	   is	   possible	   for	   subliminal	   inputs	   to	   be	   integrated	   with	  explicit	   verbal	   information.	   However,	   Dual-­‐Process	   theories	   of	   learning	   and	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behaviour	   suggest	   this	   integration	   may	   be	   on	   an	   additive,	   rather	   than	   an	  interactive,	  basis.	  
	  1.6 Summary	  and	  Thesis	  
	  The	   definition	   and	   meaning	   attributed	   to	   the	   placebo	   phenomenon	   depends	  largely	  on	  when,	  and	  by	  whom,	  the	  term	  is	  being	  used.	  Whilst	  historically	  placebos	  have	   been	   used	   as	   an	   inert	   tool	   within	   RCT’s,	   the	   academic	   community	   has	  developed	   a	   more	   response-­‐based	   approach.	   Within	   the	   academic	   community,	  conditioning	  and	  response	  expectancy	  have	  been	  the	  predominant	  models	  used	  to	  explain	   the	   placebo	   phenomena.	   However,	  more	   recently	   a	  more	   unified	   theory,	  integrating	   a	   range	   of	   psychological	   and	   biological	   mechanisms,	   has	   been	  proposed.	  	  Infornet	  theory	  proposes	  human	  beings	  possess	  not	  only	  serial-­‐processing	  system,	   but	   also	   parallel-­‐processing	   systems,	   thus	   allowing	   humans	   to	   process	   a	  vast	   range	   of	   inputs	   at	   any	   given	   time,	   and	   to	   adapt	   response	   to	   the	   most	  appropriate	   in	  any	  given	  situation.	  The	  placebo	  response	   is	   seen	  as	  a	   short-­‐term	  problem-­‐solving	  response	  to	  any	  current	  situation	  resulting	  from	  the	  combination	  of	   a	   number	   of	   different	   inputs.	   For	   example,	   inputs	   may	   come	   in	   the	   form	   of	  explicit	   verbal	   information,	   (response	   expectancy),	   or	   implicit	   non-­‐verbal	  information,	   (conditioning).	   The	   placebo	   effect	   is	   viewed	   as	   a	   normal	   response	  demonstrated	  in	  an	  unusual	  way,	  not	  a	  specific	  phenomenon	  in	  itself.	  Whilst	  this	  theory	  goes	  a	  long	  way	  in	  providing	  a	  cohesive	  account	  of	  how	  traditional	   placebo	   mechanisms	   may	   operate	   together,	   there	   is	   a	   large	   area	   of	  psychological	  research	  devoted	  to	  investigating	  the	  effect	  of	  non-­‐reportable	  inputs	  on	  human	  behaviour	  and	  response	  that	  has	  been	  overlooked.	  Subliminal	  priming	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research	  has	  demonstrated	   that	   inputs	  presented	  at	  a	  subliminal	   level	  but	   learnt	  outside	   of	   the	   traditional	   conditioning	   paradigm	   can	   influence	   behavioural,	  emotional	   and	   evaluative	   response.	   The	   question	   remains	  whether	   inputs	   learnt	  and	   presented	   in	   this	   way	   can	   moderate	   physiological	   and	   evaluative	   response	  within	   a	   placebo	   context,	   and	  how	   they	  may	   integrate	  with	   other	   inputs.	   It	   is	   to	  these	  questions	  that	  the	  following	  work	  is	  addressed.	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Chapter	  2	  	  
	  Are	  subliminal	  primes	  used	  in	  placebo	  responding?	  
	  2.1	   Introduction	  
	  Traditionally	   response	   expectancy	   and	   conditioning	  models	   of	   placebo	   response	  have	   been	   used	   to	   explain	   the	   placebo	   phenomena.	   However,	   more	   recently	  infornet	   theory	   has	   proposed	   a	   more	   unified	   approach	   whereby	   the	   placebo	  response	  is	  seen	  as	  a	  short-­‐term	  problem-­‐solving	  response	  to	  a	  combination	  of	  a	  number	  of	  different	  inputs.	  These	  inputs	  can	  take	  many	  forms,	  for	  example,	  explicit	  verbal	   information,	   (response	   expectancy),	   or	   implicit	   non-­‐verbal	   information,	  (conditioning).	  	  	   Infornet	  theory	  states	  that	  the	  priority	  of	  these	  inputs	  may	  alter	  depending	  on	   context.	   For	   example,	   as	   it	   is	   a	   stronger	   predictor	   of	   environmental	  contingencies,	  explicit	  verbal	  information	  is	  more	  likely	  to	  evoke	  a	  response	  than	  implicit	   conditioned	   information	   in	   a	   short-­‐term	   problem-­‐solving	   situation,	  (Hyland,	  2011a;	  Stewart-­‐Williams	  &	  Podd,	  2004a).	  	   In	  relation	  to	  placebo	  response,	  infornet	  theory	  concentrates	  on	  the	  effects	  of	   inputs	   that	   are	   processed	   via	   associative	   learning	   or	   via	   cognitive	   learning.	  Currently,	  infornet	  theory	  assumes	  only	  inputs	  learnt	  via	  associative	  learning	  may	  be	  used	  at	  a	  non-­‐conscious	  level	  to	  alter	  response.	  However,	  there	  is	  an	  extensive	  body	  of	  research	  identifying	  numerous	  effects	  of	  subliminally	  presented	  stimuli	  on	  human	  behaviour	  and	  evaluative	   judgement,	  yet	   the	  effects	  of	   these	  stimuli	  have	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not	   been	   investigated	   specifically	  within	   a	   placebo	   context.	   This	   study	   examines	  whether	   ‘higher-­‐order’	   stimuli,	   learnt	   outside	   of	   the	   traditional	   conditioning	  paradigm	  and	  presented	  at	  a	  subliminal	  level,	  can	  influence	  placebo	  response.	  	  	   To	   this	   end,	   an	   experiment	   was	   designed	   in	   which	   participants	   were	  exposed	   to	   a	   subliminal	   prime	   within	   the	   traditional	   placebo	   paradigm.	   A	  traditional	   verbal	   expectancy	   placebo	   paradigm	   was	   chosen	   for	   two	   reasons.	  Firstly,	   extensive	   evidence	   has	   shown	   that	   consciously	   accessible	   response	  expectancies	  are	  consistently	  predictive	  of	  a	  wide	  range	  of	  placebo	  responses,	  (see	  Kirsch,	  1999	  for	  a	  review),	  and	  tend	  to	  be	  stronger	  than,	  and	  override,	  conditioned	  placebo	  effects,	  (Montgomery	  &	  Kirsch,	  1997).	  A	  verbal	  expectancy	  paradigm	  was	  therefore	  judged	  more	  likely	  to	  produce	  a	  consistent	  placebo	  response.	  	   Secondly,	   within	   a	   traditional	   conditioning	   paradigm,	   conditioned	  information	   is	   learnt	   implicitly	   within	   the	   context	   of	   the	   experiment.	   This	  experiment	   is	   investigating	   the	   role	   of	   another	   form	   of	   implicit	   information,	  (subliminal	  primes),	  within	  the	  placebo	  context.	  It	  is	  currently	  unknown	  how	  two	  types	   of	   implicit	   information	   may	   interact	   within	   an	   experimental	   context,	  therefore	   in	   order	   to	   provide	   a	   direct	   contrast	   between	   the	   placebo	   expectancy	  information	  and	  the	  subliminal	  prime	   information	  an	  explicit	  verbal	  placebo	  was	  used.	  	   One	   criticism	   levelled	   at	   a	   number	  of	   placebo	   studies	   is	   the	   lack	  of	   direct	  physiological	  evidence	  of	  the	  placebo	  effect.	  The	  use	  of	  reported	  information,	  (such	  as	  self-­‐report	  pain	  levels),	  as	  a	  measure	  of	  placebo	  response	  means	  many	  placebo	  effects	  may	  be	  interpreted	  as	  a	  result	  of	  response	  bias,	  (Hróbjartsson	  et	  al.,	  2011).	  However,	  in	  previous	  research,	  a	  placebo	  caffeine	  paradigm	  has	  yielded	  significant	  physiological	   placebo	   responses,	   (Geers	   et	   al.,	   2005a;	   Kirsch	   &	  Weixel,	   1988).	   A	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placebo	   caffeine	   paradigm	   was	   therefore	   chosen	   in	   this	   experiment	   in	   order	   to	  include	  a	  physiological	  measure	  of	  placebo	  response,	  (systolic	  blood	  pressure).	  	   The	   placebo	   information	   used	   in	   this	   paradigm	   aimed	   to	   increase	  participants’	   expectancy,	   and	   experience	   of,	   caffeine-­‐related	   symptoms.	   The	  subliminal	   primes	   were	   chosen	   to	   lead	   participants	   to	   believe	   this	   placebo	  information	  was	   either	   genuine	   by	   using	   ‘genuine’	   related	   subliminal	   primes,	   or	  fake	  by	  using	  ‘fake’	  related	  words.	  	  The	  subliminal	  primes	  were	  presented	  via	  a	  computer-­‐based	  reaction-­‐time	  task	   based	   on	   a	   design	   commonly	   used	   within	   subliminal	   priming	   research,	  (Meerman	  et	  al.,	  2011;	  Barbot	  &	  Kouider,	  2011).	  This	  method	  of	  presentation	  was	  chosen	   as	   alternative	   methods,	   (such	   as	   the	   scrambled	   sentence	   task	   in	   which	  participants	   consciously	   perceive	   priming	   stimuli	   but	   are	   unaware	   it	  may	   affect	  their	  subsequent	  response),	  do	  have	  some	  degree	  of	  conscious	  accessibility.	  Within	  this	  experiment,	  a	  subliminally	  presented	  priming	  method	  was	  chosen	  so	  that	  the	  level	   of	   conscious	   accessibility	   was	   in	   direct	   contrast	   to	   the	   verbal	   placebo	  information.	  	  It	   was	   hypothesised	   that	   participants	   exposed	   to	   verbal	   placebo	  information	  and	  the	  ‘genuine’	  related	  subliminal	  prime	  words	  would	  demonstrate	  a	  higher	  placebo	  response	  than	  participants	  exposed	  to	  verbal	  placebo	  information	  and	  the	  ‘fake’	  related	  subliminal	  prime	  words.	  
	  2.2	   Methods	  
	  
Participants	  and	  Design	  This	   study	   included	   110	   psychology	   undergraduates,	   (88	   women	   and	   22	  men),	   who	   participated	   in	   return	   for	   partial	   course	   credit.	   As	   this	   was	   the	   first	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study	  of	   its	  kind,	   there	  was	  not	  enough	   information	  available	  on	  which	  to	  base	  a	  formal	   power	   analysis.	   Therefore,	   existing	   literature	   was	   used	   as	   a	   guide	   to	  determining	   sample	   size,	   (Geers	   et	   al.,	   2005a;	   Meerman	   et	   al.,	   2011;	   Kirsch	   &	  Weixel,	  1988).	  Due	  to	   logistical	  reasons,	  participants	  were	  tested	  in	  small	  groups	  of	  5	  people.	  For	  safety	  reasons,	  participants	  who	  smoke,	  suffer	  from	  epilepsy,	  have	  a	   known	  heart	   condition	   or	  were	   currently	   taking	   prescription	  medication	  were	  excluded	  from	  the	  experiment.	  These	  exclusions	  were	  also	  included	  in	  part	  to	  raise	  participant	   expectation	   of	   placebo	   effectiveness.	   Participants	   were	   asked	   not	   to	  consume	   any	   caffeinated	   beverages	   on	   the	   day	   of	   the	   study.	   Participants	   were	  randomly	   assigned	   to	   receive	   either	   a	   placebo	   expectation	   or	   no	   placebo	  expectation,	  and	  to	  receive	  either	  a	  ‘genuine’	  subliminal	  semantic	  prime	  or	  a	  ‘fake’	  subliminal	  semantic	  prime.	  This	  results	  in	  a	  2	  (placebo	  expectation)	  x	  2	  (semantic	  prime)	  between	  subject	  design.	  
	  
Measures	  
Systolic	  Blood	  Pressure	  Measure	  Systolic	   blood	   pressure	   measures	   were	   taken	   using	   an	   Omron	   digital	   blood	  pressure	  monitor	   attached	   to	   the	   participants	   non-­‐dominant	   arm.	   Systolic	   blood	  pressure	  was	  chosen	  as	  a	  caffeine-­‐related	  symptom	  as	  previous	  research	  has	  found	  significant	  placebo	  effects	  using	  this	  measure,	  (Kirsch	  &	  Weixel,	  1988;	  Geers	  et	  al.,	  2005a).	  
Baseline	  Caffeine	  Symptom	  Measure	  Participants	   were	   asked	   to	   rate	   the	   intensity	   of	   a	   number	   of	   caffeine	   related	  symptoms	  on	  an	  11-­‐point	  intensity	  scale	  at	  the	  beginning	  of	  the	  study.	  A	  score	  of	  0	  was	  given	  to	  the	  lowest	  symptom	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	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the	  highest	  symptom	  indication	  point.	  Scores	  for	  individual	  items	  were	  then	  added	  together	  and	  averaged	  to	  provide	  a	  mean	  baseline	  caffeine	  symptom	  score.	  	  
Expectancy	  Measure	  Participants	  were	  asked	   to	   rate	   the	   anticipated	   intensity	  of	   a	  number	  of	   caffeine	  related	  symptoms	  10	  minutes	   from	  completing	   the	  questionnaire	  on	  an	  11-­‐point	  intensity	  scale.	  A	  score	  of	  0	  was	  given	  to	  the	  lowest	  symptom	  indication	  point	  and	  a	   score	   of	   10	   was	   given	   to	   the	   highest	   symptom	   indication	   point.	   Scores	   for	  individual	   items	   were	   then	   added	   together	   and	   averaged	   to	   provide	   a	   mean	  expected	   caffeine	   symptom	   score.	   A	   Likert-­‐type	   scale	   was	   chosen	   as	   to	   gauge	  expected	   caffeine-­‐related	   symptoms	   as	   previous	   research	   has	   found	   significant	  placebo	  effects	  using	  these	  measures,	  (Kirsch	  &	  Weixel,	  1988;	  Geers	  et	  al.,	  2005a).	  	  
Self-­Report	  Caffeine	  Symptom	  Measure	  Participants	   were	   asked	   to	   rate	   the	   intensity	   of	   a	   number	   of	   caffeine	   related	  symptoms	  on	  an	  11-­‐point	  intensity	  scale	  at	  the	  end	  of	  the	  study.	  A	  score	  of	  0	  was	  given	  to	   the	   lowest	  symptom	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	   the	  highest	   symptom	   indication	   point.	   Scores	   for	   individual	   items	   were	   then	   added	  together	   and	   averaged	   to	   provide	   a	  mean	   self-­‐report	   caffeine	   symptom	   score.	   A	  Likert-­‐type	   scale	  was	   chosen	   as	   to	   gauge	   caffeine-­‐related	   symptoms	   as	   previous	  research	   has	   found	   significant	   placebo	   effects	   using	   these	   measures,	   (Kirsch	   &	  Weixel,	  1988;	  Geers	  et	  al.,	  2005a).	  
	  
Procedure	  On	   arrival,	   participants	   were	   told	   as	   a	   group	   that	   the	   purpose	   of	   the	   research	  project	   was	   to	   examine	   the	   effects	   of	   caffeine	   on	   reaction	   times.	   They	   were	  reminded	   that	   a	   caffeine	   drink	   may	   be	   administered;	   that	   their	   blood	   pressure	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would	  be	  taken;	  that	  they	  had	  the	  right	  to	  withdraw	  at	  any	  time	  and	  that	  their	  data	  would	  remain	  anonymous	  and	  confidential.	  They	  were	  then	  asked	  to	  read	  and	  sign	  a	  written	  consent	  form.	  	  	   Participants	   were	   then	   randomly	   allocated	   to	   one	   of	   four	   conditions	   –	  Placebo	  /	  Genuine	  Semantic	  Prime;	  No	  Placebo	  /	  Genuine	  Semantic	  Prime;	  Placebo	  /	   Fake	   Semantic	   Prime;	   No	   Placebo	   /	   Fake	   Semantic	   Prime.	   	   Participants	   were	  individually	   informed	  whether	   they	  were	   to	  be	  given	  a	   caffeine	  drink	  during	   the	  course	   of	   the	   experiment	   and	   then	   asked	   to	   complete	   the	   Baseline	   Caffeine	  Symptom	  Measure.	  The	  computer	  randomly	  allocated	  a	  subliminal	  prime	  condition	  to	   the	  participant	   therefore	  both	   the	  participant	   and	   the	  experimenter	   remained	  blind	  as	  to	  which	  masked	  semantic	  prime	  condition	  had	  been	  assigned.	  	   Participants	  were	  then	  seated	  at	  a	  desk	  in	  front	  of	  a	  blank	  computer	  screen	  and	  asked	   to	   relax	   and	   clear	   their	  mind	   for	   a	  duration	  of	  3	  minutes.	  Each	  of	   the	  desks	  had	  a	  partition	  screen	  positioned	  at	  each	  end	  of	   the	   table.	  The	  screen	  was	  approximately	  2	  metres	  high	  and	  90cm	  deep.	  The	  participant	  was	  therefore	  unable	  to	   observe	   anything	   to	   the	   left	   or	   right	   of	   the	   desk	   whilst	   seated.	   After	   the	  relaxation	   period,	   the	   experimenter	   placed	   a	   digital	   blood	   pressure	   cuff	   on	   the	  participants’	  non-­‐dominant	  arm	  and	  3	  blood	  pressure	  readings	  were	  then	  taken	  at	  1	  minute	  intervals.	  	  	   The	   arm	   cuff	   was	   then	   removed	   and	   the	   participants	   directed	   to	   the	  subliminal	  priming	   task	  on	   the	  computer	   screen.	  After	  describing	   the	   task	   to	   the	  participant	  the	  experimenter	  was	  then	  seated	  behind	  the	  desk	  screen	  to	  the	  left	  of	  the	  participant.	  The	  priming	  manipulation	  was	  a	  variation	  of	  a	  common	  paradigm	  whereby	  participants	   judge	  as	  quickly	  and	  accurately	  as	  possible	  whether	  briefly	  flashed	   letter	   strings	   appear	   on	   the	   left	   or	   right	   side	   of	   the	   computer	   monitor,	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(Meerman	  et	  al.,	  2011;	  Lowery	  et	  al.,	  2007).	  The	  task	  was	  presented	  to	  participants	  as	  a	  reaction	  time	  task.	  	  Following	   a	   written	   set	   of	   on-­‐screen	   instructions,	   a	   fixation	   cross	   with	   a	  	  duration	  of	  500	  ms	  appeared	   in	   the	   centre	  of	   the	   screen.	  Participants	  were	   then	  exposed	   to	   a	   prime	  word	   for	   a	   duration	   of	   34	  ms,	   (screen	   refresh	   rate	   17	  ms).	  Prime	   words	   consisted	   of	   10	   ‘genuine’	   semantic	   related	   words	   in	   the	   ‘Genuine	  Semantic	  Prime’	  conditions,	  (for	  example,	  ‘honest’,	  ‘sincere’	  and	  ‘genuine’),	  ‘and	  10	  ‘fake’	   semantic	   related	   words	   in	   the	   ‘Fake	   Semantic	   Prime’	   conditions,	   (for	  example,	  ‘phoney’,	  ‘fake’	  and	  ‘sham’).	  Words	  in	  both	  lists	  were	  matched	  for	  length,	  affect	   and	   frequency	   within	   the	   English	   language	   using	   the	   Affective	   Norms	   for	  English	   Words	   (ANEW)	   scale,	   (Bradley	   &	   Lang,	   1999).	   The	   ANEW	   list	   was	  developed	  by	  Bradley	  and	  Lang,	   (1999),	   to	  provide	  a	   set	  of	  normative	  emotional	  ratings	  for	  a	  large	  number	  of	  words	  in	  the	  English	  language.	  On	  the	  list,	  the	  words	  are	   rated	   in	   for	   valence,	   arousal,	   dominance	   and	   frequency	   within	   the	   English	  language.	  The	  ANEW	  scale	  is	  used	  as	  a	  standard	  for	  many	  studies	  of	  emotion	  and	  attention,	   (for	   example,	   Hamann	   &	   Mao,	   2002;	   Larsen	   et	   al.,	   2003;	   Lewis	   et	   al,	  2005).	  Immediately	   after	   the	   prime	   word,	   a	   7-­‐letter	   ‘X’	   string	   appeared	   on	   the	  computer	  monitor	  for	  a	  duration	  of	  150	  ms.	  Both	  the	  prime	  word	  and	  the	  7-­‐letter	  string	  appeared	  on	  either	  the	  left	  or	  right	  hand	  side	  of	  the	  screen.	  This	  letter	  string	  served	   as	   a	   backward	  mask	   for	   the	   prime	  word.	   Participants	   then	   indicated	   the	  position	  of	   the	  7-­‐letter	  string	  on	   the	  screen	  using	  either	   the	   ‘n’	  or	   ‘m’	  key	  on	   the	  keyboard.	   	   The	   screen	   then	   remained	   blank	   for	   a	   duration	   of	   500	   ms.	   Each	  participant	  was	  given	  5	  practice	  trials.	  Each	  participant	  then	  performed	  Session	  1	  of	  the	  computer	  task,	  consisting	  of	  100	  trials	  during	  which	  the	  10	  prime	  words	  are	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shown	  at	  random.	  At	  the	  end	  of	  the	  trials,	  participants	  were	  then	  prompted	  to	  wait	  for	  further	  instructions	  from	  the	  experimenter	  before	  continuing.	  	  In	   the	  placebo	  expectancy	   conditions,	  participants	  were	   then	  given	  1	   cup,	  (approx.	   200ml),	   of	   decaffeinated	   coffee	  made	  with	   5	   teaspoons	   of	   black	   coffee.	  The	  decaffeinated	  coffee	  was	  made	  in	  front	  of	  participants	  from	  a	   jar	  bearing	  the	  brand	  name	  of	  a	  well-­‐known	  caffeinated	  coffee.	  They	  were	  then	  told	  that	  it	  would	  take	  approximately	  5	  minutes	  for	  the	  coffee	  to	  take	  effect.	  Studies	  have	  shown	  that	  subliminal	  priming	  effects	  can	  last	  for	  up	  to	  2	  minutes,	  (Bargh	  &	  Chartrand,	  2000).	  In	  order	  to	  associate	  the	  placebo	  with	  the	  words	  in	  the	  subliminal	  priming	  task,	  the	  placebo	  was	  therefore	  administered	  directly	  after	  the	  priming	  task	  in	  the	  placebo	  conditions.	  	  Once	  the	  coffee	  had	  been	  administered,	  the	  experimenter	  then	  reattached	  a	  blood	  pressure	  monitor	   to	   the	  non-­‐dominant	  arm	  of	   the	  participant	  and	  3	  blood	  pressure	   readings	   at	   1	   minute	   intervals	   were	   taken.	   After	   the	   blood	   pressure	  readings	  had	  been	  taken,	  the	  arm	  cuff	  was	  removed.	  Participants	  were	  then	  asked	  to	  fill	  out	  the	  expectancy	  measure	  asking	  them	  to	  rate	  the	  anticipated	  intensity	  of	  a	  number	   of	   caffeine	   related	   symptoms	   in	   10	   minutes	   time,	   (expected	   caffeine	  symptoms).	  The	  expectancy	  questionnaire	  was	  administered	  after	   the	  placebo	   in	  order	  to	  maximise	  the	  association	  of	  the	  placebo	  with	  the	  words	  in	  the	  subliminal	  priming	  task.	  After	  completing	  the	  questionnaire,	  participants	  were	  then	  asked	  to	  sit	  and	  wait	  for	  the	  10	  minute	  period	  to	  elapse,	  after	  which	  the	  experimenter	  took	  their	  blood	  pressure	  again.	  Participants	  in	  the	  no	  placebo	  conditions	  watched	  while	  participants	  in	  the	  caffeine	   condition	   drank	   their	   coffee.	   They	   then	   had	   3	   blood	   pressure	   readings	  taken	  from	  their	  non-­‐dominant	  arm	  and	  were	  then	  asked	  to	  fill	  out	  the	  expectancy	  measure.	  After	   completing	   the	  questionnaire,	  participants	  were	   then	  asked	   to	   sit	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and	  wait	   for	   the	   10	  minute	   period	   to	   elapse,	   after	  which	   the	   experimenter	   took	  their	  blood	  pressure	  readings	  again.	  	  Once	   the	   10	   minute	   period	   has	   elapsed,	   the	   experimenter	   collected	   the	  expectancy	   questionnaire	   then	   reattached	   the	   arm	   cuff	   to	   the	   participants’	   non-­‐dominant	   arm.	   A	   further	   3	   blood	   pressure	   readings	   were	   taken	   at	   1	   minute	  intervals.	   Participants	   were	   then	   asked	   to	   fill	   in	   the	   ‘Caffeine	   Response	  Questionnaire’	  as	  a	  subjective	  measure	  of	  placebo	  response.	  In	   order	   to	   maintain	   the	   cover	   for	   the	   experiment,	   all	   participants	   were	  then	  asked	  to	  repeat	  the	  subliminal	  priming	  task	  on	  the	  computer	  screen.	  	  Participants	  then	  completed	  a	  funnel	  debriefing	  form	  to	  probe	  for	  suspicion	  or	  awareness	  of	  the	  caffeine	  placebo,	  the	  subliminal	  prime	  or	  true	  purpose	  of	  the	  study,	  (Chartrand	  &	  Bargh,	  1996).	  All	  participants	  were	  then	  informed	  of	  the	  true	  nature	  of	  the	  experiment	  and	  a	  brief	  explanation	  of	  the	  theory	  behind	  the	  research	  given.	   	  2.3	   Results	  
	  
Sample	  Characteristics	  and	  Baseline	  Scores	  One	   hundred	   and	   ten	   participants	   from	   the	   University	   of	   Plymouth	   took	   part	   in	  return	  for	  partial	  course	  credit.	  Three	  participants	  indicated	  a	  suspicion	  of	  placebo	  during	  the	  debrief	  and	  were	  excluded	  from	  the	  analysis.	  There	  were	  therefore	  86	  females	  and	  21	  males	  with	  a	  mean	  age	  of	  20.5,	   (range	  18	   to	  40),	   included	   in	   the	  analysis	  below.	  
	  An	   experimental	   error	   meant	   baseline	   caffeine	   scores	   were	   measured	   after	  participants	  had	  been	   informed	  of	   their	  placebo	  condition.	  A	  one-­‐way	  analysis	  of	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variance	   revealed	   a	   significant	   difference	   in	   baseline	   caffeine	   symptom	   scores	  between	  participants	  who	  were	  in	  the	  placebo	  condition	  and	  those	  who	  were	  not,	  (d	  =	   -­‐1.24,	   t	  =	   -­‐5.45,	  p	  <	   .0001).	   Consequently,	   baseline	   caffeine	   symptom	  scores	  were	  not	  included	  as	  a	  covariate	  in	  the	  following	  analysis.	  
	  Multiple	  one-­‐way	  analyses	  of	  variance	  showed	  no	  significant	  effects	  of	  gender	  on	  expectancy	  or	  self-­‐report	  caffeine	  scores	  therefore	  male	  and	  female	  responses	  are	  combined	  in	  the	  following	  analysis.	  
	  
Cell	  Means	  Table	  2.1	  below	  shows	  cell	  means,	  (and	  SD),	  on	  all	  measures.	  
	   Table	  2.1:	  Cell	  means	  (and	  SD)	  for	  all	  caffeine	  related	  measures	  (N=107)	  	   No	  Placebo	   Placebo	  Measure	   Genuine	  Prime	   Fake	  Prime	   Genuine	  Prime	   Fake	  Prime	  Systolic	  Blood	  Pressure	  (mm	  HG)	   	   	   	   	  Pretest	   113.7	  (10.01)	   111.3	  (11.45)	   112.2	  (12.86)	   110.7	  (11.06)	  Posttest	   108.5	  (10.29)	   108.5	  (11.87)	   110.6	  (8.92)	   108.9	  (9.61)	  Expected	  Caffeine	  Symptom	  Score	   6.09	  	  	  	  	  	  (1.35)	   5.50	  	  	  	  	  	  (1.64)	   7.34	  	  (0.88)	   7.78	  	  (1.10)	  Self-­‐Report	  Caffeine	  Symptom	  Score	   4.54	  	  	  	  	  	  (0.86)	   4.27	  	  	  	  	  	  (1.03)	   6.28	  	  (1.23)	   6.80	  	  (1.12)	  
Note.	  Higher	  expected	  caffeine	  symptom	  scores	  indicate	  higher	  expected	  levels	  of	  caffeine-­‐related	  symptoms.	  Higher	  self-­‐report	  caffeine	  symptom	  scores	  indicate	  higher	  levels	  of	  reported	  caffeine-­‐related	  symptoms.	  
	  
Expectancy	  –	  Expected	  Caffeine	  Symptom	  Scores	  Preliminary	   analyses	   among	   the	   five	   caffeine	   symptom	   items	   revealed	   that	   the	  ‘anxiety’	  and	  ‘restless’	  items	  were	  not	  significantly	  associated	  with	  the	  other	  three	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items	  on	  this	  measure.	  These	  items	  were	  consequently	  dropped	  from	  the	  analyses.	  The	  mean	  of	  the	  remaining	  three	  items	  were	  then	  calculated	  to	  provide	  expected	  caffeine	  symptom	  scores,	  (α	  =	  .65).	  The	  expected	  caffeine	  symptom	  score	  indicated	  the	   level	   of	   caffeine-­‐related	   symptoms	   participants	   expected	   10	   minutes	   from	  consuming	   the	   caffeine	   placebo,	   (see	   Table	   2.1	   above).	   The	   expected	   caffeine	  symptom	   scores	   were	   then	   entered	   into	   a	   2	   (placebo	   expectation)	   x	   2	   (prime)	  ANOVA.	   Figure	  2.1	   below	   shows	   the	  mean	   expected	   caffeine	   symptom	   scores	   by	  cell.	   Figure	  2.1:	  Mean	  Expected	  Caffeine	  Symptom	  Scores	  by	  cell	  	  	  	  	  	  	  	  	  	  This	  ANOVA	  revealed	  a	  significant	  main	  effect	  of	  placebo	  expectation,	  (F(1,99)	  =	  49.73,	  p	  <	  .0001,	  ηp2	  =	  .334)	  and	  a	  significant	  interaction	  between	  placebo	  expectation	  and	  prime,	  (F(1,99)	  =	  4.18,	  p	  =	  .04,	  ηp2	  =	  .041),	  indicating	  the	  effect	  of	  verbal	  placebo	  information	  differed	  between	  subliminal	  primes.	  No	  significant	  main	  effect	  of	  subliminal	  prime	  was	  found,	  (F(1,99)	  =	  0.09,	  p	  =	  .76,	  ηp2	  =	  .001).	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placebo	   information	   on	   expected	   caffeine	   symptoms	   was	   larger	   in	   the	   ‘Fake’	  subliminal	  prime	  condition,	  (d	  =	  -­‐2.28,	  t	  =	  -­‐5.43,	  p	  <	   .0001),	   than	  in	  the	   ‘Genuine’	  subliminal	  prime	  condition,	  (d	  =	  -­‐1.23,	  t	  =	  -­‐4.25,	  p	  =	  .0001).	  This	  is	  in	  the	  opposite	  direction	   to	   that	   predicted	   by	   the	   hypothesis,	  which	  predicted	   the	   presence	   of	   a	  ‘Fake’	  subliminal	  prime	  would	  reduce	  the	  effect	  of	  the	  verbal	  placebo	  information,	  rather	  than	  increase	  it.	  
	  
Self-­Report	  Caffeine	  Symptom	  Scores	  Preliminary	  analyses	  among	  the	  five	  self-­‐report	  caffeine	  symptom	  items	  revealed	  that	  the	  ‘anxiety’	  item	  was	  not	  significantly	  associated	  with	  the	  other	  four	  items	  on	  this	  measure.	  This	  item	  was	  consequently	  dropped	  from	  the	  analyses.	  The	  mean	  of	  the	   four	   remaining	   items	   was	   then	   calculated	   to	   provide	   a	   self-­‐report	   caffeine	  symptom	   score,	   (α	   =	   .76).	   The	   self-­‐report	   caffeine	   symptom	   score	   indicated	   the	  level	   of	   caffeine-­‐related	   symptoms	   participants	   were	   experiencing	   10	   minutes	  after	  taking	  the	  placebo,	  (see	  Table	  2.1	  above).	  The	  self-­‐report	  caffeine	  scores	  were	  then	  entered	  into	  a	  2	  (placebo	  expectation)	  x	  2	  (prime)	  ANOVA.	  Figure	  2.2	  below	  shows	  the	  mean	  self-­‐report	  caffeine	  symptom	  scores	  by	  cell.	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This	  ANOVA	  revealed	  a	   significant	  main	  effect	  of	  placebo	  expectation,	   (F(1,99)	  =	  91.70,	  p	  <	  .0001,	  ηp2	  =	  .481),	  and	  an	  interaction	  between	  placebo	  expectation	  and	  subliminal	  prime	  that	  was	  approaching	  significance,	  (F(1,99)	  =	  3.71,	  p	  =	  .07,	  ηp2	  =	  .009),	   indicating	   a	   trend	   for	   the	   effect	   of	   verbal	   placebo	   instruction	   to	   differ	  between	   subliminal	   primes.	   No	   significant	   main	   effect	   of	   subliminal	   prime	   was	  found,	  (F(1,99)	  =	  0.32,	  p	  =	  .57,	  ηp2	  =	  .003).	  Figure	  2.2	  above	  shows	  the	  difference	  in	  self-­‐report	   caffeine	   symptoms	   between	   those	   who	   received	   verbal	   placebo	  information	   and	   those	   who	   didn’t	   is	   largest	   in	   the	   ‘Fake’	   subliminal	   prime	  condition,	   (d	  =	  -­‐2.53),	  compared	  to	  participants	   in	   the	   ‘Genuine’	  prime	  condition,	  (d	   =	   -­‐1.73).	   There	   was	   a	   trend	   towards	   a	   larger	   placebo	   effect	   in	   the	   ‘Fake’	  subliminal	   prime	   condition	   when	   compared	   to	   the	   ‘Genuine’	   subliminal	   prime	  condition.	  This	  is	  in	  the	  opposite	  direction	  to	  that	  predicted	  by	  the	  hypothesis.	  	  	  
Systolic	  Blood	  Pressure	  To	  obtain	  a	  baseline	  systolic	  blood	  pressure	  score,	  the	  mean	  of	  participants’	  three	  pretest	   systolic	   blood	   pressure	   readings	   were	   calculated.	   Next,	   the	   mean	   of	   the	  participants’	  final	  three	  systolic	  blood	  pressure	  readings	  were	  calculated	  to	  form	  a	  posttest	   mean.	   (See	   Table	   2.1	   above).	   Examination	   of	   the	   means	   reveals	   that	  overall,	  systolic	  blood	  pressure	  dropped	  during	  the	  course	  of	  the	  study.	  The	  means	  were	  then	  submitted	  to	  a	  2	  (placebo	  expectation)	  x	  2	  (prime)	  ANCOVA,	  with	  mean	  pretest	   systolic	   blood	   pressure	   entered	   as	   a	   covariate.	   Posttest	   systolic	   blood	  pressure	   was	   highly	   correlated	   with	   the	   covariate	   of	   pretest	   systolic	   blood	  pressure,	  (r(105)	  =	  0.66,	  p	  <	   .0001).	  Figure	  2.3	  overleaf	  shows	  the	  mean	  posttest	  systolic	  blood	  pressure	  (mm	  Hg)	  by	  cell.	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Figure	  2.3:	  Mean	  Posttest	  Systolic	  Blood	  Pressure	  (mm	  Hg)	  by	  cell	  
	  	  This	  ANCOVA	  revealed	  no	  significant	  main	  effect	  of	  placebo	  expectation,	  (F(1,103)	  =	  1.92,	  p	  =	  .17,	  ηp2	  =	  .018);	  no	  significant	  main	  effect	  of	  prime,	  (F(1,103)	  =	  0.07,	  p	  =	  .80,	  ηp2	   =	   .001)	   and	   no	   significant	   interaction	   between	   placebo	   expectation	   and	  prime,	  (F(1,103)	  =	  0.74,	  p	  =	  .39,	  ηp2	  =	  .001).	  
	  2.4	   Discussion	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symptoms.	   This	  may	   be	   due	   to	   the	   effects	   of	   the	   prime	  wearing	   off	   as,	   in	   some	  circumstances,	  subliminal	  prime	  effects	  have	  been	  shown	  to	  only	  be	  effective	  up	  to	  2	  minutes	  after	  exposure,	  (Bargh	  &	  Chartrand,	  2000).	  Whilst	  subliminal	  primes	  were	  found	  to	  how	  the	  potential	  to	  moderate	  self-­‐report	  measures,	  neither	  verbal	  placebo	  expectation	  nor	   subliminal	  primes	  were	  found	  to	  have	  any	  significant	  effect	  on	  the	  physiological	  measure	  of	  systolic	  blood	  pressure.	  	  Whilst	  the	  difference	  in	  the	  effects	  of	  the	  ‘Fake’	  verses	  ‘Genuine’	  subliminal	  primes	  on	  self-­‐report	  measures	  was	  as	  predicted,	  the	  specific	  directions	  in	  which	  the	  primes	  acted	  were	  not.	  It	  was	  hypothesized	  that	  the	  ‘genuine’	  subliminal	  prime	  would	  increase	  participants’	  belief	  in	  the	  experiment,	  thereby	  increasing	  response	  expectancy,	   whereas	   the	   ‘fake’	   prime	   would	   decrease	   belief	   in	   the	   experiment	  resulting	  in	  a	   lower	  response	  expectancy	  rating.	  In	  fact,	   the	  opposite	  pattern	  was	  found.	   Participants	   who	   received	   a	   conscious	   placebo	   expectation	   and	   a	   ‘fake’	  subliminal	   prime	   expected	   a	   higher	   change	   in	   the	   caffeine-­‐related	   symptoms	   of	  alertness	  and	  blood	  pressure	  than	  participants	  who	  received	  a	  conscious	  placebo	  expectation	  and	  a	  ‘genuine’	  subliminal	  prime.	  	  	   The	  possible	  explanations	  for	  this	  fall	  into	  two	  categories	  –	  semantic	  use	  of	  the	  subliminal	  prime	  verses	  affective	  use	  of	  the	  subliminal	  prime.	  Firstly,	  semantic	  use	  of	   the	  subliminal	  prime	  may	  have	   led	   to	   the	   ‘Fake’	   subliminal	  prime	  eliciting	  the	   predicted	   pessimism	   regarding	   the	   experiment.	   If	   the	   effects	   of	   the	   caffeine	  were	   viewed	   as	   a	   ‘nocebo’,	   this	   may	   have	   increased	   the	   response	   rather	   than	  decreased	   it.	   For	   example,	   Geers	   et	   al.,	   (2005b),	   found	   pessimists	   react	   more	  strongly	  to	  a	  nocebo	  than	  optimists.	  Alternatively,	   instead	  of	  participants	   relating	   the	  meaning	  of	   the	  prime	   to	  the	   experiment,	   they	   may	   have	   related	   it	   to	   themselves	   thereby	   altering	   their	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behaviour.	   For	   example,	   if	   participants	   applied	   the	   ‘genuine’	   subliminal	  prime	   to	  themselves	  instead	  of	  the	  experimenter,	  it	  may	  have	  elicited	  a	  non-­‐conscious	  goal	  to	   ‘be	   genuine’.	   Non-­‐conscious	   goals	   have	   been	   shown	   to	   moderate	   placebo	  response,	   (Geers	   et	   al.,	   2005a),	   therefore	   a	   goal	   to	   ‘be	   genuine’	   may	   have	  eliminated	  any	  potential	  reporting	  bias	  in	  the	  results.	  	  	   Affective	  use	  of	  the	  subliminal	  prime	  can	  also	  provide	  an	  explanation	  for	  the	  findings.	   It	   has	   been	   demonstrated	   that	   subliminally	   invoked	   affective	   reactions	  may	   alter	   participant	   judgement	   in	   a	   corresponding	   direction,	   particularly	   on	  evaluative	  measures	  such	  as	  a	  rating	  scale,	  (Murphy	  &	  Zajonc,	  1993).	  The	  negative	  valence	  of	  the	  ‘fake’	  prime	  may	  have	  therefore	  increased	  the	  reporting	  of	  caffeine	  related	   symptoms	   if	   they	   were	   viewed	   as	   negative	   within	   the	   context	   of	   the	  experiment.	  	  The	   interaction	   between	   the	   effect	   of	   verbal	   placebo	   information	   and	  subliminal	  primes	  on	  self-­‐report	  measures	  is	  important	  in	  two	  respects.	  Firstly,	  it	  suggests	  that	  it	  is	  possible	  for	  subliminal	  inputs	  to	  integrate	  with	  conscious	  verbal	  information.	  Secondly,	  it	  intimates	  that	  the	  nature	  of	  this	  integration	  may	  not	  occur	  in	   a	   purely	   automatic	   additive	  manner	   as	   suggested	   by	  Dual-­‐Process	   theories	   of	  learning,	   (see	   Section	   1.5.2),	   but	   that	   subliminal	   and	   verbal	   information	   may	  interact	  at	  a	  strategic	  level.	  	   Further,	   the	   effect	   of	   the	   verbal	   placebo	   information	  on	  baseline	   caffeine-­‐symptom	  reporting	  is	  also	  interesting.	  Even	  though	  participants	  were	  told	  that	  the	  effects	  of	  the	  placebo	  caffeine	  would	  not	  take	  effect	  for	  another	  10	  minutes,	  there	  was	  still	  a	  significant	  effect	  on	  the	  symptoms	  they	  reported	  at	  that	  time.	  Although	  unexpected,	  this	  suggests	  that	  the	  reported	  symptoms	  were	  not	  a	  result	  of	  rational	  beliefs,	  but	  a	  result	  of	  more	   irrational	  processing,	  such	  as	  Haug’s,	   (2011),	   ‘Aliefs’,	  or	  a	  more	  spreading	  activation	  type	  effect.	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2.5	   Limitations	  
	  The	   experimental	   error	   regarding	   the	   recording	   of	   baseline	   caffeine	   scores	   after	  participants	   had	   been	   informed	   of	   their	   placebo	   caffeine	   condition	   meant	   that	  participants	  could	  have	  been	  experiencing	  different	  caffeine	  symptoms	  at	  the	  start	  of	   the	   experiment,	   thereby	   introducing	   a	   confounding	   variable	   that	   was	   not	  controlled	  for	  in	  the	  analysis.	  In	  addition,	  the	  expected	  caffeine	  symptom	  score	  was	  found	  to	  have	  only	  modest	  reliability	  and	  therefore	  may	  not	  be	  consistent.	  	   The	  data	  from	  this	  experiment	  may	  be	  seen	  to	  be	  in	  violation	  of	  a	  number	  of	  the	  assumptions	  made	  by	  the	  statistical	  analyses.	  As	  a	  Likert-­‐data	  are	  ordinal,	  the	  assumption	   that	   spacing	   between	  points	   on	   the	   scale	   are	   equal	  may	  not	   be	  met.	  However,	  even	  where	  pain	  ratings	  are	  taken	  on	  a	  continuous	  scale,	  (e.g.	  on	  a	  pain	  dial),	   there	   is	   still	   no	   guarantee	   that	   the	   distance	   between	   points	   are	   ‘equal’	  because	   the	   experience	   of	   pain	   itself	   may	   be	   subject	   to	   non-­‐linear	   scaling.	   The	  results	  from	  the	  Likert-­‐scale	  measures	  used	  in	  this	  experiment	  may	  stand	  if	  we	  are	  to	  accept	  the	  assumption	  that	  spacing	  is	  equal	  and	  follow	  the	  convention	  to	  treat	  Likert-­‐data	  as	  continuous.	  	   In	   addition,	   as	   Likert-­‐data	   are	   ordinal	   and	   therefore	   not	   normally	  distributed	   they	  may	  violate	   the	   assumption	   that	   the	   residuals	   are	  normally	   and	  independently	  distributed.	  However,	   as	   the	   residuals	   in	   this	   set	   of	   analysis	  were	  normally	   distributed	   it	   is	   irrelevant	   that	   they	   are	   derived	   from	   ordinal	   data.	  	  Further,	   (Norman,	  2010),	  argues	   that	   the	  assumption	  of	  normality	  of	  residuals	   is	  not	   critical	   in	   the	   use	   of	   Likert-­‐data,	   and	   that	   point	   estimates	   are	   unlikely	   to	   be	  affected	   by	   the	   violation	   of	   this	   assumption.	   The	   statistical	   tests	   used	   here	   are	  therefore	  generally	  robust	  to	  this	  type	  of	  violation.	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   Another	   assumption	   made	   by	   the	   statistical	   analyses	   is	   homogeneity	   of	  variance	   between	   cells.	   Levene’s	   test	   for	   equality	   of	   variances	   was	   found	   to	   be	  violated	   for	  expected	  caffeine	  symptoms,	   (F(3,99)	  =	  3.97,	  p	  =	   .01),	   in	   the	  present	  analysis.	  However,	   this	  assumption	  may	  be	  breached	   if	   the	  ratio	  of	   the	   largest	   to	  smallest	  cell	  sample	  size	  is	  less	  than	  1.5,	  (The	  Assumption	  of	  Homogeneity,	  2016).	  As	   the	  ratio	  of	   largest	   to	  smallest	  cell	  sample	  size	   is	  1.03	   in	   the	  present	  analysis,	  the	  results	  of	  the	  ANOVA	  test	  may	  stand.	  	   However,	  the	  assumption	  of	  heteroskedasticity	  of	  residuals	  was	  also	  found	  to	  be	  violated	  for	  the	  measure	  of	  expected	  caffeine	  symptoms,	   indicating	  that	  the	  interaction	   between	   placebo	   and	   prime	   may	   not	   be	   robust,	   (SE	   =	   .47,	   p	   =	   .04).	  Robust	   standard	   errors	  were	   therefore	   computed	   as	   a	   sensitivity	   analysis,	   (SE	  =	  .56,	   p	   =	   .07),	   indicating	   that	   the	   interaction	   between	   placebo	   and	   prime	  was	   no	  longer	  significant	  once	  this	  violation	  was	  taken	  into	  account.	  The	  use	  of	  caffeine	  as	  a	  placebo	  has	  also	  been	  shown	  to	  produce	  weak	  and	  inconsistent	   results,	   (Walach	  et	  al.,	  2002).	   In	   retrospect,	   the	  caffeine	  paradigm	   is	  therefore	   perhaps	   not	   the	   best	   paradigm	   to	   use	  when	   investigating	   an	   area	   that	  has	  not	  previously	  been	  examined	  within	  the	  literature.	  	  The	   group	   setting	   for	   this	   experiment	   may	   also	   have	   introduced	  confounding	   variables.	   For	   example,	   Colloca	   and	   Benedetti,	   (2009),	   found	   that	  observing	   the	   placebo	   effect	   in	   the	   experimenter	   prior	   to	   the	   placebo	   being	  administered	   increased	   the	  placebo	   effect.	   This	  may	  have	   extended	   to	   observing	  other	   participants	   in	   this	   experiment,	   thereby	   confounding	   the	   results.	   It	   is	   also	  possible	   that	   the	   ‘no	   placebo’	   control	   group	   may	   have	   experienced	   withdrawal	  symptoms	  whilst	  watching	  others	  drink	  what	  they	  believed	  to	  be	  coffee.	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2.6	   Conclusion	  
This	  study	  suggests	  subliminal	  prime	  information	  has	  the	  potential	  to	  interact	  with	  verbal	   information	   to	   alter	   placebo	   response.	   However,	   these	   findings	   were	  statistically	  weak	  and	  may	  have	  been	  confounded	  by	  experimental	  design.	  	  	  
	  2.7	   Next	  Steps	  
	  Whilst	   these	   data	   suggest	   a	   potential	   role	   for	   ‘higher-­‐order’	   subliminal	   inputs	   in	  moderating	  placebo	   response,	   an	   improved	   experimental	   design	  may	   strengthen	  their	  use	  in	  a	  placebo	  context.	  In	  addition,	  further	  information	  regarding	  whether	  the	  semantic	  or	  affective	  content	  of	  the	  subliminal	  prime	  has	  a	  stronger	  effect	  on	  placebo	  response	  is	  required.	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Chapter	  3	  	  	  Semantic	  verses	  Affective	  use	  of	  subliminal	  primes	  in	  placebo	  responding	  	  3.1	   Introduction	  
	  The	   semantic	   verses	   automatic	   associative	   processing	   of	   subliminal	   primes	   has	  been	   debated	   within	   the	   priming	   literature	   for	   decades	   and	   remains	   a	  controversial	  topic.	  However,	  in	  recent	  years	  it	  has	  become	  more	  widely	  accepted	  that	   both	   non-­‐semantic	   processing,	   (such	   as	   affective	   priming),	   and	   semantic	  processing	   of	   subliminal	   stimuli	   can	   occur	   depending	   on	   experimental	   context,	  (see	  Kouider	  &	  Dehaene,	  2007,	  and	  Van	  den	  Bussche	  et	  al.,	  2009,	  for	  a	  review).	  	  	   	  For	   example,	   following	   a	   meta-­‐analysis	   of	   masked	   subliminal	   priming	  effects,	  Van	  den	  Brussche	  et	  al.,	   (2009),	   concluded	   that	  subliminal	  primes	  can	  be	  processed	   semantically	   when	   the	   opportunity	   to	   form	   automatic	   stimulus-­‐response	  mappings	   is	  not	  present.	  The	   type	  of	  processing	   that	  occurs,	   therefore,	  depends	   on	   experimental	   context.	   This	   was	   supported	   by	   Finkbeiner	   and	  Friedman,	  (2011),	  who	  went	  further	  to	  suggest	  that	  both	  associative	  and	  semantic	  processing	  of	  subliminal	  primes	  can	  occur	  simultaneously	  in	  the	  same	  task	  and	  can	  be	  triggered	  by	  different	  aspects	  of	  experimental	  context.	  	  So	   what	   are	   the	   experimental	   conditions	   that	   can	   influence	   how	   a	  subliminal	   prime	   is	   processed,	   and	  which	   of	   these	   are	   present	  within	   a	   placebo	  paradigm?	  	  
CHAPTER	  3.	  SEMANTIC	  VERSES	  AFFECTIVE	  	  	  
	  69	  
Differences	  in	  experimental	  context	  that	  have	  been	  shown	  to	  influence	  how	  subliminal	   primes	   are	   processed	   include	   the	   type	   of	   task	   used	   to	   measure	   the	  effect,	  (Van	  den	  Bussche	  et	  al.,	  2009;	  Murphy	  &	  Zajonc,	  1983),	  prime	  congruency	  with	   target,	   (Damian,	   2001),	   and	   familiarity	   with	   prime,	   (Naccache	   &	   Dehaene,	  2001).	   Applying	   these	   studies	   to	   the	   placebo	   context	  may	  help	   indicate	  whether	  the	  affective	  or	  semantic	  use	  of	  a	  subliminal	  prime	  is	  more	  likely	  within	  a	  placebo	  paradigm.	  	  Murphy	   and	   Zajonc	   (1983)	   performed	   a	   series	   of	   experiments	  demonstrating	   that	   affective	   subliminal	   priming	   is	  more	   likely	   in	   a	   rating	   based	  task,	   (for	   example,	   a	   Likert-­‐type	   scale),	   whereas	   semantic	   subliminal	   priming	  effects	  are	  more	  likely	  in	  categorisation	  tasks.	  This	  was	  supported	  by	  Greenwald	  et	  al.,	   (1995),	   who	   found	   a	   similar	   pattern	  whereby	   semantic	   effects	   were	   seen	   in	  rational	   categorisation	   tasks	   and	   affective	   primes	   had	   a	   stronger	   influence	   on	  irrational	  rating	  tasks.	  	  	   This	   would	   suggest	   the	   interactive	   effects	   of	   the	   prime	   and	   placebo	  information	  seen	  on	  the	  expected	  caffeine	  symptom	  rating	  scale	  in	  Chapter	  2	  were	  more	  likely	  to	  be	  as	  a	  result	  of	  affective	  subliminal	  priming.	  However,	  Murphy	  and	  Zajonc,	   (1983),	   also	   claim	   that	  non-­‐conscious	  affective	   reactions	  are	   “diffuse	  and	  non-­‐specific”	   and	   can	   therefore	   be	   displaced	   onto	   unrelated	   stimuli.	   This	  wasn’t	  the	   case	   in	   the	   placebo	   paradigm	   in	   Chapter	   2,	   whereby	   the	   subliminal	   primes	  interacted	  with	  the	  placebo.	  If	  the	  effects	  of	  the	  prime	  had	  been	  “diffuse	  and	  non-­‐specific”,	  a	  main	  effect	  of	  the	  prime	  would	  have	  been	  a	  more	  likely	  result.	  Damian	   (2001)	   found	   that	   when	   the	   effects	   of	   a	   subliminal	   prime	   are	  congruent	   with	   the	   target	   this	   is	   likely	   to	   be	   the	   result	   of	   automatic	   stimulus-­‐response	  mappings.	   If	  participants	  viewed	  the	  caffeine-­‐related	  symptoms	  seen	   in	  Chapter	  2	   in	  a	  negative	   light,	   the	  negative	  valence	  of	   the	   ‘Fake’	   subliminal	  prime	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would	   have	   been	   congruent,	   suggesting	   affective	   processing	   is	   a	   possibility.	  Similarly,	   Naccache	   and	   Dehaene,	   (2001),	   found	   non-­‐semantic,	   automatic	  processing	  of	  subliminal	  primes	  is	  more	  likely	  when	  the	  recipient	  is	  familiar	  with	  the	  stimuli.	  In	  Chapter	  2,	  it	  is	  possible	  that	  participants	  were	  familiar	  with	  both	  the	  words	  in	  the	  subliminal	  prime,	  and	  the	  caffeine	  placebo.	  	  	   However,	   there	   is	   also	   evidence	   that	   semantic	   subliminal	  priming	  may	  be	  used	   within	   a	   pain	   paradigm.	   For	   example,	   Meerman	   et	   al.,	   (2011),	   found	   that	  illness-­‐related	   subliminal	   semantic	   primes	   reduced	   pain	   tolerance	   compared	   to	  neutral	   subliminal	   primes,	   whereas	   negatively	   valenced,	   non-­‐illness	   related	  subliminal	  primed	  did	  not.	  As	  pain	  is	  frequently	  used	  within	  a	  placebo	  context,	  this	  suggests	  it	  is	  possible	  that	  subliminal	  semantic	  priming	  may	  be	  applicable	  within	  a	  placebo	  paradigm.	  In	   summary,	   relevant	   subliminal	   priming	   literature	   is	   inconclusive	   as	   to	  which	  form	  of	  subliminal	  priming	  is	  more	  likely	  within	  the	  placebo	  context.	  To	  this	  end,	   an	   experiment	   was	   designed	   to	   directly	   examine	   whether	   affective	   or	  semantic	  subliminal	  priming	  is	  more	  likely	  to	   influence	  placebo	  expectancies	  and	  response.	  As	   in	   the	   previous	   chapter,	   a	   verbal	   expectancy	   placebo	   paradigm	   was	  chosen	   in	   order	   to	   provide	   a	   direct	   contrast	   between	   the	   placebo	   expectancy	  information	   and	   the	   subliminal	   prime	   information.	   However,	   in	   the	   previous	  experiment	   the	   caffeine	   placebo	   paradigm	   failed	   to	   produce	   significant	  physiological	  effects,	   and	  has	  also	  been	  shown	   to	  produce	   inconsistent	   results	   in	  previous	  research,	  (Walach	  et	  al.,	  2002).	  Therefore,	  in	  the	  following	  experiment	  a	  traditional	   placebo	   analgesic	   paradigm	   was	   used.	   In	   addition,	   in	   the	   previous	  experiment,	  testing	  participants	  in	  groups	  introduced	  the	  potentially	  confounding	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variable	  of	  social	  observation,	  (Colloca	  &	  Benedetti,	  2009),	   therefore	  participants	  were	  tested	  individually	  in	  the	  following	  experiment.	  Placebo	   analgesia	   is	   one	   of	   the	   most	   well	   documented	   and	   consistent	  placebo	  phenomena	  within	  current	  literature,	  (Colloca	  &	  Benedetti,	  2006;	  Tracey,	  2010).	  Within	   a	   laboratory	   context,	   previous	   research	   on	   placebo	   analgesia	   has	  successfully	  employed	  a	  combination	  of	  placebo	  cream	  with	  a	  painful	  stimulus	  to	  the	   fingers	   induced	   via	   the	   Fordyce	   Finger	   Crushers,	   (Montgomery	   and	   Kirsch,	  1996).	  Therefore	  this	  was	  the	  approach	  adopted	  here.	  	  The	   verbal	   placebo	   information	   in	   this	   paradigm	   leads	   participants	   to	  expect	   a	   decrease	   in	   pain	   levels	   from	   the	   Fordyce	   Finger	  Crushers	   following	   the	  application	   of	   the	   placebo	   analgesic	   cream.	   In	   the	   semantic	   subliminal	   prime	  condition,	  words	  were	  chosen	  in	  order	  to	  increase	  participant	  belief	  in	  the	  placebo	  cream’s	   effectiveness,	   (for	   example,	   ‘potent’	   and	   ‘effective’).	   In	   the	   affective	  subliminal	  prime	  condition,	  words	  were	  chosen	  to	  induce	  an	  overall	  positive	  mood	  in	   the	   participant,	   (for	   example,	   ‘delight’	   and	   ‘happy’).	   A	   set	   of	   neutral	   words	  relating	  to	  everyday	  objects	  that	  held	  no	  obvious	  direct	  semantic	  relevance	  to	  the	  placebo	  cream	  or	  valence	  was	  chosen	  as	  a	  neutral	  control.	  	  The	  subliminal	  primes	  were	  presented	  via	  a	  computer-­‐based	  reaction-­‐time	  task	   based	   on	   a	   design	   commonly	   used	   within	   subliminal	   priming	   research,	  (Meerman	   et	   al.,	   2011;	  Barbot	  &	  Kouider,	   2011).	   As	   in	   the	  previous	   experiment,	  this	  method	  of	   presenting	   the	   subliminal	   primes	  was	   chosen	   so	   that	   the	   level	   of	  conscious	  accessibility	  was	  in	  direct	  contrast	  to	  the	  verbal	  placebo	  information	  in	  order	  that	  a	  comparison	  can	  be	  made	  between	  the	  two	  forms	  of	  input.	  It	  was	  hypothesised	  that	  both	  the	  semantic	  and	  affective	  subliminal	  primes	  would	   increase	   the	   effect	   of	   the	   verbal	   placebo	   expectations	   compared	   to	   the	  neutral	  subliminal	  prime.	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3.2	   Methods	  
	  
Participants	  and	  Design	  This	   study	   included	   103	   psychology	   undergraduates,	   (85	   women	   and	   15	  men),	  who	  participated	  in	  return	  for	  partial	  course	  credit.	  Existing	  literature	  was	  used	  as	  a	  guide	   to	  determining	  sample	  size,	   (Geers	  et	  al.,	  2005a;	  Meerman	  et	  al.,	  2011;	  Montgomery	  &	  Kirsch,	  1996).	  For	   safety	   reasons,	  participants	  who	  smoke,	  suffer	   from	   epilepsy,	   have	   a	   known	   heart	   condition	   or	   were	   currently	   taking	  prescription	   medication	   were	   excluded	   from	   the	   experiment.	   These	   exclusions	  were	  also	  included	  in	  part	  to	  raise	  participant	  expectation	  of	  placebo	  effectiveness.	  	  Participants	  were	  randomly	  assigned	  to	  receive	  either	  a	  placebo	  expectation	  or	  no	  placebo	   expectation,	   and	   to	   receive	   an	   affective	   subliminal	   prime,	   a	   semantic	  subliminal	   semantic	   prime	   or	   a	   neutral	   subliminal	   prime.	   This	   results	   in	   a	   2	  (placebo	  expectation)	  x	  3	  (prime)	  mixed	  design.	  	  
Measures	  
Pain	  Stimuli	  Pain	  was	  generated	  using	  two	  identical	  Fordyce	  Finger	  Crushers,	  (shown	  in	  Figure	  3.1	  overleaf).	  The	  device	  consists	  of	  a	  weight	  (900g)	  at	   the	  end	  of	  a	  movable	  bar	  (231g)	  that	  pivots	  from	  a	  stand	  at	  one	  end.	  Participants	  place	  their	  index	  finger	  on	  a	  grooved	  notch	  on	   top	  of	  a	  50mm	  stand	  and	   the	  bar	   is	  gently	   lowered	  onto	   the	  finger.	  The	  bar	  tapers	  to	  a	  2mm	  point	  of	  contact.	  The	  apparatus	  is	  adjusted	  so	  that	  the	   remaining	   three	   fingers	   can	   rest	   on	   the	  platform	  between	   the	   stand	   and	  bar	  attachment.	   The	   apparatus	   is	   designed	   to	   deliver	   approximately	   2041	   grams	   of	  force	   to	   the	   finger.	   A	   set	   of	   identical	   apparatus	   is	   used	   simultaneously	   on	   each	  hand.	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   Figure	  3.1:	  Fordyce	  Finger	  Crushers	  	  	  	  	  	  	  	  	  
	  
Placebo	  Cream	  The	   cream	   consisted	   of	   an	   aqueous	   cream	   purchased	   from	   the	   local	   chemist.	   In	  order	  to	  ensure	  the	  cream	  was	  a	  plausible	  analgesic,	  the	  label	  was	  printed	  on	  a	  dot-­‐matrix	   printer,	   (as	   used	   in	   chemists).	   The	   drug	   name	   ‘Trivaricane’,	   invented	   by	  Irving	  Kirsch	  and	  used	   in	  previous	  placebo	   studies,	  was	  visible	  on	   the	   label.	  The	  label	   also	   displayed	   the	   caption	   ‘Apply	   thinly	   to	   affected	   area’,	   and	   a	   fictitious	  consistency,	   (Chlorophate	  0.1%,	  Phenylhydrate-­‐3	  0.2%),	   (as	   shown	   in	  Figure	  3.2	  below).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Figure	  3.2:	  The	  placebo	  analgesic	  packaging	  	  	  	  	  	  	  	  
Expectancy	  Measure	  	  Expectancy	   ratings	   were	   measured	   on	   an	   11-­‐point	   intensity	   scale,	   with	   the	  endpoints	   marked	   0:	   No	   pain	   at	   all	   and	   10:	   The	   worst	   pain	   you	   can	   imagine.	   A	  separate	   pain	   rating	   was	   taken	   for	   each	   hand.	   Participants	   were	   asked:	   “How	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intensely	   do	   you	   think	   the	   lever	   will	   hurt	   on	   the	   finger	   [with	   /	   without]	   the	  cream?”	  A	  score	  of	  0	  was	  given	  to	  the	  lowest	  pain	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  highest	  pain	  indication	  point.	  The	  pain	  intensity	  score	  given	  to	  the	  question	  relating	  to	  the	  finger	  with	  the	  cream	  was	  used	  as	  the	  expected	  pain	  score	  within	   the	   placebo	   condition.	   The	   pain	   intensity	   score	   given	   to	   the	   question	  relating	   to	   the	   finger	   without	   the	   cream	   was	   used	   as	   the	   expected	   pain	   score	  within	   the	   no	   placebo	   condition.	   A	   Likert-­‐type	   pain	   scale	  was	   chosen	   as	   a	   large	  proportion	  of	  research	  into	  placebo	  analgesia	  has	  found	  significant	  placebo	  effects	  using	  this	  measure,	  (Spiro,	  1997;	  Tracey,	  2010).	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Mood	  Measure	  	  Mood	   ratings	   were	   measured	   using	   the	   Positive	   and	   Negative	   Affect	   Schedule,	  (PANAS; Watson	   et	   al.,	   1998).	   The	   PANAS	   contains	   a	   list	   of	   10	   descriptors	   of	  positive	  affect,	  (e.g.,	  excited),	  and	  10	  descriptors	  of	  negative	  affect,	  (e.g.,	  distressed).	  The	   descriptors	   are	   rated	   on	   5-­‐point	   scales	   with	   the	   endpoints	   marked	   1:	   Very	  
Slightly	   or	   Not	   At	   All	   to	   5:	   Extremely.	   Responses	   to	   the	   10	   positive	   items	   are	  summed	  to	  create	  a	  positive	  mood	   index	  and	  responses	   to	   the	  10	  negative	   items	  are	   summed	   to	  create	  a	  negative	  mood	   index.	  The	  PANAS	  scale	  was	  chosen	  as	   it	  has	  been	  shown	  to	  be	  a	  reliable	  and	  valid	  measure	  of	  positive	  and	  negative	  mood,	  (Crawford	  &	  Henry,	  2004).	  
	  
Procedure	  On	   arrival,	   participants	   were	   told	   that	   the	   focus	   of	   the	   research	   project	   was	   to	  examine	  the	  effects	  of	  pain	  on	  reaction	  times.	  They	  were	  reminded	  that	  a	  painful	  stimulus	  would	  be	  applied;	   that	   they	  have	  the	  right	   to	  withdraw	  at	  any	  time	  and	  that	  their	  data	  will	  remain	  anonymous	  and	  confidential.	  They	  were	  then	  asked	  to	  read	  and	  sign	  a	  written	  consent	  form.	  	  Participants	  were	  then	  randomly	  allocated	  to	  one	  of	  three	  conditions	  by	  the	  computer	   –	   semantic	   subliminal	   prime,	   affective	   subliminal	   prime	   or	   neutral	  subliminal	   prime.	   The	   experimenter	   was	   therefore	   blind	   as	   to	   which	   subliminal	  prime	  condition	  was	  allocated.	  Participants	   were	   then	   seated	   at	   a	   desk	   and	   directed	   to	   a	   subliminal	  priming	  task	  on	  the	  computer	  screen.	  The	  desk	  had	  a	  partition	  screen	  positioned	  at	  each	  end	  of	  the	  table.	  The	  screen	  was	  approximately	  2	  metres	  high	  and	  90cm	  deep.	  The	  participant	  was	  therefore	  unable	  to	  observe	  anything	  to	  the	  left	  or	  right	  of	  the	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desk	  whilst	  seated.	  After	  describing	  the	  computer	  task	  the	  experimenter	  was	  then	  seated	  behind	  the	  screen	  to	  the	  left	  of	  the	  participant.	  	  The	  priming	  manipulation	  was	  a	  variation	  of	  a	  common	  paradigm	  whereby	  participants	   judge	   as	   quickly	   and	   accurately	   as	   possible	   whether	   briefly	   flashed	  letter	  strings	  appear	  on	  the	  left	  or	  right	  side	  of	  the	  computer	  monitor,	  (Meerman	  et	  al.,	  2011;	  Lowery	  et	  al.,	  2007).	  The	  task	  was	  presented	  to	  participants	  as	  a	  reaction	  time	  task.	  Following	  a	  written	  set	  of	  on-­‐screen	  instructions,	  a	  fixation	  cross	  appeared	  in	  the	  centre	  of	  the	  screen	  for	  duration	  of	  500	  ms.	  Participants	  were	  then	  exposed	  to	   a	   prime	   word	   for	   a	   duration	   of	   34	   ms,	   (screen	   refresh	   rate	   17	   ms).	   In	   the	  semantic	   prime	   condition,	   participants	  were	   subliminally	   exposed	   to	   four	  words	  relating	   to	   the	   effectiveness	   and	   potency	   of	   the	   analgesic	   cream,	   (for	   example,	  ‘effective’	   and	   ‘potent’).	   In	   the	   affective	   prime	   condition,	   participants	   were	  subliminally	   exposed	   to	   four	   words	   relating	   to	   positive	   affect,	   (for	   example,	  ‘delight’	   and	   ‘happy’).	   In	   the	   neutral	   prime	   condition,	   participants	   were	  subliminally	  exposed	  to	  words	  relating	  to	  everyday	  objects,	  (for	  example,	   ‘barrel’	  and	  ‘chair’).	  	  Words	  in	  the	  affective	  prime	  condition	  were	  rated	  between	  8.0	  and	  8.56	  in	  the	   ‘Affective	  Norms	  for	  English	  Words’	  (ANEW)	  list	  compiled	  in	  earlier	  research	  by	   Bradley	   &	   Lang,	   (1999),	   and	   words	   in	   the	   neutral	   prime	   condition	   were	  everyday	  objects	   rated	  between	  5.0	   and	  5.22	   in	   the	   ‘Affective	  Norms	   for	  English	  Words’	  (ANEW)	  list.	  The	  ANEW	  list	  was	  developed	  by	  Bradley	  and	  Lang,	  (1999),	  to	  provide	  a	  set	  of	   normative	   emotional	   ratings	   for	   a	   large	   number	   of	   words	   in	   the	   English	  language.	  On	   the	   list,	   the	  words	  are	  rated	   in	   for	  valence,	  arousal,	  dominance	  and	  frequency	  within	  the	  English	  language.	  The	  ANEW	  scale	  is	  used	  as	  a	  standard	  for	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many	  studies	  of	  emotion	  and	  attention,	  (for	  example,	  Hamann	  &	  Mao,	  2002;	  Larsen	  et	  al.,	  2003;	  Lewis	  et	  al,	  2005).	  Words	  in	  all	  lists	  were	  also	  matched	  for	  length	  and	  frequency	  within	  the	  English	  language	  using	  same	  scale.	  Immediately	   after	   the	   prime	   word,	   a	   7-­‐letter	   ‘X’	   string	   appeared	   on	   the	  computer	  monitor	  for	  a	  duration	  of	  150	  ms.	  Both	  the	  prime	  word	  and	  the	  7-­‐letter	  string	  appeared	  on	  either	  the	  left	  or	  right	  hand	  side	  of	  the	  screen.	  This	  letter	  string	  served	  as	  a	  backward	  mask	  for	  the	  prime	  word.	  Participants	  indicated	  the	  position	  of	  the	  7-­‐letter	  string	  on	  the	  screen	  using	  either	  the	  ‘n’	  or	  ‘m’	  key	  on	  the	  keyboard.	  	  The	   screen	   then	   remained	   blank	   for	   duration	   of	   500	   ms.	   Each	   participant	   was	  given	   5	   practice	   trials.	   Each	   participant	   then	   completed	   the	   reaction	   time	   the	  computer	   task,	   consisting	  of	   100	   trials	   during	  which	   the	   four	  prime	  words	  were	  shown	  at	  random.	  At	  the	  end	  of	  the	  trials,	  participants	  were	  prompted	  to	  wait	  for	  further	  instructions	  from	  the	  experimenter	  before	  continuing.	  Studies	   have	   shown	   that	   subliminal	   priming	   effects	   can	   last	   for	   up	   to	   2	  minutes,	   (Bargh	   &	   Chartrand,	   2000).	   In	   order	   to	   associate	   the	   placebo	  with	   the	  words	  in	  the	  subliminal	  priming	  task,	  the	  placebo	  was	  administered	  directly	  after	  the	  priming	  task	  in	  the	  placebo	  conditions.	  The	  experimenter	  wore	  surgical	  gloves	  to	  apply	  the	  placebo	  cream	  to	  either	  the	  left	  or	  right	  index	  finger	  of	  the	  participant	  at	  random.	  The	  cream	  was	  described	  to	  participants	  as	   ‘a	  well-­‐used	  and	  effective	  drug	   that	   is	   safe	   and	  well-­‐tested’.	   The	   participant’s	   other	   index	   finger	   remained	  untreated.	  Expectancy	  ratings	  were	  then	  taken	  and	  participants	  asked	  to	  complete	  a	  mood	  manipulation	  check	  consisting	  of	  a	  ‘Positive	  and	  Negative	  Affect	  Schedule’	  questionnaire,	   (Watson	   et	   al.,	   1998).	   The	   expectancy	   questionnaire	   was	  administered	  after	  the	  placebo	  in	  order	  to	  maximise	  the	  association	  of	  the	  placebo	  with	   the	   words	   in	   the	   subliminal	   priming	   task.	   Pain	   was	   then	   applied	  simultaneously	   to	   both	   index	   fingers	   for	   a	   period	   of	   1	  minute	   using	   the	   Fordyce	  
CHAPTER	  3.	  SEMANTIC	  VERSES	  AFFECTIVE	  	  	  
	   78	  
Finger	  Crushers.	  Pain	  intensity	  was	  then	  measured	  separately	  for	  both	  fingers.	  In	  order	  to	  maintain	  the	  cover	  for	  the	  experiment,	  participants	  were	  asked	  to	  repeat	  the	  subliminal	  priming	  task	  on	  the	  computer	  screen,	  (Session	  2).	  	  All	   participants	   then	   completed	   a	   funnel	   debriefing	   form	   to	   probe	   for	  suspicion	   or	   awareness	   of	   the	   analgesic	   placebo,	   the	   subliminal	   prime	   or	   true	  purpose	   of	   the	   study,	   (Chartrand	   &	   Bargh,	   1996).	   All	   participants	   were	   then	  informed	  of	  the	  true	  nature	  of	  the	  experiment	  and	  a	  brief	  explanation	  of	  the	  theory	  behind	  the	  research	  given.	  	  3.3	   Results	  
Sample	  Characteristics	  and	  Baseline	  Scores	  One	  hundred	  and	  three	  participants	  from	  the	  University	  of	  Plymouth	  took	  part	  in	  return	  for	  partial	  course	  credit.	  Three	  participants	  indicated	  a	  suspicion	  of	  placebo	  during	   debrief	   and	   were	   excluded	   from	   the	   analysis.	   There	   were	   therefore	   85	  females	  and	  15	  males	  with	  a	  mean	  age	  of	  21.4,	   (range	  18	   to	  53),	   included	   in	   the	  analysis	  below.	  	  Multiple	  one-­‐way	  analyses	  of	  variance	  showed	  no	  significant	  effects	  of	  gender	  on	  expectancy	   or	   self-­‐report	   pain	   scores	   therefore	   male	   and	   female	   responses	   are	  combined	  in	  the	  following	  analyses.	  	  
Manipulation	  Checks	  Responses	  to	  the	  10	  positive	  items	  on	  the	  PANAS	  scale	  were	  summed	  to	  create	  a	  positive	   mood	   score,	   (α	   =	   .88), and	   responses	   to	   the	   10	   negative	   items	   on	   the	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PANAS	  scale	  were	  summed	   to	  create	  a	  negative	  mood	  score, (α	  =	   .78). Table	  3.1	  overleaf	  shows	  mean	  PANAS	  scores,	  (and	  SD),	  by	  subliminal	  prime	  condition.	  
	  	  	  	  	  Table	  3.1:	  Mean	  PANAS	  scores,	  (and	  SD)	  by	  subliminal	  prime	  condition	  (N=107)	  
	  	  
Note.	   Higher	   positive	   affect	   scores	   indicate	   higher	   levels	   of	   positive	   affect.	   Higher	   negative	  	  	  affect	  scores	  indicate	  higher	  levels	  of	  negative	  affect.	  	  Multiple	  simple	  contrasts	  between	  cell	  means	  revealed	  a	  significant	  difference	   in	  mean	  positive	  mood	  PANAS	  scores	  between	  affective	  and	  neutral	  subliminal	  prime	  conditions,	   (t(2)	  =	  2.73,	  p	  =	   .01,	  d	  =	  0.64),	  but	  not	  between	  semantic	  and	  neutral	  subliminal	   prime	   conditions,	   (t(2)	   =	   1.07,	   p	   =	   .29,	   d	   =	   0.28).	   There	   were	   no	  significant	   differences	   in	   mean	   negative	   mood	   PANAS	   scores	   between	   any	  conditions.	   This	   indicates	   that	   the	   affective	   subliminal	   prime	   manipulation	   was	  successful.	  
	  
Cell	  Means	  
	  Table	  3.2	  overleaf	  shows	  cell	  means,	  (and	  SD),	  on	  all	  measures.	  	  	  	  	  	  
	   Semantic	  Prime	   Affective	  Prime	   Neutral	  Prime	  	  Positive	  Affect	  PANAS	  Score	  	   26.31	  (5.93)	   29.28	  (8.22)	   24.56	  (6.52)	  	  Negative	  Affect	  PANAS	  Score	  	   14.06	  (5.12)	   13.93	  (4.11)	   14.00	  (4.33)	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Table	  3.2:	  Cell	  means	  (and	  SD)	  for	  all	  pain	  measures	  (N=107)	  	   Placebo	   No	  Placebo	  Measure	   Semantic	  Prime	   Affective	  Prime	   Neutral	  Prime	   Semantic	  Prime	   Affective	  Prime	   Neutral	  Prime	  Expected	  Pain	  Scores	   3.40	  (1.87)	   3.72	  (1.51)	   4.28	  (1.68)	   5.30	  (1.89)	   6.21	  (1.78)	   5.92	  (2.60)	  Self-­‐Report	  Pain	  Scores	   5.11	  (2.08)	   4.79	  (2.90)	   5.00	  (2.56)	   6.09	  (2.56)	   6.24	  (2.05)	   5.56	  (1.78)	  
Note.	  Higher	  pain	  scores	  indicate	  higher	  levels	  of	  expected	  and	  reported	  pain.	  	  
	  
Expectancy	  –	  Expected	  Pain	  Scores	  Means	   for	   expected	   pain	   measures	   are	   shown	   in	   Table	   3.2	   above.	   These	   were	  submitted	   to	   a	   2	   (placebo)	   *	   3	   (prime)	   mixed	   effects	   regression. F	   tests	   for	  categorical	   effects	   and	   interactions	   are	   not	   available	   in	   linear	  mixed-­‐models.	   To	  conduct	  a	  null	  hypothesis	   significance	   test	   for	   the	  effect	  of	   a	   categorical	   factor,	   a	  Chi	  Squared	  value	   is	  obtained	  by	  comparing	  the	  difference	   in	   likelihood	  between	  models	  with	  and	  without	  the	  factor	  (with	  degrees	  of	  freedom	  being	  N-­‐1	  where	  N	  is	  the	  number	  of	   levels	   of	   the	   factor).	   Figure	  3.3	  below	   shows	  mean	   expected	  pain	  scores	  by	  cell.	   Figure	  3.3:	  Mean	  expected	  pain	  scores	  by	  cell	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This	   analysis	   yielded	   a	   significant	   main	   effect	   of	   placebo,	   (x2	   (1)	   =	   159.25,	   p	   <	  .0001,	  f2	  =	  1.519),	  but	  no	  significant	  main	  effect	  of	  prime,	  (x2	  (2)	  =	  4.45,	  p	  =	  .11,	  f2	  =	  -­‐1.599).	   The	   interaction	   between	   placebo	   and	   prime	   showed	   a	   trend	   towards	  significance,	  (x2	  (2)	   	  =	  5.15,	  p	  =	   .07,	  f2	  =	  -­‐0.051),	  indicating	  the	  size	  of	  the	  effect	  of	  the	   placebo	   on	   expected	   pain	   may	   have	   differed	   slightly	   between	   primes.	   An	  examination	   of	   cell	  means,	   (shown	   in	   Figure	   3.3	   above),	   shows	   the	   effect	   of	   the	  placebo	  on	  expected	  pain	  was	  greater	  in	  the	  affective	  prime	  condition,	  (d	  =	  –	  2.48),	  compared	   to	   the	   semantic	   prime	   condition,	   (d	   =	   –	   1.80),	   and	   the	   neutral	   prime	  condition,	  (d	  =	  –	  1.64).	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This	  analysis	  yielded	  a	  significant	  main	  effect	  of	  placebo	  on	  self-­‐report	  pain	  scores,	  (x2	  (1)	  =	  15.78,	  p	  =	  .0001,	  f2	  =	  0.151).	  Examination	  of	  cell	  means,	  (shown	  in	  Figure	  3.4	   above),	   indicate	   that	   lower	   pain	  was	   reported	   in	   the	   placebo	   conditions.	   No	  significant	  main	  effect	  of	  prime,	  (x2	   (2)	  =	  0.69,	  p	  =	   .71,	   f2	  =	  -­‐1.105),	  or	   interaction	  between	  placebo	  and	  prime,	  (x2	  (2)	  =	  2.07,	  p	  =	  .35,	  f2	  =	  -­‐0.021),	  was	  found.	  
	  3.4	   Discussion	  
	  This	   experiment	   found	   a	   significant	   main	   effect	   of	   the	   placebo	   in	   the	   predicted	  direction,	  reducing	  both	  expected	  pain	  and	  self-­‐report	  pain.	  This	  experiment	  also	  found	   an	   interaction	   that	   was	   approaching	   significance	   between	   placebo	   and	  subliminal	   prime	   in	   expected	  pain.	   This	   trend	  was	  not	   found	   in	   self-­‐report	   pain,	  possibly	  because	  the	  effects	  of	  the	  prime	  wore	  off.	  	   Although	  only	  approaching	  significance,	  the	  interactive	  effect	  of	  the	  placebo	  and	  subliminal	  prime	  on	  expected	  pain	  supports	  Van	  den	  Brussche	  et	  al.,	   (2009),	  by	   demonstrating	   both	   semantic	   and	   non-­‐semantic	   processing	   of	   subliminal	  primes	  is	  possible.	  The	  results	  of	  this	  experiment	  show	  both	  the	  semantic	  and	  non-­‐semantic	   processing	   of	   primes	   have	   the	   potential	   to	   moderate	   response	  expectancy	  within	  a	  placebo	  context.	  	   In	  this	  experiment,	  the	  effect	  of	  the	  placebo	  on	  expected	  pain	  was	  greater	  in	  the	   affective	   subliminal	   prime	   condition	   than	   the	   semantic	   subliminal	   prime	  condition,	   (compared	   to	   neutral).	   This	   supports	   Murphy	   and	   Zajonc’s,	   (1983),	  finding	  that	  affective	  priming	  is	  greater	  when	  measured	  using	  a	  ratings	  task,	  (such	  as	   the	   Likert-­‐type	   pain	   scale	   used	   here).	   However,	   once	   again,	   this	   was	   not	   an	  undifferentiated	  automatic	  effect	  but	  strategically	  interacted	  with	  the	  placebo.	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This	  finding	  is	  also	  contrary	  to	  the	  results	  of	  Meerman	  et	  al.,	  (2011),	  where	  no	  effect	  of	  affective	  subliminal	  primes	  on	  pain	  tolerance	  was	  found.	  It	  is	  possible	  that	   Meerman	   and	   colleagues	   didn’t	   find	   these	   effects	   as	   they	   were	   using	   a	  behavioural	  measure	  of	  pain	  rather	  than	  a	  ratings	  scale	  where	  the	  effects	  of	  non-­‐conscious	  affective	  primes	  are	  more	  likely	  to	  be	  seen,	  (Murphy	  &	  Zajonc,	  1993).	  
	  3.5	   Limitations	  
	   The	  data	  from	  this	  experiment	  may	  be	  seen	  to	  be	  in	  violation	  of	  two	  of	  the	  assumptions	   made	   by	   the	   statistical	   analyses.	   As	   a	   Likert-­‐data	   are	   ordinal,	   the	  assumption	   that	   spacing	   between	  points	   on	   the	   scale	   are	   equal	  may	  not	   be	  met.	  However,	  even	  where	  pain	  ratings	  are	  taken	  on	  a	  continuous	  scale,	  (e.g.	  on	  a	  pain	  dial),	   there	   is	   still	   no	   guarantee	   that	   the	   distance	   between	   points	   are	   ‘equal’	  because	   the	   experience	   of	   pain	   itself	   may	   be	   subject	   to	   non-­‐linear	   scaling.	   The	  results	  from	  the	  Likert-­‐scale	  measures	  used	  in	  this	  experiment	  may	  stand	  if	  we	  are	  to	  accept	  the	  assumption	  that	  spacing	  is	  equal	  and	  follow	  the	  convention	  to	  treat	  Likert-­‐data	  as	  continuous.	  	   In	   addition,	   as	   Likert-­‐data	   are	   ordinal	   and	   therefore	   not	   normally	  distributed	  they	  may	  violate	  the	  assumption	  made	  by	  the	  statistical	  analyses	  that	  the	   residuals	   are	   normally	   and	   independently	   distributed.	   However,	   as	   the	  residuals	  in	  this	  set	  of	  analysis	  were	  normally	  distributed	  it	  is	  irrelevant	  that	  they	  are	   derived	   from	   ordinal	   data.	   	   Further,	   (Norman,	   2010),	   argues	   that	   the	  assumption	  of	  normality	  of	   residuals	   is	  not	   critical	   in	   the	  use	  of	  Likert-­‐data,	   and	  that	  point	  estimates	  are	  unlikely	  to	  be	  affected	  by	  the	  violation	  of	  this	  assumption.	  The	   statistical	   tests	   used	   here	   are	   therefore	   generally	   robust	   to	   this	   type	   of	  violation.	   However,	   the	   Likert-­‐type	   scales	   used	   to	   measure	   expected	   and	   self-­‐
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report	  pain	   in	  placebo	  and	  no	  placebo	  conditions	  consisted	  of	  only	  a	  single	   item.	  They	  are	  therefore	  less	  likely	  to	  be	  reliable	  and	  valid	  measures	  of	  pain.	  	  It	  is	  also	  possible	  the	  PANAS	  measure	  could	  have	  acted	  as	  a	  prime	  for	  affect,	  or	   brought	   the	   non-­‐conscious	   affect	   generated	   by	   the	   prime	   into	   consciousness	  therefore	  confounding	  the	  results.	  	  	  3.6	   Conclusion	  
	  It	  is	  possible	  that	  both	  affective	  and	  semantic	  processing	  of	  subliminal	  primes	  may	  interact	  with	   verbal	   information	   in	   the	   generation	   of	   response	   expectancies	   in	   a	  placebo	   context.	   However,	   this	   effect	   was	   only	   approaching	   significance	   in	   this	  experiment.	   The	   affective	   subliminal	   priming	   appeared	   stronger	   than	   semantic	  priming,	  possibly	  due	  to	  the	  use	  of	  a	  ratings	  scale	  as	  a	  measurement.	  	  
	  3.7	   Next	  Steps	  
	  These	  data	  suggest	   that	   the	  effects	  of	  an	  affective	  subliminal	  prime	  are	  strongest	  within	   the	  placebo	  pain	  paradigm	  therefore	   this	   type	  of	  subliminal	  prime	  will	  be	  used	   in	   the	   next	   study.	  However,	   once	   again,	   the	   effects	   of	   the	   subliminal	   prime	  were	  only	  significant	  on	  expected	  pain	  levels,	  not	  self-­‐report	  pain.	  	  Literature	   in	   the	   field	   of	   mood	   research	   suggests	   positive	   and	   negative	  mood	   may	   be	   independent	   of	   each	   other,	   (Watson	   &	   Tellegen,	   1985).	   The	   next	  study	   will	   therefore	   examine	   whether	   positively	   and	   negatively	   valenced	  subliminal	  primes	  have	  diametrically	  opposed	  effects.	  	  	  
	  85	  
Chapter	  4	  	  Valence	  of	  subliminal	  primes	  in	  placebo	  responding	  	  4.1	   Introduction	  
	  The	   results	   of	   the	   previous	   experiment	   suggest	   the	   processing	   of	   affective	  subliminal	   prime	   words	   could	   potentially	   interact	   with	   a	   placebo	   to	   alter	  response	   expectancy.	   Specifically,	   positively	   valenced	   subliminal	   primes	   may	  increase	  expectations	  regarding	  the	  effects	  of	  a	  placebo.	  	   Within	   the	   mood	   literature,	   Watson	   and	   Tellegen,	   (1985),	   claim	   that	  positive	  and	  negative	  affect	  are	  independent	  of	  each	  other,	  not	  opposite	  ends	  of	  the	   same	   scale.	   The	   next	   step	   is	   therefore	   to	   examine	   whether	   a	   negatively	  valenced	  prime	  will	  have	  a	  diametrically	  opposed	  effect	  to	  a	  positively	  valenced	  subliminal	   prime.	   In	   other	   words,	   will	   negatively	   valenced	   prime	   words	  decrease	   expectations	   regarding	   the	   effects	   of	   the	   placebo?	   If	   positive	   and	  negative	  affects	  are	  independent	  of	  each	  other,	  this	  isn’t	  automatically	  the	  case.	  	  	  	  	  	  	  	  	   However,	   other	   authors	   claim	   positive	   and	   negative	   affects	   are	   bipolar	  opposites.	  Authors	  such	  as	  Warr	  et	  al.,	  (1983),	  and	  Russell	  and	  Carroll,	  (1999),	  claim	  they	  simply	  appear	  to	  be	  independent	  due	  to	  measurement	  and	  reporting	  issues	  allowing	  the	  presence	  of	  mood	  repair.	  	   This	   experiment	  was	   designed	   to	   directly	   investigate	  whether	   positive	  and	   negatively	   valenced	   subliminal	   primes	  would	   have	   diametrically	   opposed	  effects	  in	  a	  placebo	  context.	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In	   order	   to	   maintain	   consistency	   and	   allow	   comparison	   between	  potential	   subliminal	   prime	   effects,	   the	   same	   placebo	   analgesic	   paradigm	   was	  used	   in	   this	   experiment	   as	   in	   the	   previous	   chapter.	   Subliminal	   prime	   words	  were	  chosen	  to	  induce	  either	  a	  positive	  or	  negative	  mood	  state	  in	  participants.	  A	  set	  of	  neutral	  words	   relating	   to	  everyday	  objects	   that	  held	  no	  direct	   semantic	  relevance	  or	  valence	  was	  chosen	  as	  a	  neutral	  control.	  	  	   It	  was	  hypothesised	  that	  both	  the	  positive	  and	  negative	  subliminal	  prime	  information	   would	   significantly	   alter	   the	   use	   of	   the	   verbal	   expectancy	  information	  compared	  to	  neutral.	  	  	  4.2	   Methods	  
	  
Participants	  and	  Design	  This	  study	  included	  66	  psychology	  undergraduates,	  (54	  females	  and	  12	  males),	  who	   participated	   in	   small	   groups	   in	   return	   for	   partial	   course	   credit.	   Existing	  literature	  was	  used	  as	  a	  guide	  to	  determining	  sample	  size,	  (Geers	  et	  al.,	  2005a;	  Meerman	   et	   al.,	   2011;	   Montgomery	   &	   Kirsch,	   1996).	   For	   safety	   reasons,	  participants	  who	  smoke,	  suffer	  from	  epilepsy,	  have	  a	  known	  heart	  condition	  or	  were	   currently	   taking	   prescription	   medication	   were	   excluded	   from	   the	  experiment.	   These	   exclusions	   were	   also	   included	   in	   part	   to	   raise	   participant	  expectation	   of	   placebo	   effectiveness.	   Participants	   were	   randomly	   assigned	   to	  receive	  either	  a	  placebo	  expectation	  or	  no	  placebo	  expectation,	  and	  to	  receive	  a	  positive	   subliminal	   prime,	   a	   negative	   subliminal	   semantic	   prime	   or	   a	   neutral	  subliminal	   prime.	  This	   results	   in	   a	   2	   (placebo	   expectation)	   x	   3	   (prime)	  mixed	  design.	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Measures	  The	   pain	   stimuli,	   measures	   and	   placebo	   cream	   used	   in	   this	   experiment	   were	  identical	  to	  those	  used	  in	  Chapter	  3.	  
	  
Procedure	  The	  procedure	  used	  in	  this	  experiment	  was	  identical	  to	  that	  used	  in	  Chapter	  3	  with	  the	  following	  exceptions.	  In	   the	   positive	   affect	   prime	   condition,	   participants	   were	   subliminally	  exposed	  to	  seven	  words	  relating	   to	  positive	  affect	   (for	  example,	   ‘laughing’	  and	  ‘happy’).	   In	  the	  negative	  affect	  prime	  condition,	  participants	  were	  subliminally	  exposed	   to	   seven	  words	   relating	   to	   negative	   affect,	   (for	   example,	   ‘lonely’	   and	  ‘unhappy’).	   In	   the	   neutral	   prime	   condition,	   participants	   were	   subliminally	  exposed	  to	  words	  relating	  to	  everyday	  objects,	  (for	  example,	  ‘barrel’	  and	  ‘chair’).	  Words	   in	   the	   positive	   affective	   prime	   condition	   were	   rated	   between	   8.0	   and	  8.56	  in	  the	  ‘Affective	  Norms	  for	  English	  Words’	  (ANEW)	  list	  compiled	  in	  earlier	  research	   by	   Bradley	   and	   Lang,	   (1999).	  Words	   in	   the	   negative	   affective	   prime	  condition	   were	   rated	   between	   1.0	   and	   1.97	   on	   the	   same	   scale.	   Words	   in	   the	  neutral	  prime	  condition	  were	  everyday	  objects	  rated	  between	  5.0	  and	  5.22	  on	  the	   same	  scale.	  Words	   in	  all	   lists	  were	  also	  matched	   for	   length	  and	   frequency	  within	  the	  English	  language	  using	  same	  scale.	  In	  addition,	  due	  to	  logistical	  reasons,	  the	  partition	  screens	  at	  the	  end	  of	  the	   table	   used	   by	   the	   participant	   to	   perform	   the	   computer	   task	   were	  unavailable.	   The	   experimenter	   was	   therefore	   seated	   directly	   behind	   the	  participant,	   (facing	   in	   the	   opposite	   direction),	   during	   the	   course	   of	   the	  subliminal	  priming	  computer	  task.	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4.3	   Results	  
	  
Sample	  Characteristics	  and	  Baseline	  Scores	  Sixty-­‐six	   participants	   from	   the	  University	   of	   Plymouth	   took	   part	   in	   return	   for	  partial	   course	   credit.	   Six	   participants	   indicated	   a	   suspicion	   of	   placebo	   during	  debrief	  and	  were	  excluded	  from	  the	  analysis.	  There	  were	  therefore	  53	  females	  and	  7	  males	  with	  a	  mean	  age	  of	  20.4,	  (range	  18	  to	  42),	  included	  in	  the	  analysis	  below.	  	  Multiple	  one-­‐way	  analyses	  of	  variance	  showed	  no	  significant	  effects	  of	  gender	  on	  expectancy	  or	   self-­‐report	  pain	  scores	   therefore	  male	  and	   female	   responses	  are	  combined	  in	  the	  following	  analyses.	  	  
Manipulation	  Checks	  Responses	  to	  the	  10	  positive	  items	  on	  the	  PANAS	  scale	  were	  summed	  to	  create	  a	  positive	  mood	  score,	   (α	  =	   .87), and	  responses	   to	   the	  10	  negative	   items	  on	   the	  PANAS	  scale	  were	  summed	  to	  create	  a	  negative	  mood	  score, (α	  =	  .77). Table	  4.1	  below	  shows	  mean	  PANAS	  scores,	  (and	  SD),	  by	  subliminal	  prime	  condition.	  	  
Table	  4.1:	  Mean	  PANAS	  scores,	  (and	  SD)	  by	  subliminal	  prime	  condition	  (N=60)	  	  











Note.	   Higher	   positive	   affect	   scores	   indicate	   higher	   levels	   of	   positive	   affect.	   Higher	  negative	  	  	  affect	  scores	  indicate	  higher	  levels	  of	  negative	  affect.	  
	   Positive	  Prime	   Negative	  Prime	   Neutral	  Prime	  Positive	  Affect	  PANAS	  Score	  	   24.68	  (6.33)	   24.38	  (7.44)	   25.06	  (6.25)	  Negative	  Affect	  PANAS	  Score	  	   13.05	  (4.72)	   14.17	  (5.22)	   12.94	  (3.84)	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Multiple	   simple	   contrasts	   between	   cell	   means	   revealed	   the	   positive	   and	  negative	   affective	   prime	   manipulations	   were	   not	   successful.	   There	   was	   no	  significant	  difference	  in	  mean	  positive	  mood	  PANAS	  score	  between	  the	  positive	  prime	   and	   neutral	   prime	   conditions,	   (t(2)	   =	   0.17,	  p	   =	   .87),	   and	   no	   significant	  difference	  in	  mean	  negative	  mood	  PANAS	  score	  between	  the	  negative	  prime	  and	  neutral	  prime	  conditions,	  (t(2)	  =	  0.81,	  p	  =	  .42).	  	  	  
Cell	  Means	  Table	  4.2	  below	  shows	  cell	  means,	  (and	  SD),	  on	  all	  measures.	  
	   Table	  4.2:	  Cell	  means	  (and	  SD)	  for	  all	  pain	  measures	  (N=60)	  	   Placebo	   No	  Placebo	  Measure	   Positive	  Prime	   Negative	  Prime	   Neutral	  Prime	   Positive	  Prime	   Negative	  Prime	   Neutral	  Prime	  Expected	  Pain	  Scores	   3.52	  (1.87)	   3.41	  (1.41)	   3.82	  (1.85)	   6.21	  (2.04)	   6.33	  (1.93)	   6.59	  (2.00)	  Self-­‐Report	  Pain	  Scores	   6.21	  (2.32)	   7.17	  (2.50)	   6.59	  (2.74)	   6.73	  (2.59)	   8.04	  (1.83)	   8.00	  (1.58)	  
Note.	  Higher	  pain	  scores	  indicate	  higher	  levels	  of	  expected	  and	  reported	  pain.	  	  	  
Expectancy	  –	  Expected	  Pain	  Scores	  Means	   for	   expected	  pain	  measures	  are	   shown	   in	  Table	  4.2	   above.	  These	  were	  submitted	   to	   a	   2	   (placebo)	   *	   3	   (prime)	   mixed	   effects	   regression. F	   tests	   for	  categorical	  effects	  and	  interactions	  are	  not	  available	  in	  linear	  mixed-­‐models.	  To	  conduct	  a	  null	  hypothesis	  significance	  test	  for	  the	  effect	  of	  a	  categorical	  factor,	  a	  Chi	   Squared	   value	   is	   obtained	   by	   comparing	   the	   difference	   in	   likelihood	  between	  models	  with	  and	  without	  the	  factor	  (with	  degrees	  of	  freedom	  being	  N-­‐
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1	  where	  N	  is	  the	  number	  of	  levels	  of	  the	  factor). Figure	  4.1	  below	  shows	  mean	  expected	  pain	  scores	  by	  cell.	  	   Figure	  4.1:	  Mean	  expected	  pain	  scores	  by	  cell	  	  
	  	  	  	  	  	  
	  This	  analysis	  yielded	  a	   significant	  main	  effect	  of	  placebo,	   (x2	   (1)	  =	  122.31,	  p	   <	  .0001,	   ,	   f2	   =	   1.771).	   Examination	   of	   cell	   means,	   (shown	   in	   Figure	   4.1	   above),	  indicate	  that	  lower	  pain	  was	  expected	  in	  the	  placebo	  conditions.	  No	  significant	  main	   effect	   of	   prime,	   (x2	   (2)	   =	   0.62,	   p	   =	   .73,	   ,	   f2	   =	   -­‐2.506),	   and	   no	   significant	  interaction	   between	  placebo	   and	  prime,	   (x2	   (1)	   =	   	   0.16,	  p	   =	   .92,	   ,	   f2	   =	   -­‐0.003),	  were	  found.	  	  
	  

















Positive Prime Negative Prime
Neutral Prime
CHAPTER	  4.	  VALENCE	  OF	  SUBLIMINAL	  PRIME	  
	  91	  
between	  models	  with	  and	  without	  the	  factor	  (with	  degrees	  of	  freedom	  being	  N-­‐1	  where	  N	  is	  the	  number	  of	  levels	  of	  the	  factor).	  	  Figure	  4.2	  below	  shows	  mean	  self-­‐report	  pain	  scores	  by	  cell.	  	   Figure	  4.2:	  Mean	  self-­‐report	  scores	  by	  cell	  	  	  	  	  	  	  	  	  
This	   analysis	   yielded	   a	   significant	   main	   effect	   of	   placebo	   on	   self-­‐report	   pain	  scores,	  (x2	  (1)	  =	  9.90,	  p	  =	  .002,	  ,	  f2	  =	  -­‐0.166).	  Examination	  of	  cell	  means,	  (shown	  in	   Figure	   4.2	   above),	   indicate	   that	   lower	   pain	   was	   reported	   in	   the	   placebo	  conditions.	   No	   significant	   main	   effect	   of	   prime,	   (x2	   (2)	   =	   0.69,	   p	   =	   .71,	   ,	   f2	   =	  2.897),	  and	  no	  significant	  interaction	  between	  placebo	  and	  prime,	  (x2	  (2)	  =	  1.36,	  
p	  =	  .51,	  ,	  f2	  =	  -­‐0.023),	  were	  found.	  
	  4.4	   Discussion	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significantly	   reduced.	   However,	   this	   study	   did	   not	   replicate	   findings	   from	   the	  previous	   chapters	   as	   neither	   the	   positive	   nor	   negatively	   valenced	   prime	  interacted	  with	  the	  placebo	  to	  alter	  response	  expectancy	  or	  reported	  pain.	  	  	   It	  is	  possible	  that	  the	  failure	  of	  this	  experiment	  to	  replicate	  the	  results	  of	  the	   studies	   in	   the	   previous	   chapters	   were	   due	   to	   a	   Type	   1	   statistical	   error.	  However,	  as	  minor	  changes	  to	  methodology	  and	  seemingly	  trivial	  experimental	  details	   have	   been	   cited	   as	   the	   reason	   behind	   the	   failure	   to	   replicate	   previous	  subliminal	  priming	  studies,	  (Kahneman,	  2012;	  Meerman	  et	  al.,	  2012),	   it	   is	  also	  worth	  considering	  an	  alternative	  explanation.	  One	   explanation	   that	   may	   account	   failure	   of	   this	   study	   to	   replicate	  previous	   findings	   is	   the	  positioning	  of	   the	  experimenter	  within	  the	   laboratory.	  	  Due	   to	   logistical	   reasons,	   the	   experimenter	   in	   this	   study	   was	   not	   positioned	  behind	  a	  screen	  during	  the	  priming	  task,	  but	  sat	  directly	  behind	  the	  participant.	  It	   is	   possible	   that,	   although	   out	   of	   sight	   of	   the	   participant,	   the	   position	   of	   the	  experimenter	  diverted	  attention	  away	  from	  the	  priming	  task.	  Kahneman	  (2012)	  cites	   seemingly	   unimportant	   methodological	   details	   as	   one	   reason	   why	  subliminal	  priming	  studies	  may	  fail	  to	  replicate.	  Similarly	  Bargh,	  (2014),	  claims	  priming	   studies	  may	   fail	   to	   replicate	   due	   to	   the	   expertise	   required	   in	   setting	  them	  up.	  However,	   if	   this	  degree	  of	  expertise	   is	   required	   to	   find	   the	  effects,	   it	  may	   call	   into	   question	   their	   ecological	   validity.	   Replication	   issues	   within	   the	  priming	  literature	  are	  covered	  in	  more	  detail	  in	  Section	  7.4.	  	   	  4.5	   Limitations	  
	   The	   data	   from	   this	   experiment	   may	   be	   seen	   to	   be	   in	   violation	   of	   a	  number	  of	  the	  assumptions	  made	  by	  the	  statistical	  analyses.	  As	  a	  Likert-­‐data	  are	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ordinal,	  the	  assumption	  that	  spacing	  between	  points	  on	  the	  scale	  are	  equal	  may	  not	  be	  met.	  However,	  even	  where	  pain	  ratings	  are	  taken	  on	  a	  continuous	  scale,	  (e.g.	  on	  a	  pain	  dial),	  there	  is	  still	  no	  guarantee	  that	  the	  distance	  between	  points	  are	   ‘equal’	   because	   the	   experience	   of	   pain	   itself	  may	   be	   subject	   to	   non-­‐linear	  scaling.	  The	  results	  from	  the	  Likert-­‐scale	  measures	  used	  in	  this	  experiment	  may	  stand	   if	  we	   are	   to	   accept	   the	   assumption	   that	   spacing	   is	   equal	   and	   follow	   the	  convention	  to	  treat	  Likert-­‐data	  as	  continuous.	  In	   addition,	   as	   Likert-­‐data	   are	   ordinal	   and	   therefore	   not	   normally	  distributed	   they	  may	   violate	   the	   assumption	  made	   by	   the	   statistical	   analyses	  that	  the	  residuals	  are	  normally	  and	  independently	  distributed.	  However,	  as	  the	  residuals	   in	   this	   set	   of	   analysis	  were	  normally	   distributed	   it	   is	   irrelevant	   that	  they	  are	  derived	   from	  ordinal	  data.	   	   Further,	   (Norman,	  2010),	   argues	   that	   the	  assumption	  of	  normality	  of	  residuals	  is	  not	  critical	  in	  the	  use	  of	  Likert-­‐data,	  and	  that	   point	   estimates	   are	   unlikely	   to	   be	   affected	   by	   the	   violation	   of	   this	  assumption.	  The	  statistical	  tests	  used	  here	  are	  therefore	  generally	  robust	  to	  this	  type	  of	  violation.	  Again,	  it	  is	  possible	  the	  PANAS	  measure	  could	  have	  acted	  as	  a	  prime	  for	  affect,	   or	   brought	   the	   non-­‐conscious	   affect	   generated	   by	   the	   prime	   into	  consciousness	  offering	  the	  opportunity	  for	  mood	  repair.	  
	  4.6	   Conclusion	  
This	  study	  failed	  to	  replicate	  findings	  from	  the	  previous	  chapters	  as	  neither	  the	  positive	   nor	   negatively	   valenced	   prime	   interacted	   with	   the	   placebo	   to	   alter	  response	  expectancy	  or	  reported	  pain.	  	  Whether	   positive	   and	   negatively	   valenced	   subliminal	   primes	   have	  diametrically	  opposed	  effects	  in	  a	  placebo	  context	  remains	  unknown.	  Subliminal	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priming	  effects	  may	  be	  extremely	  sensitive	  to	  small	  changes	  in	  the	  environment	  or	  participant	  circumstance.	  	  	   	  	  4.7	   Next	  Steps	  
	  The	   influence	   of	   positive	   and	   negative	   affect,	   (elicited	   consciously	   or	   non-­‐consciously),	   on	   placebo	   responding	   is	   potentially	   an	   area	   of	   investigation	   in	  itself.	  However,	  as	  this	  experiment	  failed	  to	  replicate	  findings	  from	  experiments	  in	   previous	   chapters,	   the	   direction	   of	   study	   now	   needs	   to	   turn	   away	   from	  manipulating	  details	  of	   the	  subliminal	  prime	  towards	  strengthening	   the	  prime	  in	  order	  to	  increase	  reliability.	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Chapter	  5	  	  	  The	  novel	  placebo	  and	  use	  of	  subliminal	  primes	  
	  5.1	   Introduction	  
	  The	   effects	   of	   the	   subliminal	   prime	   were	   inconsistent	   in	   the	   two	   previous	  experiments.	  Identifying	  an	  alternative	  methodology	  that	  increases	  the	  strength	  of	   the	   subliminal	   prime	   would	   allow	   a	   more	   reliable	   examination	   of	   its	  application	  within	  the	  placebo	  paradigm.	  	  One	  way	   in	  which	   to	   strengthen	   the	  effect	  of	   the	   subliminal	  prime	  was	  identified	  by	  Draine	  and	  Greenwald,	  (1998).	   	  During	  a	  number	  of	  experiments	  aimed	  at	  investigating	  the	  optimal	  way	  in	  which	  to	  produce	  reliable	  subliminal	  priming,	  they	  found	  that	  using	  specific	  viewing	  apparatus	  that	  presented	  images	  from	  each	  side	  of	  the	  prime	  display	  screen	  directly	  into	  the	  respective	  eye	  of	  the	  participant	   did	   indeed	   produce	   consistent	   results.	   However,	   due	   to	   practical	  considerations,	  this	  specialist	  equipment	  was	  not	  feasible	  for	  the	  set	  of	  studies	  in	  this	  thesis.	  Another	  potential	  way	   in	  which	   to	  strengthen	  the	  use	  of	   the	  subliminal	  prime	  may	  be	  extrapolated	   from	   the	  placebo	   literature.	  Previous	   research	  has	  found	  that	  both	  prior	  experience	  with	  the	  placebo,	  (Colloca	  &	  Benedetti,	  2006),	  and	   experience	  with	   a	   pain	   stimulus	   itself,	   (Geers	   et	   al.,	   2014),	   can	  moderate	  placebo	   response.	   One	   explanation	   given	   by	   Geers	   and	   colleagues,	   (2014),	   is	  that	  prior	  experience	  can	  moderate	  how	  reliant	  individuals	  are	  on	  experimenter	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provided	   information	   and	   other	   contextual	   cues.	   In	   other	   words,	   the	   less	  previous	  experience	  the	  participant	  has	  with	  the	  paradigm,	  the	  more	  they	  rely	  on	  external	  cues	  found	  in	  the	  environment.	  This	   expands	   on	  work	   carried	   out	   by	  Miller,	   (1981),	   who	   posited	   that	  certainty	  reduces	  environmental	  attention,	  whereas	  authors	  such	  as	  Barlow	  et	  al.,	  (1996)	  and	  Blanchard	  et	  al.,	  (1993),	  found	  that,	  conversely,	  uncertainty	  can	  increase	  somatic	  and	  environmental	  attention.	  	  It	  is	  possible	  that	  the	  increased	  attention	  to	  environmental	  cues	  found	  in	  an	   uncertain	   context	   may	   extend	   to	   subliminally	   presented	   information	   in	   a	  placebo	   paradigm.	   In	   addition,	   if	   the	   subliminal	   prime	   can	   be	   incorporated	  within	   the	   placebo	   itself,	   (as	   opposed	   to	   being	   presented	   separately	   as	   in	  previous	  experiments),	  this	  may	  also	  increase	  strengthen	  its	  effects.	  	  The	   aim	   of	   this	   study	   was	   to	   increase	   uncertainty	   regarding	   the	  effectiveness	  of	   the	  placebo,	   thereby	   increasing	   the	  use	  of	  environmental	  cues	  and	   strengthening	   the	   effects	   of	   the	   subliminal	   prime.	   Extrapolating	   from	  previous	  placebo	  research,	  a	  novel	  paradigm	  was	  designed	  that	  would	  increase	  the	  uncertainty	  of	   the	  verbal	  placebo	   information	  thereby	   increasing	  attention	  to	  subliminal	  prime	  information.	  A	  paradigm	  was	  designed	  whereby	   instead	  of	  using	  a	  placebo	  analgesic	  cream,	   participants	  would	  be	   told	   that	   a	   computer	   task	  had	  been	  designed	   to	  provide	  an	  analgesic	  effect,	  (i.e.	  the	  computer	  task	  was	  the	  placebo).	  	  Geers	  et	  al.	  (2014)	  hypothesise	  that	  lack	  of	  familiarity	  with	  key	  aspects	  of	  a	  placebo	  experiment,	   (such	  as	   the	  placebo	   itself	  or	   the	  pain	  stimuli),	   leads	   to	  increased	   uncertainty	   regarding	   verbal	   outcome	   expectancy	   information.	   This	  uncertainty	   can	   in	   turn	   lead	   to	   more	   reliance	   on	   other	   environmental	   cues	  present	   within	   the	   placebo	   context.	   This	   potentially	   may	   include	   increased	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attention	  to	  subliminal	  prime	  information.	  As	  participants	  are	  more	  likely	  to	  be	  familiar	  with	  the	  concept	  of	  cream	  as	  an	  analgesic,	  (widely	  available	  as	  an	  over-­‐the-­‐counter	   product),	   than	   a	   computer	   task,	   one	   can	   assume	   that	   using	   a	  computer	  task	  as	  a	  placebo	  is	  more	  likely	  to	  induce	  uncertainty	  regarding	  verbal	  placebo	  outcome	  expectations,	   therefore	   increasing	  reliance	  on	  environmental	  information	  such	  as	  subliminal	  primes.	  Two	  sets	  of	  subliminal	  prime	  words	  were	  chosen.	  The	  first	  set	  of	  words	  related	  to	  the	  concept	  of	  ‘illness’.	  The	  second	  set	  of	  words	  related	  to	  ‘animals’	  in	  order	  to	  provide	  a	  neutral	  control	  category.	  These	  words	  were	  chosen	  as	  they	  had	  already	  been	  used	  in	  previous	  research	  demonstrating	  a	  significant	  impact	  of	  subliminal	  priming	  on	  pain	  tolerance,	  (Meerman	  et	  al.,	  2011).	   	  The	   subliminal	   primes	  were	   presented	   via	   a	   computer-­‐based	   reaction-­‐time	  task	  based	  on	  a	  design	  commonly	  used	  within	  subliminal	  priming	  research,	  (Meerman	  et	  al.,	  2011;	  Barbot	  &	  Kouider,	  2011).	  As	  in	  the	  previous	  experiment,	  this	  method	  of	  presenting	  the	  subliminal	  primes	  was	  chosen	  so	  that	  the	  level	  of	  conscious	  accessibility	  was	  in	  direct	  contrast	  to	  the	  verbal	  placebo	  information	  in	  order	  that	  a	  comparison	  can	  be	  made	  between	  the	  two	  forms	  of	  input.	  This	   paradigm	   also	   tested	   participants	   on	   a	   individual	   basis	   so	   as	   to	  avoid	   the	   confounding	   variable	   of	   social	   observation,	   (Colloca	   &	   Benedetti,	  2009).	  It	   was	   hypothesised	   that	   the	   illness	   related	   subliminal	   prime	   would	  decrease	   the	   effect	   of	   the	   verbal	   placebo	   information	   when	   compared	   to	   the	  neutral	  subliminal	  prime.	  	  5.2	   Methods	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Participants	  and	  Design	  This	   experiment	   used	   99	   psychology	   undergraduate	   participants,	   (82	   female	  and	   17	   males),	   who	   participated	   in	   return	   for	   partial	   course	   credit.	   Existing	  literature	  was	  used	  as	  a	  guide	  to	  determining	  sample	  size,	  (Geers	  et	  al.,	  2005a;	  Meerman	   et	   al.,	   2011;	   Montgomery	   &	   Kirsch,	   1996).	   For	   safety	   reasons,	  participants	  who	  smoke,	  suffer	  from	  epilepsy,	  have	  a	  known	  heart	  condition	  or	  were	   currently	   taking	   prescription	   medication	   were	   excluded	   from	   the	  experiment.	   These	   exclusions	   were	   also	   included	   in	   part	   to	   raise	   participant	  expectation	   of	   placebo	   effectiveness.	   Participants	   were	   randomly	   assigned	   to	  receive	   either	   illness	   related	   words	   or	   neutral	   words	   as	   a	   subliminal	   prime.	  Participants	  were	  also	  randomly	  assigned	  to	  have	  either	  a	  conscious	  expectancy	  of	   an	   increase	   in	   pain	   tolerance,	   or	   no	   conscious	   expectancy,	   resulting	   in	   a	  2(Expectancy)	  x	  2(Prime)	  between	  subject	  design.	  
	  
Measures	  
Expectancy	  Measure	  	  A	   Likert-­‐type	   pain	   scale	   was	   chosen	   to	   measure	   expected	   pain	   as	   a	   large	  proportion	   of	   research	   into	   placebo	   analgesia	   has	   found	   significant	   placebo	  effects	  using	  this	  measure,	  (Spiro,	  1997;	  Tracey,	  2010).	  Expectancy	  ratings	  were	  measured	  on	  an	  11-­‐point	  intensity	  and	  unpleasantness	  scale,	  with	  the	  endpoints	  marked	  0:	  Not	  At	  All	  Intense/Unpleasant	  and	  10:	  Extremely	  Intense	  /	  Unpleasant.	  A	   single	   pain	   rating	   was	   taken	   covering	   the	   pain	   experienced	   in	   both	   hands.	  Participants	  were	  asked:	  “How	  intense	  do	  you	  think	  the	  pain	  in	  your	  fingers	  will	  be?”	   and	   “How	   unpleasant	   do	   you	   think	   the	   pain	   in	   your	   fingers	   will	   be?”	  respectively.	  A	   score	  of	   0	  was	   given	   to	   the	   lowest	  pain	   indication	  point	   and	   a	  score	  of	  10	  was	  given	  to	  the	  highest	  pain	  indication	  point.	  Scores	  for	  individual	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items	  were	  then	  added	  together	  and	  averaged	  to	  provide	  a	  mean	  expected	  pain	  score,	  (α	  =	  .87).	  	  	  	  
Pain	  Intensity	  Measure	  A	   Likert-­‐type	   pain	   scale	   was	   chosen	   to	   measure	   pain	   intensity	   as	   a	   large	  proportion	   of	   research	   into	   placebo	   analgesia	   has	   found	   significant	   placebo	  effects	   using	   this	  measure,	   (Spiro,	   1997;	   Tracey,	   2010).	   Pain	   intensity	   ratings	  were	   measured	   on	   an	   11-­‐point	   intensity	   and	   unpleasantness	   scale,	   with	   the	  endpoints	  marked	  0:	  Not	  At	  All	   Intense/Unpleasant	  and	  10:	  Extremely	  Intense	  /	  
Unpleasant.	   A	   single	   pain	   rating	   was	   taken	   covering	   the	   pain	   experienced	   in	  both	   hands.	   Participants	   were	   asked:	   “How	   intense	   was	   the	   pain	   in	   your	  fingers?”	   and	   “How	   unpleasant	  was	   the	   pain	   in	   your	   fingers?”	   respectively.	   A	  score	  of	  0	  was	  given	  to	  the	  lowest	  pain	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  highest	  pain	  indication	  point.	  Scores	  for	  individual	  items	  were	  then	  added	  together	  and	  averaged	  to	  provide	  a	  mean	  self-­‐report	  pain	  score,	  (α	  =	  .79).	  	  
Pain	  Tolerance	  Measure	  Pain	   tolerance	   was	   included	   in	   this	   study	   as	   previous	   research	   has	   found	  significant	   effects	   of	   subliminal	   priming	   on	   this	   behavioural	  measure	   of	   pain,	  (Meerman	   et	   al.,	   2011).	   Pain	   tolerance	   was	   defined	   as	   the	   time	   elapsed	   (in	  seconds)	   between	   the	   levers	   being	   simultaneously	   lowered	   onto	   both	   index	  fingers	  and	  the	  point	  at	  which	  the	  participant	  asks	  for	  the	  levers	  to	  be	  released.	  It	   was	   not	   specifically	   stated	   to	   participants	   that	   the	   lever	   application	   was	  timed,	  and	  the	  stopwatch	  was	  kept	  behind	  the	  experimenter	  screen.	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Procedure	  On	  arrival,	  participants	  were	  told	  that	  the	  focus	  of	  the	  research	  project	  is	  to	   examine	   the	   effects	   of	   cognitive	   effort	   on	  pain.	   They	  were	   reminded	   that	   a	  painful	   stimulus	  would	  be	  applied;	   that	   they	  had	   the	  right	   to	  withdraw	  at	  any	  time	  and	  that	  their	  data	  would	  remain	  anonymous	  and	  confidential.	  They	  were	  then	  asked	  to	  read	  and	  sign	  a	  written	  consent	  form.	  	  Participants	   were	   then	   randomly	   allocated	   to	   one	   of	   four	   conditions	   –	  Illness	   related	   or	   Neutral	   subliminal	   prime,	   combined	   with	   Verbal	   Placebo	  (decreased	  pain)	  or	  No	  Verbal	  Placebo.	  The	  experimenter	  was	  blind	  as	  to	  which	  subliminal	  prime	  condition	  was	  allocated.	  Participants	  were	  then	  seated	  at	  a	  desk.	  The	  desk	  had	  a	  partition	  screen	  positioned	  at	  each	  end	  of	  the	  table.	  The	  screen	  was	  approximately	  2	  metres	  high	  and	  90cm	  deep.	  The	  participant	  was	  therefore	  unable	  to	  observe	  anything	  to	  the	  left	  or	  right	  of	  the	  desk	  whilst	  seated.	  	  Participants	   were	   then	   shown	   the	   Fordyce	   Finger	   Crushers.	   It	   was	  explained	  to	  the	  participant	  that	  the	  Fordyce	  Finger	  Crushers	  would	  be	  used	  to	  apply	  pressure	  to	  their	  index	  fingers	  following	  a	  reaction	  time	  task.	  The	  Finger	  Crushers	  were	  then	  positioned	  behind	  the	  screen	  to	  the	   left	  of	   the	  participant.	  They	   were	   therefore	   unable	   to	   observe	   the	   Finger	   Crushers	   during	   the	  computer	  task.	  Participants	   were	   then	   directed	   to	   a	   subliminal	   priming	   task	   on	   the	  computer	  screen.	  Participants	  in	  the	  two	  ‘Verbal	  Placebo’	  conditions	  were	  then	  told	  that	  the	  reaction	  time	  task	  they	  were	  about	  to	  perform	  had	  been	  specifically	  designed	  to	  decrease	  the	  amount	  of	  pain	  they	  felt	  when	  the	  levers	  were	  applied.	  They	  were	  told	  that,	  “this	  works	  via	  a	  process	  of	  cognitive	  distraction,	  whereby	  if	  the	  rational	  part	  of	  your	  brain	  is	  active	  it	  cannot	  register	  as	  much	  pain	  -­‐	  a	  bit	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like	   if	   you	   scratch	   yourself	   when	   you’re	   busy	   and	   it	   doesn’t	   hurt	   until	   you	  actually	  notice	  it.”	  They	  were	  then	  asked	  to	  complete	  the	  task	  to	  the	  best	  of	  their	  ability	  and	  informed	  that	  they	  will	  be	  asked	  questions	  about	  the	  task	  at	  the	  end	  of	  the	  experiment.	  Participants	   in	  the	  two	   ‘No	  Verbal	  Placebo’	  conditions	  were	  informed	  that	  the	  task	  had	  been	  specifically	  designed	  for	  use	  in	  this	  experiment.	  They	   were	   then	   asked	   to	   complete	   the	   task	   to	   the	   best	   of	   their	   ability	   and	  informed	   that	   they	   will	   be	   asked	   questions	   about	   the	   task	   at	   the	   end	   of	   the	  experiment.	   After	   describing	   the	   computer	   task	   the	   experimenter	   was	   then	  seated	  behind	  the	  screen	  to	  the	  left	  of	  the	  participant.	  	  The	   priming	   manipulation	   was	   a	   variation	   of	   a	   common	   paradigm	  whereby	   participants	   judge	   as	   quickly	   and	   accurately	   as	   possible	   whether	  briefly	   flashed	   letter	   strings	   appear	   on	   the	   left	   or	   right	   side	   of	   the	   computer	  monitor,	  (Meerman	  et	  al.,	  2011;	  Lowery	  et	  al.,	  2007).	  The	  task	  was	  presented	  to	  participants	  as	  a	  reaction	  time	  task.	  Following	   a	   written	   set	   of	   on-­‐screen	   instructions,	   a	   fixation	   cross	  appeared	  in	  the	  centre	  of	  the	  screen	  for	  duration	  of	  500	  ms.	  Participants	  were	  then	   exposed	   to	   a	   prime	  word	   for	   a	   duration	   of	   34	  ms.	   In	   the	   illness	   related	  prime	   conditions,	   participants	   were	   subliminally	   exposed	   to	   eight	   words	  relating	   to	   illness,	   (for	   example,	   ‘fever’	   and	   ‘infection’).	   In	   the	   neutral	   prime	  condition,	   participants	   were	   subliminally	   exposed	   to	   eight	   words	   relating	   to	  animals,	   (for	   example,	   ‘squirrel’	   and	   ‘gorilla’).	   These	   words	   have	   been	  previously	  used	  in	  a	  subliminal	  priming	  study	  demonstrating	  that	  subliminally	  presented	  illness	  related	  words	  could	  decrease	  pain	  tolerance,	  (Meerman	  et	  al.,	  2011).	  Words	   in	  both	   lists	  were	  matched	   for	   length	   and	   frequency	  within	   the	  English	   language	   using	   the	   ‘Affective	   Norms	   for	   English	   Words’	   (ANEW)	   list,	  (Bradley	   &	   Lang,	   1999).	   As	   the	   original	   word	   lists	   were	   presented	   to	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participants	  in	  the	  Dutch	  language,	  two	  of	  the	  original	  10	  words	  were	  removed	  from	  each	  list	  as	  they	  did	  not	  match	  in	  length	  in	  the	  English	  language.	  Immediately	  after	   the	  prime	  word,	  a	  7-­‐letter	   ‘X’	   string	  appeared	  on	   the	  computer	  monitor	   for	   a	   duration	   of	   150ms.	   Both	   the	   prime	  word	   and	   the	   7-­‐letter	   string	   appeared	  on	   either	   the	   left	   or	   right	   hand	   side	   of	   the	   screen.	   This	  letter	   string	   served	   as	   a	   backward	   mask	   for	   the	   prime	   word.	   Participants	  indicated	  the	  position	  of	  the	  7-­‐letter	  string	  on	  the	  screen	  using	  either	  the	  ‘n’	  or	  ‘m’	  key	  on	  the	  keyboard.	  	  The	  screen	  then	  remained	  blank	  for	  a	  duration	  of	  500	  ms.	   Each	   participant	   was	   given	   5	   practice	   trials.	   Each	   participant	   then	  performed	   the	   computer	   task,	   consisting	   of	   100	   trials	   during	  which	   the	   eight	  prime	  words	  are	   shown	  at	   random.	  At	   the	  end	  of	   the	   trials,	  participants	  were	  prompted	   to	   wait	   for	   further	   instructions	   from	   the	   experimenter	   before	  continuing.	  	  Participants	  were	  then	  asked	  to	  complete	  the	  Expectancy	  Questionnaire	  and	   a	   mood	  manipulation	   check	   consisting	   of	   a	   ‘Positive	   and	   Negative	   Affect	  Schedule’	   questionnaire,	   (Watson	   et	   al.,	   1998).	   As	   the	   subliminal	   prime	   and	  placebo	   were	   administered	   simultaneously	   in	   this	   experiment,	   in	   order	   to	  investigate	  the	  effects	  of	  the	  prime	  on	  expectancy,	  the	  expectancy	  questionnaire	  had	  to	  be	  administered	  after	  the	  placebo.	  Next,	  participants	  were	  informed	  that	  the	  Fordyce	  Finger	  Crushers	  were	  going	  to	  be	  applied,	  and	  that	  they	  should	  say	  the	  word	  ‘Stop’	  when	  they	  wish	  the	  levers	  to	  be	  removed	  and	  the	  experimenter	  would	   then	   remove	   the	   levers.	   Pain	  was	   then	   applied	   simultaneously	   to	   both	  index	   fingers	   using	   the	   Fordyce	   Finger	   Crusher.	   A	   stopwatch	   was	   used	   to	  measure	   the	   amount	   of	   time	   elapsed	   (in	   seconds)	   between	   the	   levers	   being	  applied	   and	   the	   moment	   the	   participant	   asked	   for	   the	   levers	   to	   be	   removed.	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Unbeknown	  to	  the	  participant,	  the	  crushers	  were	  to	  be	  applied	  for	  a	  maximum	  of	  4	  minutes	  before	  they	  were	  removed.	  All	  participants	  were	  then	  asked	  to	  fill	  in	  the	  Pain	  Report	  Questionnaire	  followed	  by	  a	  funnel	  debriefing	  form	  to	  probe	  for	  suspicion	  or	  awareness	  of	  the	  true	  purpose	  of	  the	  study,	  (Chartrand	  &	  Bargh,	  1996).	  All	  participants	  will	  were	  then	   informed	  of	   the	   true	  nature	  of	   the	  experiment	  and	  a	  brief	   explanation	  of	  the	  theory	  behind	  the	  research	  given.	  	  5.3	   Results	  
Sample	  Characteristics	  and	  Baseline	  Scores	  Ninety-­‐nine	  participants	  from	  the	  University	  of	  Plymouth	  took	  part	  in	  return	  for	  partial	   course	   credit.	   Three	   participants	   indicated	   suspicion	   of	   subliminal	  priming	   during	   debrief	   and	   were	   excluded	   from	   the	   analysis.	   There	   were	  therefore	  80	   females	  and	  16	  males	  with	  a	  mean	  age	  of	  21.7,	   (range	  18	   to	  39),	  included	  in	  the	  analyses	  below.	  
	  Multiple	  one-­‐way	  analysis	  of	  variance	  showed	  a	  significant	  effect	  of	  gender	  on	  expected	  pain	  scores,	  (t(94)	  =	  -­‐3.36,	  p	  =	  .001,	  d	  =	  0.84),	  and	  a	  significant	  effect	  of	  gender	  on	  pain	  tolerance	  scores,	  (t(94)	  =	  4.23,	  p	  =	  .0001,	  d	  =	  0.87).	  There	  was	  no	  significant	  effect	  of	  gender	  on	  self-­‐report	  pain	  scores,	  (t(94)	  =	  -­‐1.3,	  p	  =	  .20,	  d	  =	  0.35).	  
	  
Cell	  Means	  	  Table	  5.1	  overleaf	  shows	  cell	  means,	  (and	  SD),	  on	  all	  measures.	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Table	  5.1:	  Cell	  means	  (and	  SD)	  for	  all	  pain	  measures	  (N=96)	  	   Placebo	   No	  Placebo	  Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  Expected	  Pain	  Score	   5.66	  (2.19)	   6.09	  (1.58)	   6.27	  (1.78)	   5.60	  (1.46)	  Self-­‐Report	  Pain	  Score	   6.54	  (2.01)	   7.46	  (1.82)	   7.14	  (1.81)	   6.93	  (1.80)	  Pain	  Tolerance	  Score	  (ms) 86.44	  (78.43)	   54.00	  (53.54)	   74.25	  (76.25)	   76.00	  (67.68)	  
Note.	   Higher	   expected	  pain	   and	   self-­‐report	   pain	   scores	   indicate	   higher	   levels	   of	   expected	   and	  reported	  pain.	  Higher	  pain	  tolerance	  scores	  indicate	  higher	  levels	  of	  pain	  tolerance.	  	  	  
Expectancy	  –	  Expected	  Pain	  Scores	  Means	   for	   expected	  pain	  measures	  are	   shown	   in	  Table	  5.1	   above.	  These	  were	  submitted	   to	  a	  2	   (placebo)	   *	  2	   (prime)	  ANOVA.	  Figure	  5.1	  below	  shows	  mean	  expected	  pain	  scores	  by	  cell.	  
	   Figure	  5.1:	  Mean	  expected	  pain	  scores	  by	  cell	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This	  analysis	  yielded	  no	  significant	  main	  effect	  of	  placebo,	  (F(1,92)	  =	  0.03,	  p	  =	  .87,	  ηp2	  =	  .0003);	  no	  significant	  main	  effect	  of	  prime,	  (F(1,92	  =	  0.11,	  p	  =	  .75,	  ηp2	  =	  .001)	  and	  no	  significant	  interaction	  between	  placebo	  and	  prime,	  (F(1,92)	  =	  2.20,	  
p	  =	  .14,	  ηp2	  =	  .023).	  	  
Self-­Report	  Pain	  Scores	  Means	  for	  self-­‐report	  pain	  measures	  are	  shown	  in	  Table	  5.1	  above.	  These	  were	  submitted	   to	  a	  2	   (placebo)	   *	  2	   (prime)	  ANOVA.	  Figure	  5.2	  below	  shows	  mean	  self-­‐report	  pain	  scores	  by	  cell.	   	  Figure	  5.2:	  Mean	  self-­‐report	  pain	  scores	  by	  cell	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Pain	  Tolerance	  Scores	  Means	   for	  pain	   tolerance	  measures	  are	  shown	   in	  Table	  5.1	  above.	  These	  were	  submitted	   to	  a	  2	   (placebo)	   *	  2	   (prime)	  ANOVA.	  Figure	  5.3	  below	  shows	  mean	  pain	  tolerance	  scores	  by	  cell.	  	   Figure	  5.3:	  Mean	  pain	  tolerance	  scores	  by	  cell	  	  	  	  	  	  	  	  
This	  analysis	  yielded	  no	  significant	  main	  effect	  of	  placebo,	  (F(1,92)	  =	  0.11,	  p	  =	  .74,	  ηp2	  =	  .001);	  no	  significant	  main	  effect	  of	  prime,	  (F(1,92)	  =	  1.10,	  p	  =	  .30	  ηp2	  =	  .012)	  and	  no	  significant	  interaction	  between	  placebo	  and	  prime,	  (F(1,92)	  =	  1.37,	  
p	  =	  .25,	  ηp2	  =	  .015).	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Expectancy	  –	  Expected	  Pain	  Scores	  (Including	  gender)	  Means	   for	   expected	   pain	   scores,	   (and	   SD),	   by	   gender	   are	   shown	   in	   Table	   5.2	  below.	   Table	  5.2:	  Mean	  expected	  pain	  scores	  (and	  SD)	  by	  gender	  (N=96)	  	   Placebo	   No	  Placebo	  
Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  
Expected	  Pain	  Score	  –	  Female (n	  =	  80)	   6.18	  (1.75)	   5.98	  (1.56)	   6.25	  (1.78)	   5.94	  (1.29)	  Expected	  Pain	  Score	  –	  Male (n	  =	  16)	   1.83	  (0.76)	   7.25	  (1.77)	   5.38	  (1.53)	   3.67	  (0.58)	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This	   analysis	   yielded	  a	   significant	  main	   effect	   of	   gender,	   (F(1,88)	  =	  11.60,	  p	   =	  .001,	  ηp2	  =	  .116;	  a	  significant	  interaction	  between	  placebo	  and	  prime,	  (F(1,88)	  =	  15.40,	   p	   =	   .0002,	   ηp2	   =	   .149);	   a	   significant	   interaction	   between	   prime	   and	  gender,	   (F(1,88)	   =	   5.63,	   p	   =	   .02,	   ηp2	   =	   .0601)	   and	   a	   significant	   interaction	  between	  placebo,	  prime	  and	  gender,	  (F(1,88)	  =	  11.77,	  p	  =	  .0009,	  ηp2	  =	  .118).	  This	  indicates	  that	  the	  effect	  of	  the	  placebo	  information	  and	  the	  effect	  of	  the	   subliminal	   prime	   differed	   between	   genders.	   To	   clarify	   this	   interaction,	  simple	  contrasts	  were	  performed.	  These	  revealed	  the	  effect	  of	  the	  illness	  prime	  on	   expected	   pain	   was	   only	   significant	   if	   the	   participant	   was	   male	   and	   had	  received	  the	  verbal	  placebo	  information,	  (F(1,88)	  =	  14.01,	  p	  =	   .0003,	  d	  =	  3.98).	  Examination	   of	   the	   cell	   means	   indicates	   that	   the	   illness	   prime	   decreased	  expected	   pain	   reports	   in	   males	   that	   had	   received	   the	   verbal	   placebo	  information.	  This	  is	  in	  the	  opposite	  direction	  to	  that	  predicted.	  
	  
Self-­Report	  Pain	  Scores	  (Including	  gender)	  Means	   for	  self-­‐report	  pain	  scores,	   (and	  SD),	  by	  gender	  are	  shown	   in	  Table	  5.3	  below.	   Table	  5.3:	  Mean	  self-­‐report	  pain	  scores	  (and	  SD)	  by	  gender	  (N=96)	  	   Placebo	   No	  Placebo	  
Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  
Self-­‐Report	  Pain	  Score	  –	  Female (n	  =	  80)	   6.61	  (1.86)	   7.33	  (1.85)	   7.40	  (2.00)	   7.21	  (1.73)	  Self-­‐Report	  Pain	  Score	  –	  Male (n	  =	  16)	   6.00	  (3.46)	   8.75	  (1.06)	   6.50	  (1.04)	   5.38	  (1.53)	  
Note.	  Higher	  self-­‐report	  pain	  scores	  indicate	  higher	  levels	  of	  reported	  pain.	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Means	   across	   cells	   were	   submitted	   to	   a	   2(placebo)	   *	   2(prime)	   *	   2(gender)	  ANOVA.	  Figure	  5.5	  below	  shows	  mean	  self-­‐report	  pain	  scores	  by	  gender.	  	   Figure	  5.5:	  Mean	  self-­‐report	  pain	  scores	  by	  gender	  	  	  	  	  	  	  	  
This	   analysis	   yielded	   a	   significant	   interaction	   between	   placebo	   and	   prime,	  (F(1,88)	   =	   4.55,	  p	   =	   .03,	  ηp2	  =	   .049),	   indicating	   that,	  when	   taking	   gender	   into	  account,	  the	  use	  of	  the	  prime	  differed	  between	  placebo	  conditions.	  Examination	  of	   cell	  means,	   (shown	   in	  Table	  5.3	   above),	   indicate	   that,	   compared	   to	  neutral,	  the	  illness	  prime	  increased	  the	  placebo	  effect,	  reducing	  self-­‐report	  pain	  in	  males	  who	   had	   received	   the	   verbal	   placebo	   information.	   This	   is	   in	   the	   opposite	  direction	  to	  that	  predicted.	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Table	  5.4:	  Mean	  pain	  tolerance	  scores	  (and	  SD)	  by	  gender	  (N=96)	  	   Placebo	   No	  Placebo	  
Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  
Pain	  Tolerance	  –	  Female (n	  =	  80)	   76.50	  (68.10)	   44.38	  (42.05)	   55.40	  (61.55)	   64.88	  (64.07)	  Pain	  Tolerance	  –	  Male (n	  =	  16)	   159.33	  (126.73)	   155.00	  (123.04)	   121.38	  (92.69)	   139.00	  (60.56)	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This	   analysis	   yielded	  a	   significant	  main	   effect	   of	   gender,	   (F(1,88)	  =	  17.02,	  p	   =	  .0001,	  ηp2	  =	  .162).	  Examination	  of	  the	  cell	  means	  indicates	  that	  males	  reported	  less	  pain	  than	  females.	  
	  5.4	   Discussion	  
	  No	   overall	   significant	   effects	   of	   either	   the	   verbal	   placebo	   information	   or	  subliminal	  prime	  information	  on	  placebo	  response	  were	  found	  in	  this	  study.	  The	  post-­‐hoc	  inclusion	  of	  gender	  as	  an	  independent	  variable	  found	  the	  uncertainty	  of	  a	  novel	  paradigm	  appeared	  to	  strengthen	  the	  effect	  of	  prime	  information	   in	  males	  who	  had	  been	  given	  verbal	  placebo	  information.	  One	  possible	  explanation	  is	   a	  Motivation	   –	   Attention	   effect,	   such	   as	   described	   in	   Aigner	   and	   Svanums’,	  (2014),	  Motivation	  /	  Attention	  model.	  	   Males	   have	   been	   found	   to	   have	   a	   non-­‐conscious	   goal	   to	   feel	   less	   pain,	  particularly	  if	  a	  female	  experimenter	  is	  present,	  (Aletky	  &	  Carlin,	  1975;	  Kállai	  et	  al.,	   2004;	   Aslaksen	   et	   al.,	   2007).	   According	   to	   Aigner	   and	   Svanums’	   model,	  motivation	  increases	  attention	  to	  goal-­‐relevant	  stimuli.	  If	  males	  did	  have	  a	  non-­‐conscious	  goal	  to	  feel	  less	  pain	  in	  this	  experiment,	  the	  computer	  task	  containing	  the	  subliminal	  prime	  could	  therefore	  have	  become	  goal-­‐relevant	  to	  males	  when	  they	  were	  given	  the	  verbal	  placebo	  information	  stating	  that	  the	  computer	  task	  would	   reduce	   the	   amount	   of	   pain	   they	   would	   feel.	   Male	   participants	   could	  therefore	  have	  paid	  more	  attention	  to	  the	  computer	  task,	  sensitising	  them	  to	  the	  subliminal	  prime,	  (Milyavsky	  et	  al.,	  2012).	  In	  this	  context,	  it	  is	  possible	  that	  the	  conscious	  verbal	  information	  was	  required	  to	  guide	  attention	  to	  the	  subliminal	  cues.	   This	   supports	   Stafford’s,	   (2014),	   claims	   that	   the	   use	   of	   subliminally	  
CHAPTER	  5.	  NOVEL	  PLACEBO	  AND	  SUBLIMINAL	  PRIME	  	  	  
	   112	  
presented	   information	   may	   require	   the	   presence	   of	   relevant	   conscious	  information.	  	  	   The	  finding	  that	  the	  subliminal	  illness	  prime	  increased	  the	  placebo	  effect,	  (instead	  of	  decreasing	  it	  as	  predicted),	  is	  in	  contrast	  to	  the	  findings	  of	  Meerman	  et	   al.,	   (2011).	   There	   are	   two	   possible	   explanations	  why	   the	   subliminal	   illness	  prime	  increased	  the	  placebo	  effect,	  instead	  of	  decreasing	  it	  as	  predicted.	  	  The	   first	   is	   that	   the	   incongruency	   of	   the	   illness	   prime	   to	   participant	  expectation	   distracted	   attention	   away	   from	   potential	   pain.	   The	   increase	   in	  placebo	  effect	  following	  an	  illness	  related	  subliminal	  prime	  match	  the	  results	  of	  Valentini	   et	   al.,	   (2014),	   who	   found	   that	   subliminally	   presented	   facial	  expressions	   of	   pain	   increased	   placebo	   analgesia.	   The	   explanation	   given	   by	  Valentini	   and	   her	   colleagues	   involves	   an	   interaction	   between	   expectancy	   and	  attention.	  Valentini	  proposed	  that	  the	  subliminal	  information	  demanded	  a	  high	  attentional	   load	   as	   it	   was	   incongruent	   to	   the	   verbal	   placebo	   information,	  therefore	   distracting	   attention	   from	   the	   pain.	   	   While	   this	   seems	   a	   plausible	  explanation	   for	   the	   effects	   on	   self-­‐report	   pain,	   it	   is	   unclear	   how	   distraction	  would	  reduce	  levels	  of	  expected	  pain,	  as	  there	  is	  no	  physical	  sensation	  to	  divert	  attention	  from	  at	  this	  point.	  An	  alternative	  explanation	   is	   the	  subliminal	   illness	  prime	   increased	   the	  motivation	   of	   male	   participants	   to	   respond	   to	   the	   placebo	   information.	   At	   a	  subliminal	  level,	  in	  detecting	  information	  in	  the	  opposing	  direction	  to	  their	  goal,	  a	  ‘repair’	  effect	  could	  have	  taken	  place,	  similar	  to	  the	  mechanisms	  found	  in	  non-­‐conscious	  mood	  repair,	  (see	  Gyurak	  et	  al.,	  2011,	  for	  a	  review).	  	   Contrary	   to	   previous	   chapters,	   no	   overall	   main	   effect	   of	   placebo	   was	  found	   in	   this	   experiment.	   Previous	   research	   findings	   that	   suggest	   increasing	  uncertainty	  of	  placebo	  expectation	  can	  reduce	   the	  placebo	  effect,	   (Geers	  et	  al.,	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2006).	  It	  is	  possible	  that	  the	  novel	  paradigm	  increased	  uncertainty	  of	  the	  verbal	  information	  in	  all	  participants,	  reducing	  its	  credibility	  to	  the	  point	  where	  it	  had	  no	  effect.	  	  	  5.5	   Limitations	  
	  Although	   this	   is	   the	   first	   study	   to	   find	   a	   significant	   (posthoc)	   effect	   of	   the	  subliminal	   prime	   on	   the	   self-­‐report	   pain	   measure,	   the	   addition	   of	   the	   pain	  tolerance	   measure	   could	   have	   confounded	   the	   self-­‐report	   pain	   scores.	   The	  longer	  the	  participant	  held	  their	  finger	  in	  the	  levers,	  the	  more	  likely	  they	  were	  to	   report	   higher	   pain	   levels.	   To	   test	   this,	   verbal	   placebo	   and	   pain	   tolerance	  scores	   were	   entered	   into	   an	   ANOVA.	   This	   analysis	   found	   that	   pain	   tolerance	  (seconds)	   significantly	   predicted	   self-­‐report	   pain	   scores,	   (F(1,96)	   =	   6.77,	   p	   =	  .01),	  indicating	  this	  is	  a	  possibility.	  	  The	   data	   from	   this	   experiment	   may	   be	   seen	   to	   be	   in	   violation	   of	   a	  number	  of	  the	  assumptions	  made	  by	  the	  statistical	  analyses.	  As	  a	  Likert-­‐data	  are	  ordinal,	  the	  assumption	  that	  spacing	  between	  points	  on	  the	  scale	  are	  equal	  may	  not	  be	  met.	  However,	  even	  where	  pain	  ratings	  are	  taken	  on	  a	  continuous	  scale,	  (e.g.	  on	  a	  pain	  dial),	  there	  is	  still	  no	  guarantee	  that	  the	  distance	  between	  points	  are	   ‘equal’	   because	   the	   experience	   of	   pain	   itself	  may	   be	   subject	   to	   non-­‐linear	  scaling.	  The	  results	  from	  the	  Likert-­‐scale	  measures	  used	  in	  this	  experiment	  may	  stand	   if	  we	   are	   to	   accept	   the	   assumption	   that	   spacing	   is	   equal	   and	   follow	   the	  convention	  to	  treat	  Likert-­‐data	  as	  continuous.	  In	   addition,	   as	   Likert-­‐data	   are	   ordinal	   and	   therefore	   not	   normally	  distributed	   they	  may	   violate	   the	   assumption	  made	   by	   the	   statistical	   analyses	  that	  the	  residuals	  are	  normally	  and	  independently	  distributed.	  However,	  as	  the	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residuals	   in	   this	   set	   of	   analysis	  were	  normally	   distributed	   it	   is	   irrelevant	   that	  they	  are	  derived	   from	  ordinal	  data.	   	   Further,	   (Norman,	  2010),	   argues	   that	   the	  assumption	  of	  normality	  of	  residuals	  is	  not	  critical	  in	  the	  use	  of	  Likert-­‐data,	  and	  that	   point	   estimates	   are	   unlikely	   to	   be	   affected	   by	   the	   violation	   of	   this	  assumption.	  The	  statistical	  tests	  used	  here	  are	  therefore	  generally	  robust	  to	  this	  type	  of	  violation.	  The	   inclusion	   of	   a	   third	   independent	   variable	   in	   the	   post-­‐hoc	   analyses	  resulted	   in	   very	   low	   cell	   sample	   sizes.	   Consequently	   there	   may	   have	   been	  outliers	  present	   in	   individual	  cells	  that	  weren’t	  apparent	   in	  the	  overall	  sample	  thus	   violating	   the	   assumptions	   of	   the	   statistical	   analyses.	   For	   example,	   the	  average	   expected	   pain	   score	   for	   male	   participants	   who	   received	   both	   the	  placebo	  and	  illness	  prime,	  (shown	  in	  Figure	  5.4),	  appears	  to	  be	  the	  result	  of	  an	  outlier	   in	   this	   cell.	   The	   results	   of	   the	   post-­‐hoc	   analyses	  may	   therefore	   not	   be	  robust	  due	  to	  violation	  of	  this	  assumption.	  	   In	  addition,	  the	  explanation	  for	  the	  posthoc	  gender	  effects	  found	  in	  this	  study	   centres	   on	   a	   motivational	   explanation.	   However,	   motivation	   was	   not	  directly	  measured	  in	  this	  experiment,	  only	  inferred.	  	  	   Again,	  it	  is	  possible	  the	  PANAS	  measure	  could	  have	  acted	  as	  a	  prime	  for	  affect,	   or	   brought	   the	   non-­‐conscious	   affect	   generated	   by	   the	   prime	   into	  consciousness	  offering	  the	  opportunity	  for	  mood	  repair.	  	   	  5.6	   Conclusion	  
	  Overall,	   no	   significant	   effect	   of	   either	   verbal	   information	   or	   subliminal	   prime	  information	   on	   placebo	   response	   was	   found.	   In	   post-­‐hoc	   analysis,	   the	  unfamiliarity	   of	   a	   novel	   paradigm	   appeared	   to	   increase	   the	   use	   of	   subliminal	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prime	   information	   compared	   to	   the	   more	   traditional	   paradigms	   used	   in	  previous	   chapters,	   but	   only	   in	   males	   who	   had	   also	   received	   verbal	   placebo	  information.	  Although	  this	  finding	  may	  not	  be	  robust,	  it	  was	  suggested	  that	  this	  was	  due	  to	  differences	  motivation	  altering	  attention	  to	  goal-­‐relevant	  stimuli.	  	  5.7	   Next	  Steps	  
	  Differences	  in	  motivation	  were	  only	  inferred	  in	  this	  experiment.	  The	  next	  study	  will	  therefore	  directly	  manipulate	  motivation	  in	  order	  to	  examine	  whether	  the	  gender	  effect	  seen	  in	  the	  novel	  paradigm	  disappears.	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Chapter	  6	  	  
	  Motivation	  and	  the	  use	  of	  subliminal	  primes	  in	  placebo	  responding	  
	  6.1	   Introduction	  
	  The	   results	   of	   the	   experiment	   in	   Chapter	   5	   suggest	   that	   it	   is	   possible	   for	  motivation	   to	   alter	   attention	   to	   subliminal	   primes	  within	   a	  placebo	  paradigm.	  Jensen	  and	  Kardy	  (1991)	  define	  motivation	  within	  an	  experimental	  context	  as,	  “the	  degree	  to	  which	  subjects	  desire	  to	  experience	  a	  symptom	  change”,	  (p.	  146).	  Similarly,	  Hyland,	  (2011a),	  states	  that,	  	  
	  	   “Motivation	   is	   a	   psychological	   construct	   that	   is	   used	   to	   explain	  behaviours	  that	  are	  energised	  and	  directed	  towards	  a	  goal”,	  (p.	  1828).	  
	  	   As	   discussed	   in	   section	   1.3.4,	   motivation	   has	   been	   shown	   to	   mediate	  placebo	  response,	  (Jensen	  &	  Kardy,	  1991;	  Vase	  et	  al.,	  2003;	  Geers	  et	  al.,	  2005a).	  It	  has	  also	  been	  shown	  to	  mediate	  the	  use	  of	  subliminal	  primes,	  (Randolph-­‐Seng	  &	  Mather,	  2009;	  Strahan	  et	  al.,	  2002).	  An	  early	  experiment	  by	  Aletky	  and	  Carlin,	  (1975),	   demonstrated	   that	   if	   motivation	   is	   manipulated	   within	   a	   placebo	  experimental	  context,	  the	  effects	  of	  gender	  disappear,	  suggesting	  gender	  effects	  may	  be	  due	  to	  differences	  in	  motivation.	  	  	   In	   addition,	   manipulating	   attention	   has	   also	   been	   shown	   to	   mediate	  placebo	  response,	  (Geers	  et	  al.,	  2006),	  and	  use	  of	  subliminal	  primes,	  (Meerman,	  2013).	   These	   two	   effects	   were	   combined	   in	   a	   Motivation-­‐Attention	   model	   of	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placebo	   responding,	   (Aigner	   &	   Svanum,	   2014),	   suggesting	   that	   motivation	  increases	   attention	   to	   goal-­‐relevant	   stimuli.	   Although	   this	   model	   focuses	   on	  attention	   to	  supraliminal	   stimuli	   in	   the	  placebo	  context,	   it	   is	  possible	   that	   this	  effect	  may	  extend	  to	  subliminally	  presented	  information.	  	  	  This	   experiment	   was	   designed	   to	   investigate	   the	   possibility	   that	  motivation	   increases	   attention	   to	   subliminally	  presented	   information	  within	   a	  placebo	  context.	  	  In	  order	  to	  provide	  a	  direct	  comparison	  with	  the	  results	  of	  the	  previous	  experiment,	   (in	   which	   motivation	   was	   not	   directly	   manipulated	   but	   only	  inferred),	  the	  same	  placebo	  paradigm	  was	  used	  but	  with	  the	  addition	  of	  a	  direct	  motivation	   manipulation.	   This	   would	   allow	   a	   direct	   comparison	   of	   results,	  allowing	   support	   for	   the	  motivation	   explanation	   given	   for	   the	   findings	   in	   the	  previous	  chapter.	  Motivation	   was	   manipulated	   using	   positively	   and	   negatively	   valenced	  personality	   type	  descriptions,	  with	  participants	   informed	   that	  people	  with	   the	  positive	  personality	  type	  are	  less	  likely	  to	  experience	  pain	  from	  the	  levers.	  	  This	  method	  was	  used	  as	  it	  has	  been	  successfully	  used	  in	  manipulating	  motivation	  in	  previous	   research,	   (Jenson	   &	   Karoly,	   1991).	   Other	   methods,	   such	   as	   the	  scrambled	   sentence	   task	   used	   by	   Geers	   et	   al.,	   (2005a),	   use	   non-­‐conscious	  activation	   of	   relevant	   goals.	   However,	   this	   type	   of	   method	   would	   have	  introduced	  another	  form	  of	  implicit	  information	  to	  the	  experimental	  context	  in	  addition	  to	  the	  subliminal	  prime	  information.	  It	  is	  currently	  unknown	  how	  two	  types	   of	   implicit	   information	   are	   interact	   within	   an	   experimental	   context	  therefore	  these	  methods	  were	  avoided.	  It	   was	   hypothesised	   that	   the	   illness	   related	   subliminal	   prime	   would	  significantly	   decrease	   the	   effect	   of	   the	   verbal	   placebo	   information	   when	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compared	   to	   the	   neutral	   subliminal	   prime,	   but	   only	   in	   participants	   who	   had	  received	  the	  motivation	  manipulation.	  	  
	  6.2	   Methods	  
	  
Participants	  and	  Design	  This	  experiment	  used	  103	  psychology	  undergraduate	  participants	  in	  return	  for	  partial	   course	   credit.	   Existing	   literature	   was	   used	   as	   a	   guide	   to	   determining	  sample	  size,	  (Geers	  et	  al.,	  2005a;	  Meerman	  et	  al.,	  2011;	  Jensen	  et	  al.,	  2012).	  For	  safety	   reasons,	   participants	   who	   smoke,	   suffer	   from	   epilepsy,	   have	   a	   known	  heart	  condition	  or	  were	  currently	  taking	  prescription	  medication	  were	  excluded	  from	   the	   experiment.	   These	   exclusions	   were	   also	   included	   in	   part	   to	   raise	  participant	   expectation	   of	   placebo	   effectiveness.	   Participants	   were	   randomly	  assigned	  to	  receive	  either	  illness	  related	  words	  or	  neutral	  words	  as	  a	  subliminal	  prime.	  Participants	  were	  randomly	  assigned	  to	  receive	  either	  a	  verbal	  conscious	  expectancy	  of	  an	  increase	  in	  pain	  tolerance,	  or	  no	  verbal	  conscious	  expectancy.	  Participants	  were	  also	  randomly	  assigned	   to	  be	  motivated	   to	   feel	   less	  pain,	  or	  not	   motivated.	   This	   results	   in	   a	   2(Expectancy)	   x	   2(Prime)	   x	   2(Motivation)	  between-­‐subject	  design.	  
	  
Measures	  
Expectancy	  Measure	  	  A	   Likert-­‐type	   pain	   scale	   was	   chosen	   to	   measure	   expected	   pain	   as	   a	   large	  proportion	   of	   research	   into	   placebo	   analgesia	   has	   found	   significant	   placebo	  effects	  using	  this	  measure,	  (Spiro,	  1997;	  Tracey,	  2010).	  Expectancy	  ratings	  were	  measured	  on	  an	  11-­‐point	  intensity	  and	  unpleasantness	  scale,	  with	  the	  endpoints	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marked	  0:	  Not	  At	  All	  Intense/Unpleasant	  and	  10:	  Extremely	  Intense	  /	  Unpleasant.	  A	   single	   pain	   rating	   was	   taken	   covering	   the	   pain	   experienced	   in	   both	   hands.	  Participants	  were	  asked:	  “How	  intense	  do	  you	  think	  the	  pain	  in	  your	  fingers	  will	  be?”	   and	   “How	   unpleasant	   do	   you	   think	   the	   pain	   in	   your	   fingers	   will	   be?”	  respectively.	  A	   score	  of	   0	  was	   given	   to	   the	   lowest	  pain	   indication	  point	   and	   a	  score	  of	  10	  was	  given	  to	  the	  highest	  pain	  indication	  point.	  Scores	  for	  individual	  items	  were	  then	  added	  together	  and	  averaged	  to	  provide	  a	  mean	  expected	  pain	  score,	  (α	  =	  .85).	  
	  
Pain	  Intensity	  Measure	  A	   Likert-­‐type	   pain	   scale	   was	   chosen	   to	   measure	   self-­‐report	   pain	   as	   a	   large	  proportion	   of	   research	   into	   placebo	   analgesia	   has	   found	   significant	   placebo	  effects	   using	   this	  measure,	   (Spiro,	   1997;	   Tracey,	   2010).	   Pain	   intensity	   ratings	  were	   measured	   on	   an	   11-­‐point	   intensity	   and	   unpleasantness	   scale,	   with	   the	  endpoints	  marked	  0:	  Not	  At	  All	   Intense/Unpleasant	  and	  10:	  Extremely	  Intense	  /	  
Unpleasant.	   A	   single	   pain	   rating	   was	   taken	   covering	   the	   pain	   experienced	   in	  both	   hands.	   Participants	   were	   asked:	   “How	   intense	   was	   the	   pain	   in	   your	  fingers?”	   and	   “How	   unpleasant	  was	   the	   pain	   in	   your	   fingers?”	   respectively.	   A	  score	  of	  0	  was	  given	  to	  the	  lowest	  pain	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  highest	  pain	  indication	  point.	  Scores	  for	  individual	  items	  were	  then	  added	  together	  and	  averaged	  to	  provide	  a	  mean	  self-­‐report	  pain	  score,	  (α	  =	  .79).	  
	  
Procedure	  On	  arrival,	  participants	  were	  told	  that	  the	  focus	  of	  the	  research	  project	  was	  to	  examine	   the	   effects	   of	   personality	   and	   cognitive	   effort	   on	   pain.	   They	   were	  reminded	   that	   a	  painful	   stimulus	  would	  be	  applied;	   that	   they	  had	   the	   right	   to	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withdraw	   at	   any	   time	   and	   that	   their	   data	   would	   remain	   anonymous	   and	  confidential.	  They	  were	  asked	  to	  read	  and	  sign	  a	  written	  consent	  form.	  	  Participants	   were	   then	   randomly	   allocated	   to	   one	   of	   six	   conditions	  according	  to	  the	  following	  three	  independent	  variables–	  Illness	  related/	  Neutral	  subliminal	   prime;	   Verbal	   Placebo	   /	   No	   Verbal	   Placebo	   and	   Motivation	   /	   No	  Motivation.	  The	  experimenter	  was	  blind	  as	  to	  which	  subliminal	  prime	  condition	  was	  allocated.	  Participants	  were	  then	  seated	  at	  a	  desk.	  The	  desk	  had	  a	  partition	  screen	  positioned	  at	  each	  end	  of	  the	  table.	  The	  screen	  was	  approximately	  2	  metres	  high	  and	  90cm	  deep.	  The	  participant	  was	  therefore	  unable	  to	  observe	  anything	  to	  the	  left	  or	  right	  of	  the	  desk	  whilst	  seated.	  	  Participants	   were	   then	   shown	   the	   Fordyce	   Finger	   Crushers.	   It	   was	  explained	  to	  the	  participant	  that	  the	  Fordyce	  Finger	  Crushers	  would	  be	  used	  to	  apply	  pressure	  to	  their	  index	  fingers	  following	  a	  reaction	  time	  task.	  The	  Finger	  Crushers	  were	  then	  positioned	  behind	  the	  screen	  to	  the	   left	  of	   the	  participant.	  They	   were	   therefore	   unable	   to	   observe	   the	   Finger	   Crushers	   during	   the	  computer	  task.	  Participants	  were	  then	  told	  that	  for	  ethical	  reasons	  the	  experimenter	  was	  required	   to	   give	   them	   some	   further	   information	   about	   the	   purpose	   of	   the	  experiment	   before	   it	   began.	   In	   all	   conditions,	   participants	   were	   then	   given	   a	  written	   fictitious	   description	   of	   two	   personality	   types.	   The	   fictitious	   ‘Type	   B’	  personality	   characteristics	   were	   described	   in	   a	   positive	   manner,	   while	   the	  fictitious	   ‘Type	   A’	   personality	   characteristics	   were	   described	   in	   a	   negative	  manner.	  The	  characteristics	  were	  taken	  from	  Alicke’s,	  (1985),	  list	  of	  personality	  traits.	  The	  Type	  B	  characteristics	  were	  taken	  from	  the	  high	  desire	  /	  low	  control	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rated	   list.	   The	   Type	   A	   characteristics	   were	   taken	   from	   the	   low	   desire	   /	   low	  control	  list.	  In	  the	  ‘Motivation’	  conditions,	  the	  information	  then	  provided	  a	  fictitious	  rational	   for	   a	   strong	   relationship	   between	   personality	   and	   pain.	   It	   described	  how	   feeling	   less	   pain	   from	   the	   levers	   indicated	   a	   Type	   B	   personality,	   while	  feeling	   higher	   pain	   from	   the	   levers	   indicated	   a	   Type	  A	   personality.	   In	   the	   ‘No	  Motivation’	  conditions,	  the	  information	  stated	  previous	  research	  had	  only	  found	  a	  very	  weak	  relationship	  between	  personality	  and	  pain.	  Once	  participants	  had	  read	  the	  information	  they	  were	  then	  directed	  to	  a	  computer	   screen	   where	   they	   carried	   out	   a	   reaction	   time	   task	   containing	   the	  subliminal	  primes.	  In	  the	  ‘Verbal	  Placebo’	  conditions,	  participants	  were	  told	  the	  task	   had	   been	   specifically	   designed	   to	   decrease	   the	   amount	   of	   pain	   they	   feel	  when	  the	  levers	  were	  applied.	  They	  were	  told	  that	  this	  worked	  via	  a	  process	  of	  ‘Cognitive	  Distraction’,	  whereby	  if	  the	  rational	  part	  of	  their	  brain	  is	  highly	  active	  it	   cannot	   register	   as	   much	   pain.	   In	   the	   ‘No	   Verbal	   Placebo’	   conditions,	   the	  instructions	   stated	   that	   the	   task	  had	  been	   specifically	  designed	   for	  use	   in	   this	  experiment.	   They	   were	   then	   asked	   to	   complete	   the	   task	   to	   the	   best	   of	   their	  ability	  and	  informed	  that	  they	  will	  be	  asked	  questions	  about	  the	  task	  at	  the	  end	  of	   the	   experiment.	   After	   describing	   the	   computer	   task	   the	   experimenter	   was	  then	  seated	  behind	  the	  screen	  to	  the	  left	  of	  the	  participant.	  	  The	   priming	   manipulation	   was	   a	   variation	   of	   a	   common	   paradigm	  whereby	   participants	   judge	   as	   quickly	   and	   accurately	   as	   possible	   whether	  briefly	   flashed	   letter	   strings	   appear	   on	   the	   left	   or	   right	   side	   of	   the	   computer	  monitor,	  (Meerman	  et	  al.,	  2011;	  Lowery	  et	  al.,	  2007).	  The	  task	  was	  presented	  to	  participants	  as	  a	  reaction	  time	  task.	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Following	   a	   written	   set	   of	   on-­‐screen	   instructions,	   a	   fixation	   cross	  appeared	  in	  the	  centre	  of	  the	  screen	  for	  a	  duration	  of	  500	  ms.	  Participants	  were	  then	   exposed	   to	   a	   prime	   word	   for	   a	   duration	   of	   34ms.	   In	   the	   illness	   related	  prime	   conditions,	   participants	   were	   subliminally	   exposed	   to	   eight	   words	  relating	   to	   illness,	   (for	   example,	   ‘fever’	   and	   ‘infection’).	   In	   the	   neutral	   prime	  condition,	   participants	   were	   subliminally	   exposed	   to	   eight	   words	   relating	   to	  animals,	  (for	  example,	  ‘squirrel’	  and	  ‘gorilla’).	  All	  of	  the	  prime	  words	  used	  in	  this	  experiment	   have	   been	   previously	   used	   in	   a	   subliminal	   priming	   study	  demonstrating	   that	   subliminally	   presented	   illness	   related	  words	   can	   decrease	  pain	   tolerance,	   (Meerman	   et	   al.,	   2011).	  Words	   in	   both	   lists	  were	  matched	   for	  length	  and	  frequency	  within	  the	  English	  language	  using	  the	  ‘Affective	  Norms	  for	  English	  Words	  (ANEW)	   list,	   (Bradley	  &	  Lang,	  1999).	  As	   the	  original	  word	   lists	  were	   presented	   to	   participants	   in	   the	   Dutch	   language,	   two	   of	   the	   original	   10	  words	   were	   removed	   from	   each	   list	   as	   they	   did	   not	   match	   in	   length	   in	   the	  English	  language.	  Immediately	  after	   the	  prime	  word,	  a	  7-­‐letter	   ‘X’	   string	  appeared	  on	   the	  computer	  monitor	   for	   a	   duration	   of	   150	  ms.	   Both	   the	   prime	  word	   and	   the	   7-­‐letter	   string	   appeared	  on	   either	   the	   left	   or	   right	   hand	   side	  of	   the	   screen.	  This	  letter	   string	   served	   as	   a	   backward	   mask	   for	   the	   prime	   word.	   Participants	  indicated	  the	  position	  of	  the	  7-­‐letter	  string	  on	  the	  screen	  using	  either	  the	  ‘n’	  or	  ‘m’	  key	  on	  the	  keyboard.	  	  The	  screen	  then	  remained	  blank	  for	  a	  duration	  of	  500	  ms.	   Each	   participant	   was	   given	   5	   practice	   trials.	   Each	   participant	   then	  performed	   the	   computer	   task,	   consisting	   of	   100	   trials	   during	  which	   the	   eight	  prime	  words	  were	  shown	  at	  random.	  At	  the	  end	  of	  the	  trials,	  participants	  were	  prompted	   to	   wait	   for	   further	   instructions	   from	   the	   experimenter	   before	  continuing.	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Participants	  were	  then	  asked	  to	  complete	  the	  Expectancy	  Questionnaire.	  As	  the	  subliminal	  prime	  and	  placebo	  were	  administered	  simultaneously	  in	  this	  experiment,	   in	  order	   to	   investigate	   the	  effects	  of	   the	  prime	  on	  expectancy,	   the	  expectancy	   questionnaire	   had	   to	   be	   administered	   after	   the	   placebo.	   Next,	   the	  Fordyce	  Finger	  Crushers	  were	  applied	  to	  both	   index	  fingers	   for	  a	  period	  of	  60	  seconds.	  When	  the	  Finger	  Crushers	  had	  been	  removed,	  all	  participants	  were	  then	  asked	  complete	  the	  Pain	  Report	  Questionnaire	  followed	  by	  a	  funnel	  debriefing	  form	   to	   probe	   for	   suspicion	   or	   awareness	   of	   the	   true	   purpose	   of	   the	   study,	  (Chartrand	   &	   Bargh,	   1996).	   All	   participants	   were	   then	   informed	   of	   the	   true	  nature	   of	   the	   experiment	   and	   a	   brief	   explanation	   of	   the	   theory	   behind	   the	  research	  given.	  
	  6.3	   Results	  
	  
Sample	  Characteristics	  and	  Baseline	  Scores	  One	  hundred	  and	  three	  participants	  from	  the	  University	  of	  Plymouth	  took	  part	  in	   return	   for	   partial	   course	   credit.	   One	   participant	   indicated	   suspicion	   of	  subliminal	   priming	   on	   the	   debrief	   questionnaire	   and	   was	   excluded	   from	   the	  analysis.	   There	   were	   therefore	   82	   females	   and	   20	  males	   with	   a	   mean	   age	   of	  20.6,	  (range	  18	  to	  41),	  included	  in	  the	  analyses	  below.	  
	  Multiple	  one-­‐way	  analysis	  of	  variance	  revealed	  no	  significant	  effect	  of	  gender	  on	  expected	  pain	  scores,	  (t(100)	  =	  0.11,	  p	  =	  .91,	  d	  =	  0.028),	  but	  a	  significant	  effect	  of	  gender	  on	  self-­‐report	  pain	  scores,	  (t(100)	  =	  -­‐2.52,	  p	  =	  .01,	  d	  =	  0.625).	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Manipulation	  Check	  One-­‐way	   analyses	   of	   variance	   revealed	   no	   significant	   difference	   in	  motivation	  scores	   between	   participants	   in	   motivated	   verses	   non-­‐motivated	   conditions,	  (t(100)	  =	  0.01,	  p	  =	  .99,	  d	  =	  0.0004),	  indicating	  that	  the	  motivation	  manipulation	  didn’t	  work.	  
	  
Expectancy	  –	  Expected	  Pain	  Scores	  Means	  for	  expected	  pain	  measures,	  (and	  SD),	  are	  shown	  in	  Table	  6.1	  below.	  
	   Table	  6.1:	  Cell	  means	  (and	  SD)	  for	  expected	  pain	  by	  cell	  (N=102)	  	   Placebo	   No	  Placebo	  
Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  
Motivated	   4.75	  (2.16)	   4.27	  (1.85)	   4.92	  (2.10)	   5.00	  (1.61)	  Non-­‐Motivated	   5.04	  (1.48)	   5.39	  (1.54)	   5.14	  (1.93)	   5.58	  (1.76)	  
Note.	  Higher	  expected	  pain	  scores	  indicate	  higher	  levels	  of	  expected	  pain.	  	  These	   were	   submitted	   to	   a	   2(placebo)	   *	   2(prime)	   *	   2(motivation)	   ANOVA.	  Figure	  6.1	  overleaf	  shows	  mean	  expected	  pain	  scores	  by	  cell.	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Figure	  6.1:	  Mean	  expected	  pain	  scores	  by	  cell	  	  
	  	  	  	  	  	  	  	  This	  analysis	  yielded	  no	  significant	  main	  effect	  of	  placebo,	  (F(1,94)	  =	  0.66,	  p	  =	  .42,	  ηp2	  =	  .007);	  no	  significant	  main	  effect	  of	  prime,	  (F(1,94)	  =	  0.07,	  p	  =	  .79,	  ηp2	  =	  .0007)	  and	  no	  significant	  main	  effect	  of	  motivation,	  (F(1,94)	  =	  2.28,	  p	  =	  .13,	  ηp2	  =	  .024).	  There	  were	  also	  no	  significant	  interactions	  between	  any	  of	  the	  variables.	  
	  
Self-­Report	  Pain	  Scores	  Means	  for	  self-­‐report	  pain	  measures,	  (and	  SD),	  are	  shown	  in	  Table	  6.2	  below.	  	  	  	  	  	  	  	  	  	  Table	  6.2:	  Cell	  means	  (and	  SD)	  for	  self-­‐report	  pain	  by	  cell	  (N=102)	  	   Placebo	   No	  Placebo	  
Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  
Motivated	   6.04	  (2.23)	   6.68	  (1.79)	   7.00	  (2.10)	   7.28	  (1.72)	  Non-­‐Motivated	   6.83	  (2.54)	   7.06	  (1.93)	   6.96	  (2.33)	   7.42	  (2.07)	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These	   means	   were	   submitted	   to	   a	   2(placebo)	   *	   2(prime)	   *	   2(motivation)	  ANOVA.	  Figure	  6.2	  below	  shows	  mean	  self-­‐report	  pain	  scores	  by	  cell.	  	   Figure	  6.2:	  Mean	  self-­‐report	  pain	  scores	  by	  cell	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Average	  Reaction	  Time	  (ms)	  After	  eliminating	  outliers	  and	  the	  initial	  practice	  session,	  the	  average	  response	  time	   for	   the	   duration	   of	   the	   reaction	   time	   task,	   (excluding	   initial	   practice	  sessions),	  was	  calculated	  for	  each	  participant	  in	  milliseconds.	  The	  measures	  in	  milliseconds	  were	  not	  accurately	  recorded	  due	  to	  a	  technical	   fault	  and	  as	  such	  appeared	   to	   be	   too	   short	   to	   be	   realistic.	   However,	   they	   have	   been	   analysed	  based	  on	  the	  assumption	  that	  they	  are	  still	   linearly	  related	  in	  time,	  (i.e.	  higher	  values	  mean	  slower	  responses),	  and	   the	  order	  of	   responses	   therefore	  remains	  intact.	  Table	  6.3	  below	  shows	  the	  mean,	  (and	  SD),	  reaction	  time	  (ms)	  by	  cell.	  	   Table	  6.3:	  Mean	  (and	  SD)	  reaction	  time	  (ms)	  by	  cell	  (N=100)	  	  	   Placebo	   No	  Placebo	  
Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  
Motivated	   20.92	  (15.79)	   26.82	  (16.19)	   44.00	  (62.47)	   38.10	  (34.12)	  Non-­‐Motivated	   56.33	  (58.55)	   39.78	  (34.62)	   26.14	  (15.54)	   21.67	  (13.87)	  
Note.	  Higher	  reaction	  time	  scores	  indicate	  slower	  reaction	  times.	  	  These	   were	   submitted	   to	   a	   2(placebo)	   *	   2(prime)	   *	   2(motivation)	   ANOVA.	  Figure	  6.3	  overleaf	  shows	  mean	  reaction	  time	  by	  cell	  in	  milliseconds.	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Figure	  6.3:	  Mean	  reaction	  time	  (ms)	  by	  cell	  	  	  	  	  	  	  	  
	  This	   analysis	   revealed	   no	   significant	   main	   effects.	   However,	   the	   interaction	  between	  placebo	  and	  motivation	  was	  significant,	  (F(1,94)	  =	  7.95,	  	  p	  =	  .01,	  ηp2	  =	  .005).	  Examination	  of	  the	  cell	  means	  indicate	  that	  participants	  who	  received	  the	  verbal	  placebo	  and	  the	  motivation	  manipulation	  had	  faster	  reaction	  times	  than	  participants	  who	  didn’t	  receive	  either	  the	  placebo	  or	  motivation	  manipulation.	  
	  
Number	  of	  Correct	  Responses	  As	  a	  posthoc	   indication	  of	  attention,	   the	  average	  number	  of	   correct	   responses	  given	   during	   the	   reaction	   time	   task,	   (excluding	   initial	   practice	   sessions	   and	  outliers),	   was	   calculated	   for	   each	   participant.	   Table	   6.4	   overleaf	   shows	   the	  mean,	  (and	  SD),	  number	  of	  correct	  responses	  by	  cell.	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Table	  6.4:	  Mean	  (and	  SD)	  number	  of	  correct	  responses	  by	  cell	  (N=100)	  	   Placebo	   No	  Placebo	  
Measure	   Illness	  Prime	   Neutral	  Prime	   Illness	  Prime	   Neutral	  Prime	  
Motivated	   87.17	  (23.00)	   100.81	  (6.06)	   101.25	  (4.37)	   100.60	  (7.80)	  Non-­‐Motivated	   99.33	  (9.32)	   102.22	  (6.06)	   101.64	  (5.02)	   97.58	  (14.09)	  
Note.	  Higher	  mean	  number	  of	  correct	  responses	  indicates	  more	  accurate	  responding.	  	  These	   were	   submitted	   to	   a	   2(placebo)	   *	   2(prime)	   *	   2(motivation)	   ANOVA.	  Figure	  6.4	  below	  shows	  the	  mean	  number	  of	  correct	  responses	  by	  cell.	  	   Figure	  6.4:	  Mean	  number	  of	  correct	  responses	  by	  cell	  	  	  	  	  	  	  	  
























Neutral Prime, No Motivation Neutral Prime, Motivation
Illness Prime, No Motivation Illness Prime, Motivated
CHAPTER	  6.	  MOTIVATION	  AND	  SUBLIMINAL	  PRIME	  	  	  
	   130	  
indicating	   that	   the	   effect	   of	   the	   verbal	   placebo	   information	   on	   the	   number	   of	  correct	  responses	  given	  differed	  between	  subliminal	  primes.	  Examination	  of	  cell	  means	   indicates	   that	   participants	   in	   the	   motivated	   condition	   who	   received	   a	  verbal	   placebo	   and	   an	   illness	   prime	   had	   fewer	   correct	   responses	   than	   other	  participants.	  	  
	  6.4	   Discussion	  
	  This	   study	   failed	   to	   replicate	   findings	   from	   the	   previous	   chapter	   as	   the	  motivation	  manipulation	   in	   this	  study	  did	  not	  significantly	  alter	   the	  use	  of	   the	  verbal	   placebo	   information	   or	   the	   subliminal	   prime	   information	   within	   the	  placebo	  paradigm.	  	   One	  possible	  reason	  for	  this	  is	  that	  the	  motivation	  manipulation	  did	  not	  work.	  This	  is	  supported	  by	  analysis	  of	  the	  motivation	  manipulation	  check.	  	  This	  may	   be	   due	   to	   the	   motivation	   manipulation	   directly	   preceding	   the	   verbal	  placebo	   information	   within	   the	   experimental	   design.	   Participants	   may	   have	  consciously	   realised	   they	  were	   being	  manipulated	   and	   therefore	   either	   didn’t	  believe	  the	  motivation	  information	  or	  had	  the	  opportunity	  to	  consciously	  repair	  its	  effects.	  	   In	   addition,	   no	   overall	   main	   effect	   of	   placebo	   was	   found	   in	   this	  experiment.	  As	   in	   the	  previous	   chapter,	   it	   is	   possible	   that	   the	  novel	   paradigm	  increased	  uncertainty	  of	  the	  verbal	  information	  in	  all	  participants,	  reducing	  its	  credibility	  to	  the	  point	  where	  no	  effect	  was	  found.	  Although	   the	   findings	   of	   this	   experiment	   did	   not	   support	   the	   initial	  hypotheses,	  comments	  in	  the	  debriefing	  questionnaires	  indicate	  that	  a	  number	  of	  participants	  believed	  that	  the	  most	   important	  aspect	  of	   the	  experiment	  was	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their	  performance	  on	   the	   computer	   task,	   (not	   their	  pain	   threshold	   as	  was	   the	  intention).	  This	  may	  be	  due	  to	  the	  use	  of	  a	  ratings	  scale	  as	  a	  measure	  of	  pain	  as	  opposed	   to	   the	   behavioural	   pain	   tolerance	   measure	   used	   in	   the	   previous	  chapter.	   It	   is	   therefore	   possible	   that	   participants	   focussed	   their	   attention	   on	  their	  computer	  task	  performance	  and	  processed	  relevant	  cues	  accordingly.	  Posthoc	  analyses	  of	  the	  reaction	  time	  task	  data	  suggests	  this	  may	  be	  the	  case,	   as	   some	   of	   the	   independent	   variables	   had	   a	   significant	   effect	   on	   the	  computer	   task	  measurements	   instead	  of	   the	  pain	  measurements.	  For	  example,	  there	  was	   a	   significant	   interactive	   effect	   of	   the	   verbal	  placebo	  and	  motivation	  manipulation	   on	   reaction	   times,	   suggesting	   that	   although	   the	   motivation	  manipulation	  didn’t	  work	  at	  a	  conscious	  level,	  it	  may	  have	  had	  a	  non-­‐conscious	  effect	   in	   some	  participants.	   If	   this	  was	   the	   case,	   this	  non-­‐conscious	  effect	  may	  only	  be	  detected	  via	  behavioural	  measures	  such	  as	  reaction	  times,	  rather	  than	  via	  a	  conscious	  ratings	  measure.	  	  In	  addition,	  participants	  who	  were	  motivated	   to	   feel	   less	  pain	   from	  the	  levers	   and	   were	   told	   that	   the	   computer	   task	   would	   reduce	   pain,	   had	  significantly	   faster	   reaction	   times	   than	   those	   who	   weren’t	   given	   that	  information.	  This	  suggests	  that	  the	  verbal	  placebo	  and	  motivation	  manipulation	  further	  increased	  concentration	  on	  the	  computer	  task.	  However,	  the	  subliminal	  prime	   had	   no	   significant	   effect	   on	   how	   quickly	   participants	   responded	   to	   the	  computer	  task.	  Although	   the	  subliminal	  prime	  had	  no	  significant	  effect	  on	  how	  quickly	  participants	   responded,	   the	   subliminal	   prime	   did	   significantly	   effect	   how	  accurate	   their	   responses	   were.	   Subliminal	   prime	   information	   significantly	  interacted	  with	  verbal	  placebo	  information	  in	  moderating	  the	  number	  of	  correct	  responses	  given	  in	  the	  computer	  task.	  Participants	  had	  fewer	  correct	  responses	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if	   they	  were	   told	   the	   computer	   task	  would	   reduce	  pain	   and	   they	   received	   the	  subliminal	   illness	   prime.	   This	   supports	  Murphy	   and	   Zajonc’s,	   (1993),	   findings	  that	   the	   effects	   of	   semantic	   subliminal	   primes	   are	   more	   likely	   to	   be	   seen	   on	  tasks	   that	  measure	   accuracy	   rather	   than	   speed.	   In	   addition,	   if	   the	   number	   of	  correct	   responses	   is	   seen	   as	   an	   indicator	   of	   attention,	   this	   suggests	   the	  incongruency	   of	   the	   illness	   prime	   with	   the	   verbal	   information	   did	   reduce	  attention	  to	  the	  task,	  supporting	  Valentini	  et	  al.’s,	  (2014),	  account	  of	  why	  illness	  related	  subliminal	  information	  may	  increase	  the	  placebo	  effect.	  The	  effects	  of	  the	  independent	  variables	  on	  the	  reaction	  time	  data	  in	  this	  experiment	   are	   suggestive	   that	   within	   a	   placebo	   paradigm	   participant	   belief	  about	  what	  they	  think	  is	  happening	  can	  alter	  their	  response.	  This	  highlights	  the	  importance	  of	  experimental	  design	  and	  use	  of	  cover	  stories	  in	  both	  placebo	  and	  subliminal	  priming	  contexts.	  	  
	  6.5	   Limitations	  
	  The	   inclusion	   of	   the	   motivation	   manipulation	   check	   questionnaire	   may	   have	  highlighted	  the	  motivation	  manipulation,	  therefore	  reducing	  its	  effects.	  The	   inaccurate	   recording	   of	   the	   computer	   task	   reaction	   times,	   (in	  milliseconds),	   means	   the	   units	   as	   a	   direct	   measure	   of	   speed	   are	   unreliable.	  Although	  it	  was	  assumed	  that	  the	  values	  are	  still	  linearly	  related	  to	  time,	  (with	  higher	  values	  reflecting	  slower	  responses),	  the	  units	  and	  their	  distribution	  may	  not	   provide	   an	   accurate	   reflection	   of	   speed	   of	   response	   during	   the	   computer	  task.	   The	   data	   from	   this	   experiment	   may	   be	   seen	   to	   be	   in	   violation	   of	   a	  number	  of	  the	  assumptions	  made	  by	  the	  statistical	  analyses.	  As	  a	  Likert-­‐data	  are	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ordinal,	  the	  assumption	  that	  spacing	  between	  points	  on	  the	  scale	  are	  equal	  may	  not	  be	  met.	  However,	  even	  where	  pain	  ratings	  are	  taken	  on	  a	  continuous	  scale,	  (e.g.	  on	  a	  pain	  dial),	  there	  is	  still	  no	  guarantee	  that	  the	  distance	  between	  points	  are	   ‘equal’	   because	   the	   experience	   of	   pain	   itself	  may	   be	   subject	   to	   non-­‐linear	  scaling.	  The	  results	  from	  the	  Likert-­‐scale	  measures	  used	  in	  this	  experiment	  may	  stand	   if	  we	   are	   to	   accept	   the	   assumption	   that	   spacing	   is	   equal	   and	   follow	   the	  convention	  to	  treat	  Likert-­‐data	  as	  continuous.	  In	   addition,	   as	   Likert-­‐data	   are	   ordinal	   and	   therefore	   not	   normally	  distributed	   they	  may	   violate	   the	   assumption	  made	   by	   the	   statistical	   analyses	  that	  the	  residuals	  are	  normally	  and	  independently	  distributed.	  However,	  as	  the	  residuals	   in	   this	   set	   of	   analysis	  were	  normally	   distributed	   it	   is	   irrelevant	   that	  they	  are	  derived	   from	  ordinal	  data.	   	   Further,	   (Norman,	  2010),	   argues	   that	   the	  assumption	  of	  normality	  of	  residuals	  is	  not	  critical	  in	  the	  use	  of	  Likert-­‐data,	  and	  that	   point	   estimates	   are	   unlikely	   to	   be	   affected	   by	   the	   violation	   of	   this	  assumption.	  The	  statistical	  tests	  used	  here	  are	  therefore	  generally	  robust	  to	  this	  type	  of	  violation.	  The	   inclusion	   of	   3	   independent	   variables	   in	   the	   experimental	   design	  resulted	   in	   low	   cell	   sample	   sizes.	   Consequently	   there	  may	   have	   been	   outliers	  present	   in	   individual	   cells	   that	   weren’t	   apparent	   in	   the	   overall	   sample,	   thus	  violating	   the	   assumptions	  of	   the	   statistical	   analyses.	   For	   example,	   in	   the	  post-­‐hoc	   analyses,	   the	   mean	   number	   of	   correct	   responses	   for	   participants	   who	  received	   the	  motivation	  manipulation	  and	  both	   the	  placebo	  and	   illness	  prime,	  (shown	   in	   Figure	   6.4),	   appears	   to	   be	   the	   result	   of	   an	   outlier	   in	   this	   cell.	   The	  results	  of	  the	  post-­‐hoc	  analyses	  may	  therefore	  not	  be	  robust	  due	  to	  violation	  of	  this	  assumption.	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In	  addition,	  Levene’s	  test	   for	  equality	  of	  variances	  was	  also	  found	  to	  be	  violated	   for	   the	   number	   of	   correct	   responses	   measure,	   (F(3,98)	   =	   11.01,	   p	   <	  .0001),	   meaning	   there	   was	   no	   homogeneity	   of	   variance	   between	   cells	   in	   this	  measure.	  	  The	  results	  of	  the	  statistical	  tests	  may	  therefore	  be	  invalid	  in	  the	  post-­‐hoc	  analysis.	  
	  6.6	   Conclusion	  
	  This	   study	   failed	   to	   replicate	   findings	   from	   the	   previous	   chapter	   as	   the	  motivation	  manipulation	   in	   this	  study	  did	  not	  significantly	  alter	   the	  use	  of	   the	  verbal	   placebo	   information	   or	   the	   subliminal	   prime	   information	   within	   the	  placebo	  paradigm.	  Post-­‐hoc	  analysis	  of	  the	  reaction	  time	  data	  suggests	  attention	  may	  have	  been	  transferred	  to	  the	  computer	  task	  instead	  of	  pain	  within	  the	  experimental	  context,	   and	   that	   there	  may	  be	  a	  possible	   interaction	  between	  motivation	  and	  use	  of	  experimentally	  provided	  information	  in	  task	  performance.	  However,	  the	  task	   performance	   data	   is	   not	   reliable	   enough	   to	   give	   much	   weight	   to	   this	  suggestion.	   	  Careful	  planning	  of	  experimental	  design	  within	  a	  more	  traditional	  placebo	  context	  may	  be	  able	  to	  study	  this	  potential	  effect	  in	  more	  detail.	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Chapter	  7	  	  
	  General	  Discussion	  
	  7.1	   Summary	  of	  Key	  Findings	  
	  
Can	   subliminal	   inputs,	   learnt	   outside	   of	   a	   traditional	   conditioning	  
paradigm,	  be	  used	  in	  placebo	  responding?	  	  
	  This	   series	   of	   experiments	   found	   no	   reliable	   effect	   of	   subliminal	   prime	  information	  on	  placebo	  response	  within	  a	  short-­‐term	  placebo	  context.	  Although	  experiments	   in	   Chapter’s	   2,	   3	   and	   5	   show	   the	   potential	   for	   subliminally	  presented	  information	  to	  interact	  with	  verbal	  information	  in	  a	  placebo	  context,	  these	   findings	  were	  weak	   and	   inconsistent.	   In	   addition,	   the	   use	   of	   subliminal	  prime	  information	  appeared	  to	  be	  highly	  sensitive	  to	  contextual	  information.	  	  	   This	   lack	   of	   replication	   reflects	   replication	   issues	   encountered	   in	   the	  subliminal	  priming	  field	  over	  the	  last	  6	  years,	  (Bower,	  2012).	  Following	  a	  high	  profile	   fraud	   case,	   it	   was	   highlighted	   that	   many	   studies	   demonstrating	  significant	  effects	  of	  subliminal	  priming	  were	  not	  being	  replicated,	  (Yong,	  2012).	  For	   example,	   the	   famous	   study	   by	   Bargh	   et	   al.,	   (1996),	   demonstrating	   how	  participants	   move	   more	   slowly	   following	   exposure	   to	   subliminally	   presented	  words	   relating	   to	   the	   elderly	   was	   not	   replicated	   in	   Belgium,	   (Doyen,	   2012).	  Similarly,	   Meerman	   et	   al.,	   (2012),	   did	   not	   replicate	   their	   own,	   (2011),	   study	  demonstrating	   the	   effects	   of	   illness	   related	   subliminal	   prime	   words	   on	   pain	  tolerance.	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Many	   different	   reasons	   for	   the	   failure	   of	   subliminal	   priming	   studies	   to	  replicate	   on	   a	   larger	   scale	   have	   been	   proposed.	   For	   example,	   Doyen,	   (2012),	  cites	   non-­‐conscious	   experimenter	   bias.	   Kahneman	   (2012)	   asserts	   that	   even	  minor	  changes,	  such	  as	  the	  colour	  of	  the	  room,	  or	  trivial	  details,	  such	  as	  the	  day	  of	  the	  week,	  can	  lead	  to	  failure	  to	  replicate.	  	  The	  failure	  of	  this	  set	  of	  experiments	  to	  find	  consistent	  evidence	  for	  the	  effects	   of	   subliminal	   prime	   information	   within	   a	   short-­‐term	   placebo	   context	  supports	  the	  replication	  criticisms	  levelled	  at	  the	  subliminal	  priming	  field.	  The	  replication	   problems	   encountered	   here	   also	   support	   the	   assertion	   that	   trivial,	  contextual	  details	  may	  be	  the	  cause	  of	  these	  inconsistencies.	  One	  way	  in	  which	  small	  contextual	  details	  may	  alter	  participant	  response	  to	   subliminal	   primes	   is	   by	   altering	   attention.	   For	   example,	   in	   this	   set	   of	  experiments,	   the	   group	   setting	   in	   Chapter	   2	   increased	   the	   motivation	   of	  participants	   to	   respond	   to	   the	   placebo	   thereby	   increasing	   their	   attention	   to	  goal-­‐relevant	  stimuli,	  (Geers	  et	  al.,	  2014).	  In	  Chapter	  4,	  altering	  the	  position	  of	  the	   experimenter	   may	   have	   detracted	   attention	   from	   the	   subliminal	   prime	  information,	  and	  in	  Chapter	  5,	  increased	  motivation	  to	  respond	  to	  the	  placebo	  in	  male	  participants	  may	  have	  also	  have	   increased	  attention	   to	   subliminal	  prime	  information.	   Whilst	   this	   wasn’t	   replicated	   in	   Chapter	   6,	   it	   is	   possible	   that	  participant	   attention	   may	   have	   been	   diverted	   towards	   computer	   task	  performance	  instead	  of	  pain	  response	  by	  small	  changes	  in	  experimental	  design.	  However,	   whilst	   these	   subtle	   changes	   in	   attention	   may	   account	   for	  inconsistencies	   across	   this	   set	   of	   experiments,	   no	   overall	   reliable	   effect	   of	  subliminally	  presented	  information	  on	  placebo	  response	  was	  found.	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How	   does	   information	   contained	   in	   subliminal	   primes	   integrate	   with	  
conscious	  verbal	  information	  in	  a	  placebo	  context?	  
	  Whilst	   there	   isn’t	   enough	   evidence	   within	   this	   set	   of	   experiments	   for	   a	   clear	  understanding	   of	   how	   subliminal	   information	   may	   integrate	   with	   verbal	  information,	   the	   results	   of	   the	   experiments	   in	   Chapters	   2,	   3	   and	   5	   suggest	  subliminal	   and	   verbal	   information	   may	   not	   always	   integrate	   in	   a	   simple,	  additive	   manner	   as	   suggested	   by	   dual-­‐process	   theories	   of	   behaviour.	   The	  interactions	  between	  subliminal	  prime	  and	  verbal	  placebo	  information	  indicate	  that	  subliminal	  information	  may	  integrate	  with	  conscious,	  verbal	  information	  at	  a	  strategic	  level.	  This	  is	  contrary	  to	  Murphy	  and	  Zajonc’s,	  (1993),	  claim	  that	  the	  effects	  of	  affective	  subliminal	  primes	  are	  ‘diffuse	  and	  non-­‐specific’.	  If	  the	  effects	  of	   affective	   subliminal	   primes	   were	   ‘non-­‐specific,	   a	   main	   effect	   of	   the	   prime	  across	   all	   anticipated	   pain,	   (not	   only	   in	   participants	  who	   had	   received	   verbal	  placebo	  information),	  would	  be	  a	  more	  likely	  result.	  	  However,	  once	  again,	  these	  findings	  were	  weak	  and	   inconsistent,	   therefore	   considerably	  more	   research	   is	  needed	  before	  this	  conclusion	  can	  be	  drawn.	  	  
	  7.2	   Theoretical	  Implications	  
	  7.2.1	   Placebo	  Research	  
	  
Infornet	  Theory	  Infornet	   theory	   views	   the	   placebo	   effect	   as	   a	   short-­‐term	   problem-­‐solving	  response.	   Further,	   infornet	   theory	   predicts	   that	   conscious	   verbal	   information	  will	  have	  a	  stronger	  impact	  on	  short-­‐term	  placebo	  response	  than	  non-­‐conscious	  conditioned	  information	  in	  a	  short-­‐term	  context	  as	  the	  cognitive	  learning	  route	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is	  a	  stronger	  determinant	  of	  environmental	  contingencies	  within	  a	  limited	  time	  scale,	  (Hyland,	  2011a).	  	  	   Findings	   across	   this	   set	   of	   experiments	   suggest	   that	   this	   may	   also	   be	  extended	   to	   subliminally	  presented	   information.	  Conscious	  verbal	   information	  was	   a	   consistently	   stronger	   predictor	   of	   placebo	   response	   than	   higher-­‐order	  subliminal	  information	  within	  the	  traditional	  placebo	  contexts	  examined	  in	  this	  set	  of	  experiments.	  	   	  	   Whilst	   infornet	   theory	   predicts	   that	   any	   type	   of	   input	  may	   be	   used	   to	  produce	  a	  response,	  it	  appears	  that	  this	  may	  be	  constricted	  by	  context.	  Further	  research	  into	  the	  use	  of	  subliminally	  presented	  information	  within	  a	  long-­‐term	  context	   may	   shed	   some	   light	   on	   whether	   conscious	   verbal	   information	   and	  subliminally	  presented	  inputs	  are	  used	  differently	  over	  longer	  periods	  of	  time.	  	  The	   implications	   of	   this	   further	   research	   may	   suggest	   whether	   subliminally	  presented	   information	   is	  used	  at	   all,	   and	   if	   so,	  whether	   the	  proposal	  made	  by	  infornet	  theory	  that	  all	  types	  of	  input	  nay	  be	  used	  by	  the	  infornet	  is	  indeed	  valid.	  Differences	  in	  participant	  attention	  were	  one	  possible	  explanation	  given	  to	   account	   for	   the	   inconsistencies	   in	   the	   effects	   of	   subliminal	   priming	   found	  across	  this	  set	  of	  experiments.	  Infornet	  theory	  states	  that	  response	  is	  based	  on	  assessment	   of	   current	   and	   future	   priorities.	   Attention	   could	   be	   viewed	   as	   an	  output	   of	   the	   infornet	   reflecting	   that	   priority.	   Infornet	   priority	   may	   be	  determined	   by	   a	   number	   of	   internal	   and	   external	   factors.	   For	   example,	  motivation,	   expectancy	   and	   environmental	   factors	   such	   as	   social	   information	  and	   experimental	   design	   may	   interact	   to	   determine	   infornet	   priority	   and	  therefore	   attention.	   In	   the	   short-­‐term	   placebo	   contexts	   studied	   here,	   higher	  priority,	  and	  therefore	  more	  attention,	  could	  have	  been	  given	  to	  the	  conscious	  verbal	  information	  in	  the	  short-­‐term	  laboratory	  context.	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In	   an	   experimental	   context,	   measuring	   attention	   to	   response-­‐relevant	  stimuli	   could	   therefore	   indicate	   infornet	   priority	   and	   predict	   pain	   response.	  Identifying	   the	   conscious	   and	   non-­‐conscious	   aspects	   of	   the	   environment	   that	  divert	  attention	  from	  response-­‐relevant	  stimuli	  could	  also	  lead	  to	  more	  reliable	  and	   predictable	   placebo	   effects.	   For	   example,	   infornet	   priority	   could	   explain	  why	  pain	  is	  the	  most	  consistent	  paradigm	  used	  within	  placebo	  research.	  Other	  than	  threat	   to	   life,	  pain	  has	  one	  of	   the	  highest	  priorities	  within	   the	   infornet	   in	  terms	   of	   response.	   Therefore	   if	   any	   information,	   including	   verbal	   placebo	  information,	   within	   the	   environment	   relates	   to	   pain	   may	   be	   more	   likely	   to	  receive	  attention.	  	  	  
Response	  Expectancy	  Theory	  Further	  to	  Kirsch’s,	  (1985)	  claim	  that,	  	  
	   “…..	  there	  is	  an	  unmediated	  causal	  relation	  between	  response	  expectancy	  and	  subsequent	  experience,”	  (p.	  1197),	  	  
	  Chapters	  2	  and	  5	  show	  that,	   in	  some	  circumstances,	  verbally	  generated	  response	   expectancies	   may	   be	   moderated	   by	   subliminal	   information.	   It	   is	  possible	  that	  this	  is	  more	  likely	  to	  happen	  if	  the	  participant	  is	  motivated	  and	  in	  an	  unfamiliar	  context.	  	  Infornet	  theory	  describes	  how,	  
	  “The	  idea	  that	  information	  from	  the	  external	  environment	  (mediated	  via	  cognitive	  appraisal)	   leads	  directly	   to	   changes	   in	   the	   infornet’s	   activation	   rules	  provides	   a	   rationale	   for	   Kirsch’s,	   (1985,	   1997),	   assertion	   that	   response	  expectancies	  are	  directly	  mediated”,	  (p.	  252).	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   Within	   a	   short-­‐term	   laboratory	   context,	   the	   verbal	   information	   is	   a	  strong	  predictor	  of	  environmental	  contingencies,	  and	  is	  therefore	  more	  likely	  to	  predict	   response,	   (Stewart-­‐Williams	  &	   Podd;	   2004,	   Hyland,	   2011a).	   However,	  information	   from	   the	   environment	   doesn’t	   just	   come	   from	   a	   verbal	   source.	  These	   findings	   suggest	   that,	   although	   it	   is	   possible	   for	   verbal	   information	   to	  directly	   alter	   infornet	   activation	   patterns,	   motivation	   and	   familiarity	   with	  context	  may	  moderate	  this	  effect	  by	  altering	  the	  way	  other	  environmental	  cues	  are	  used.	  This	  may	  have	  important	  implications	  for	  experimental	  design.	  Currently	  experimenters	   refer	   to	   participants	   as	   having	   an	   ‘expectancy’	   without	  specifically	   measuring	   it	   simply	   because	   the	   participant	   is	   in	   the	   condition	  receiving	   verbal	   expectancy	   information,	   (for	   example,	   Krummenacher	   et	   al.,	  2014;	   Moss	   et	   al.,	   2006).	   A	   distinction	   needs	   to	   be	   made	   between	   receiving	  verbal	  expectancy	  information	  and	  actual	  expectancy	  levels.	  Results	  from	  these	  experiments	   show	   it	   is	   possible	   for	   cues	   other	   than	   the	   verbal	   expectancy	  information	  to	  moderate	  conscious	  expectancy	  levels.	  
	  
Motivational	  Theories	  The	   trends	   identified	   in	   this	   set	  of	  experiments	   support	  Aigner	  and	  Svanum’s,	  (2014),	  Motivation-­‐Attention	  Model,	  which	  claims	  that	  more	  motivated	  people	  pay	  greater	  attention	  to	  placebo	  related	  stimuli.	  The	  results	  of	  the	  experiment	  in	  Chapter	  5	  suggest	  it	  may	  be	  possible	  to	  extend	  this	  to	  include	  subliminal	  stimuli.	  However,	   the	   results	   of	   the	   experiments	   here	   also	   suggest	   that	   subliminal	  stimuli	  may	   require	   conscious	   information	  within	   the	  experimental	   context	   to	  divert	  attention	  towards	  them.	  For	  example,	  in	  Chapter	  6,	  the	  subliminal	  illness	  prime	   only	   had	   an	   effect	   in	   males	   who	   had	   received	   the	   verbal	   placebo	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information	  informing	  them	  that	  computer	  task	  was	  goal-­‐relevant.	   In	  addition,	  the	   effect	   of	   motivation	   on	   attention	   may	   be	   more	   visible	   within	   unfamiliar	  contexts,	   possibly	   due	   to	   participants	   being	   unable	   to	   use	   previously	   learnt	  heuristics.	  	   These	   findings	   also	   have	   implications	   for	   Motivational-­‐Concordance	  theory,	   (Hyland,	   2011b),	   which	   states	   that	   matching	   the	   type	   of	   participant	  motivation	  with	  the	  placebo	  therapy	  is	  more	  important	  in	  long-­‐term	  than	  short-­‐term	  placebo	   contexts.	   It	   is	   possible	   that	   in	   long-­‐term	   contexts,	   verbal	   effects	  are	   weaker	   and	   motivation	   is	   needed	   in	   order	   to	   maintain	   attention	   to	  response-­‐relevant	  stimuli	  provided	  in	  the	  therapy.	  	  7.2.2	   Subliminal	  Priming	  Research	  
	  If	   the	   interpretation	   of	   the	   results	   found	   in	   the	   experiment	   in	   Chapter	   5	   is	  correct,	   this	   experiment	   provides	   support	   for	   literature	   claiming	   that	  motivation	   moderates	   the	   effects	   of	   subliminal	   primes,	   (Strahan	   et	   al.,	   2002;	  Randolph-­‐Seng	  &	  Mather,	   2009).	  Whilst	   the	   experiment	   in	  Chapter	  6	   failed	   to	  manipulate	  motivation	  in	  order	  to	  clarify	  this,	  nonetheless	  it	  is	  possible	  that	  the	  moderating	   effects	   of	   motivation	   found	   in	   previous	   subliminal	   priming	  literature	   may	   be	   due	   to	   alterations	   in	   participant	   attention.	   As	   discussed	   in	  section	   7.1,	   differences	   in	   participant	   attention	   due	   to	   slight	   differences	   in	  experimental	  design	  may	  also	  explain	  some	  of	  the	  replication	  issues	  within	  the	  field	  of	  subliminal	  priming	  in	  general.	  	   An	   important	   theoretical	   consideration	   resulting	   from	   this	   set	   of	  experiments	  is	  the	  possibility	  that	  priming	  effects	  and	  placebo	  responses	  share	  one	  common	  mechanism.	  Infornet	  theory	  regards	  the	  placebo	  response	  as	   just	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one	   example	   of	   a	   short-­‐term	   infornet	   response	   in	   action,	   not	   a	   specific	  phenomenon.	  Another	  such	  example	  of	  short-­‐term	  infornet	  responses	  in	  action	  could	  be	  both	  subliminal	  and	  supraliminal	  priming	  effects.	  Seen	  in	  this	  way,	  the	  only	  real	  difference	  between	  placebo	  and	  priming	  effects	  are	  the	  type	  of	   input	  and	  the	  type	  of	  response	  examined	  by	  researchers.	  To	   elaborate,	   traditionally	   a	   placebo	   effect	   involves	   a	   response	   to	  conscious	   verbal	   expectancy	   information	   or	   conditioned	   information.	   This	  information	   takes	   priority	   in	   the	   experimental	   context	   and	   as	   such	   directly	  alters	   infornet	   activation	   patterns.	   A	   congruent	   response	   to	   the	   experimental	  input	   provided	   is	   therefore	   observed.	   However,	   in	   a	   priming	   context,	   other	  categories	  of	  environmental	  cues	  are	  manipulated.	  These	  cues	  are	  also	  capable	  of	   altering	   infornet	   activation	   patterns	   and	   producing	   a	   matching	   response.	  Placebo	  research	  has	  therefore	  concentrated	  on	  the	  effects	  of	  conscious	  verbal	  information	   and	   conditioned	   information,	   whilst	   priming	   research	   has	  concentrated	  on	  the	  effects	  of	  other	  forms	  of	  input.	  	  	   As	  well	  as	  different	  categories	  of	  input,	  the	  type	  of	  response	  examined	  by	  researchers	   in	   each	   field	   of	   study	   has	   also	   traditionally	   fallen	   into	   separate	  categories.	   Following	   initial	   controversy	   over	   whether	   the	   effects	   seen	  constituted	   a	   genuine	   phenomenon,	   both	   placebo	   research	   and	   priming	  research	  turned	  their	  respective	  attentions	  to	  identifying	  the	  range	  of	  responses	  affected	  by	  their	  phenomenon.	  	  	   Pain	   has	   been	   the	   most	   well	   documented	   placebo	   response,	   (Tracey,	  2010).	   However,	   other	   areas	   such	   as	   headaches,	   nausea	   and	   blood	   pressure,	  (Geers	  et	  al.,	  2005a,	  2006),	  through	  to	  medical	  complaints	  such	  as	  anxiety	  and	  depression,	  (Schapira	  et	  al.,	  1970;	  Kirsch	  &	  Sapirstein,	  1998),	  asthma,	  (Kemeny	  et	   al.,	   2007)	   and	   Parkinsons	   disease,	   (de	   la	   Fuente-­‐Fernández	   et	   al.,	   2001;	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Benedetti	   et	   al.,	   2004)	  were	   also	   identified	   as	   placebo	   responsive.	   In	   general,	  placebo	  responses	  are	  mainly	  health	  related	  outputs.	  	  	   In	   the	   field	   of	   priming	   research,	   however,	   responses	   generally	   involve	  changes	  to	  overt	  behaviour,	  (Bargh	  et	  al.,	  1996);	  evaluative	  judgements,	  (Bargh	  &	   Pietromonaco,	   1982;	   Murphy	   &	   Zajonc,	   1993),	   and	   performance	   on	  categorisation	  tasks,	  (Barbot	  &	  Kouider,	  2011;	  Draine	  &	  Greenwald,	  1998).	  	   Historically	   each	   type	   of	   response	   has	   remained	   firmly	   within	   each	  research	   field.	   Health	   related	   responses	   to	   conscious	   verbal	   information	   and	  conditioned	   effects	   were	   largely	   investigated	   within	   in	   the	   placebo	   research	  domain,	   whereas	   other	   forms	   of	   response	   to	   other	   types	   of	   cue	   fell	   into	   the	  priming	   research	   domain.	   However,	   the	   distinction	   between	   the	   two	   is	   now	  beginning	  to	  blur.	  	  	   For	   example,	   within	   the	   placebo	   literature,	   Jensen	   et	   al.,	   (2012),	   have	  started	  to	  identify	  other	  categories	  of	  input	  that	  may	  evoke	  a	  placebo	  response.	  In	  an	  experiment	  measuring	   thermal	  pain,	   they	   found	  that	  a	  placebo	  response	  may	  be	  activated	  via	  non-­‐conscious	   information	  as	  well	  as	  via	   conscious	  cues.	  	  However,	   this	   effect	  was	   still	   labelled	   as	   a	   placebo	   response	   as	   it	  was	   evoked	  using	  a	  non-­‐conscious	  conditioning	  procedure.	  Within	   the	   priming	   literature,	   Meerman	   et	   al.’s,	   (2012),	   experiment	  found	  a	  significant	  effect	  of	  a	  subliminal	  illness	  related	  prime	  on	  pain	  tolerance.	  Both	  Meerman	  et	  al.,	  (2012),	  and	  Jensen	  et	  al.,	  (2012),	  found	  a	  significant	  effect	  of	  a	  non-­‐conscious	  input	  on	  pain.	  Yet	  one	  was	  labelled	  a	  placebo	  response,	  the	  other	  a	  priming	  effect.	  So	  what	  was	  the	  difference?	  Jensen	  and	  colleagues	  used	  a	  non-­‐conscious	   conditioning	   procedure,	   whilst	   Meerman	   and	   colleagues	   used	  ‘higher	  level’	  semantic	  inputs.	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  As	  well	  as	  the	  types	  of	  cue	  that	  may	  activate	  a	  placebo	  response,	  placebo	  researchers	  are	  also	  starting	  to	  broaden	  the	  type	  of	  response	  that	  may	  react	  to	  verbal	   cues.	   For	   example,	   Colaguiri	   et	   al.,	   (2011),	   found	   verbal	   expectancy	  information	   had	   a	   significant	   effect	   on	   the	   non-­‐conscious	   cognitive	   task	   of	  implicit	   learning,	   a	   field	   which	   up	   until	   now	   has	   remained	   in	   the	   domain	   of	  priming	  researchers.	  Research	   in	   both	   placebo	   response	   and	   priming	   effects	   has	   also	  identified	  various	  moderators	  that	  can	  alter	  the	  effects	  of	  the	  original	  input.	  The	  moderators	   identified	   by	   the	   different	   fields	   are	   remarkably	   similar.	   These	  similarities	   can	  be	   explained	   if	   the	   observed	   effects	   are	   a	   result	   of	   a	   common	  mechanism.	  For	   example,	   motivation	   has	   been	   found	   to	   increase	   both	   the	   placebo	  response,	   (Jensen	   &	   Kardy,	   1991;	   Geers	   et	   al.,	   2005a),	   and	   response	   to	  subliminal	  primes,	   (Strahan	  et	  al.,	  2002).	  Another	  moderating	   factor	   identified	  in	   both	   placebo	   and	   priming	   research	   is	   that	   of	   awareness.	   If	   a	   participant	   is	  aware	   of	   the	   possibility	   of	   receiving	   a	   placebo,	   the	   placebo	   effect	   is	   reduced,	  (Geers	  et	   al.,	   2006).	   Similarly,	   if	   a	  participant	   is	   aware	   they	  are	  being	  primed,	  response	   is	  also	  reduced,	   (Verwijermen	  et	  al.,	  2013;	  Randolph-­‐Seng	  &	  Mather,	  2009).	  Cultural	  factors	  have	  also	  been	  identified	  as	  potential	  moderators	  of	  both	  placebo	   and	   priming	   responses.	   Within	   placebo	   research,	   contextual	   factors	  such	  as	  colour	  of	  pill,	  (Blackwell	  et	  al.,	  1972),	  and	  packaging	  branding	  have	  been	  shown	  to	  moderate	  placebo	  responses.	  This	  led	  Moerman	  and	  Jonas,	  (2002),	  to	  the	   proposal	   that	   placebo	   response	   was	   a	   ‘meaning	   response’	   based	   on	  environmental	  and	  cultural	  factors.	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Within	   the	   priming	   literature,	   cultural	   factors	   have	   also	   been	   used	   to	  explain	   replication	   issues.	   For	   example,	   Bargh	   et	   al.’s,	   (1996),	   study	  demonstrated	  participants	  walked	  significantly	  slower	  having	  been	  exposed	  to	  subliminal	   ‘elderly’	   primes.	   This	   study	  was	   replicated	   by	   Doyen,	   (2012),	   who	  found	   no	   significant	   effect.	   However,	   IJzerman	   et	   al.,	   (2013),	   pointed	   out	   that	  Bargh	   and	   colleagues	   carried	   out	   their	   study	   in	   the	   U.S.A.,	   where	   there	   are	  strong	  stereotypes	  for	  the	  elderly.	  Stereotypical	  associations	  for	  words	  such	  as	  ‘Florida’	  used	  in	  Bargh’s	  study	  would	  have	  been	  particularly	  strong	  in	  American	  participants.	   These	   stereotypes	   would	   have	   been	   weaker	   in	   Belgium,	   where	  Doyen	  carried	  his	  replication.	  Historically,	   proposals	   for	   the	   mechanisms	   involved	   in	   both	   placebo	  response	   and	   priming	   effects	   have	   also	   followed	   a	   similar	   path.	   Although	   the	  two	   responses	   are	   traditionally	   separate	   fields	   of	   study,	   similar	   mechanisms	  were	   put	   forward.	   In	   both	   fields,	   a	   high	   profile	   debate	   about	   whether	   an	  automatic	   mechanism	   or	   a	   cognitive	   mechanism	   was	   responsible	   for	   the	  placebo	   and	   priming	   response	  was	   seen	   in	   the	   literature.	  Within	   the	   placebo	  field	  of	  research,	  this	  was	  termed	  the	  ‘conditioning	  verses	  expectancy’	  debate.	  In	  the	   priming	   literature,	   discussion	   involved	   the	   merits	   of	   an	   automatic	  ‘spreading	  activation’	  account	  verses	  ‘high	  level’	  semantic	  mechanisms.	  In	  both	  areas,	  there	  then	  came	  a	  proposal	  that	  the	  two	  mechanisms	  may	  be	  integrated.	  	  Whilst	  Stewart-­‐Williams	  and	  Podd,	  (2004),	  suggested	  that	  human	  beings	  can	   detect	   and	   respond	   to	   environmental	   contingencies	   learnt	   via	   either	  conditioned	   effects	   or	   verbal	   expectancy	   information,	   within	   the	   priming	  literature	  Keisel	  et	  al.,	  (2007),	  proposed	  an	  “Action	  Trigger”	  account	  of	  priming	  effects.	  This	  account	  also	   integrated	  both	  automatic	  and	  semantic	  mechanisms	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and	   for	   the	   first	   time	   introduced	   the	  potential	   involvement	   of	   expectancies	   in	  the	  priming	  response.	  	  The	  ‘Action	  Trigger’	  account	  proposed	  participants	  build	  up	  expectancies	  about	   which	   category	   of	   stimuli	   require	   a	   response	   as	   a	   form	   of	   task	  preparation.	   These	   expectancies	   can	   be	   based	   on	   either	   experience	   and	   or	  verbal	   instruction.	   When	   these	   stimuli	   appear,	   they	   directly	   activate	   an	  automatic	   response.	   In	   this	  way,	   expectancy	   induced	   via	   either	   experience	   or	  cognitive	  learning	  elicits	  a	  primed	  response.	  	  This	  account	  could	  be	  combined	  with	  infornet	  theory	  to	  provide	  a	  model	  of	  response	  in	  both	  placebo	  and	  priming	  research.	  In	  this	  model,	  environmental	  cues	   provide	   information	   about	   what	   is	   a	   current	   priority,	   directly	   altering	  activation	   patterns	   in	   the	   infornet.	   These	   cues	   can	   come	   in	   many	   forms.	   For	  example,	   via	   the	   verbal	   cognitive	   information	   and	   conditioned	   information	  traditionally	   associated	   with	   placebo	   effects,	   or	   via	   subliminal	   or	   conscious	  information	  associated	  with	  priming	  research.	  Indeed,	  any	  information	  received	  by	  any	  of	   the	  senses	  may	  alter	  activation	  patterns	  based	  on	  previous	   learning,	  whether	  it	  is	  learnt	  prior	  to,	  or	  within,	  the	  experimental	  context.	  	  These	   cues	   may	   be	   processed	   and	   interact	   differently	   depending	   on	  motivation	  and	  familiarity	  with	  context.	  For	  example,	  if	  a	  participant	  is	  familiar	  with	   the	   context,	   they	   are	   more	   likely	   to	   use	   ‘heuristic’	   type	   processing	   to	  conserve	   resource.	   However,	   if	   it	   is	   an	   unfamiliar	   context	   there	   is	   no	   such	  heuristic	   available	   and	   therefore	   such	   a	   response	   is	   less	   likely	   unless	   the	  participant	   is	   motivated.	   If	   motivated,	   they	   are	   more	   likely	   to	   attend	   to,	   and	  process,	  external	  cues	  using	  high	  resource	  processing	  such	  as	  working	  memory.	  These	   differing	   contexts	   therefore	   result	   in	   different	   changes	   in	   infornet	  activation	  patterns.	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The	   resulting	   change	   in	   activation	   pattern	   then	   primes	   a	   response	   to	  relevant	   ‘trigger’	   stimuli.	   The	   ‘stimuli’	   may	   fall	   into	   a	   number	   of	   different	  categories	   depending	   on	   context,	   some	   with	   stronger	   previous	   learning	   than	  others.	   For	   example,	   stimuli	   that	   may	   elicit	   a	   response	   in	   a	   placebo	   context	  include	  tubes	  of	  cream	  or	  a	  needle,	  whilst	  ‘trigger’	  stimuli	  in	  a	  priming	  context	  may	   include	  anything	   from	  numerical	  digits	   to	  particular	  words	  depending	  on	  the	  task	  being	  measured.	  	  The	   response	   elicited	   by	   the	   stimuli	   may	   also	   fall	   into	   a	   number	   of	  different	   categories.	   For	   example,	   the	   health	   related	   responses	   such	   as	   pain	  perception	   traditionally	   associated	   with	   placebo	   effects,	   or	   response	   to	  categorisation	  tasks	  seen	  in	  priming	  studies.	  	  In	   the	  same	  way	  that	   ‘infornet	  beliefs’	  are	  non-­‐conscious,	  non-­‐cognitive	  patterns	  across	  contained	  across	  a	  parallel	  processing	  network,	  the	  changes	  in	  infornet	  activation	  patterns	  sensitising	  participant	  response	  to	  other	  cues	  in	  the	  environment	   may	   be	   viewed	   as	   ‘infornet	   expectancies’.	   These	   ‘infornet	  expectancies’	   are	   also	   non-­‐conscious	   and	   non-­‐cognitive,	   but	   are	   actually	   the	  main	   predictor	   of	   response.	   	   In	   a	   placebo	   context,	   conscious	   response	  expectancies	   appear	   to	   be	   the	   predictor	   because	   the	   conscious	   verbal	  information	   is	   the	   strongest	   cue	   in	   a	   laboratory	   context.	   In	   other	   words,	  conscious	   response	  expectancies	  may	  not	  directly	  be	   the	   cause	  of	   the	  placebo	  response,	   they	   may	   just	   happen	   to	   match	   response	   generated	   by	   infornet	  expectancy	  in	  the	  majority	  of	  placebo	  laboratory	  conditions.	  In	   this	   way,	   both	   placebo	   and	   priming	   effects	   are	   the	   result	   of	   the	  infornet	   carrying	   out	   short-­‐term	   problem	   solving	   response	   within	   an	  experimental	  context.	  Placebo	  research	  happens	  to	  have	  focussed	  on	  the	  effects	  of	  conscious	  verbal	  or	  conditioning	  inputs	  on	  health	  related	  responses,	  whereas	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priming	   research	  has	   focussed	   on	   information	  presented	   in	   different	  ways	   on	  behaviour	   and	   task	   related	   responses.	   Historically,	   both	   fields	   have	   identified	  common	  moderators	  and	  have	  had	  the	  same	  debate	  about	  the	  role	  of	  automatic	  verses	  cognitive	  learning	  in	  producing	  a	  response.	  	  More	   recent	   research	   has	   shown	   the	   fields	   of	   placebo	   and	   priming	  responses	  are	  beginning	  to	  overlap.	  Combining	  placebo	  and	  priming	  responses	  in	   a	   common	   theoretical	   model	   could	   provide	   a	   rationale	   on	   which	   to	   base	  future	  research.	  How	  the	  infornet	  ultimately	  responds	  to	  any	  given	  context	  may	  depend	  upon	  the	   ‘infornet	  expectancies’	  derived	  from	  the	   inputs	  available,	  not	  what	  category	  we	  chose	  to	  give	  those	  inputs	  or	  responses.	  	  7.3	   Practical	  Implications	  
	  The	   findings	   of	   these	   experiments	   suggest	   that	   it	   is	   at	   least	   possible	   that	  subliminal	   information	   found	   in	   a	   clinical	   setting	   may	   interact	   with	   verbal	  information	   given	   by	   the	   practitioner	   to	   some	   extent.	   This	  may	   be	   especially	  true	   of	   patients	   suffering	   from	   placebo	   responsive	   conditions	   such	   as	   pain,	  (Montgomery	  &	  Kirsch,	   1997);	   asthma,	   (Kemeny	   et	   al.,	   2007);	   irritable	   bowel	  syndrome,	   (Kaptchuk	   et	   al.,	   2008);	   anxiety	   and	   depression,	   (Schapira	   et	   al.,	  1970;	   Kirsch	   &	   Sapirstein,	   1998),	   and	   Parkinson’s	   disease,	   (de	   la	   Fuente-­‐Fernández	   et	   al.,	   2001;	   Benedetti	   et	   al.,	   2004).	   This	   may	   also	   extend	   to	  subliminal	  information	  contained	  in	  the	  home	  environment	  of	  these	  patients	  as	  well	   as	   in	   clinical	   settings.	  However,	   to	   be	   of	   practical	   significance,	   any	  direct	  intervention	   needs	   to	   be	   cost	   effective	   in	   that	   it	   has	   a	   reliable	   and	   consistent	  effect	  across	  as	  large	  number	  of	  people.	  As	  these	  findings	  suggest	  the	  effects	  of	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subliminally	   presented	   information	   in	   a	   short-­‐term	   context	   are	   weak	   and	  inconsistent,	   it	   may	   therefore	   not	   be	   cost	   effective	   to	   implement	   any	   direct	  subliminal	   intervention	  within	  a	  short-­‐term	  clinical	  setting.	  However,	  this	  may	  not	  be	  the	  case	  in	  longer-­‐term	  clinical	  environments	  or	  home	  settings	  and	  this	  area	  may	  warrant	  further	  research.	  	   The	   findings	   of	   these	   experiments	   also	   suggest	   that	   within	   a	   clinical	  setting	  it	  is	  possible	  that	  motivating	  a	  patient	  to	  get	  better	  is	  an	  important	  part	  of	  the	  clinical	  process.	  Once	  a	  patient	  is	  motivated,	  these	  findings	  suggest	  they	  are	  more	  likely	  to	  attend	  to	  and	  respond	  to	  environmental	  information,	  both	  in	  the	   clinical	   and	   home	   setting.	   Ensuring	   the	   environmental	   information	   is	  positive	   for	   motivated	   patients	   could	   then	   maximise	   treatment	   effectiveness.	  This	   would	   particularly	   be	   the	   case	   if	   the	   patient	   were	   unfamiliar	   with	   the	  medical	   context.	   Addressing	   patient	   motivation	   for	   recovery	   and	   ensuring	   a	  range	  of	  positive	  signals	  are	  available	  within	  the	  environment	  may	  be	  especially	  important	  in	  the	  placebo	  responsive	  conditions	  listed	  above.	  	  	   The	   question	   of	   exactly	   how	   to	   motivate	   patient	   recovery	   has	   been	  widely	   investigated	   in	   the	   literature	   for	  a	  number	  of	  years.	  Despite	  a	   lack	  of	  a	  clear	  definition	  of	  the	  concept	  of	  motivation	  itself,	  (Maclean	  &	  Pound,	  2000),	  it	  is	  generally	  accepted	   that	  motivation	  originating	   from	  an	   internal	  source	  such	  as	   sense	   of	   accomplishment	   is	   more	   likely	   to	   promote	   long-­‐term	   health	   than	  externally	   motivating	   factors	   such	   as	   financial	   reward,	   (Deci	   &	   Ryan,	   1987;	  Curry	  et	  al.,	  1991).	  	   One	  technique	  that	  could	  increase	  intrinsic	  patient	  motivation	  is	  the	  use	  of	   ‘Motivational	  Consulting’,	   (Butler	  et	  al.,	  1999).	  This	   technique	  combines	   the	  theoretical	  ‘stages	  of	  change’	  model,	  (Prochaska	  &	  DiClemente,	  1986),	  and	  self-­‐efficacy	   theory,	   (Bandura,	   1977),	   with	   the	   clinical	   methods	   of	   motivational	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interviewing	   and	   the	   patient-­‐centred	   method.	   In	   using	   the	   motivational	  consulting	   technique,	   clinical	   interactions	  are	  moved	  away	   from	   ‘professional-­‐centred’	   approaches	   towards	   a	   ‘patient-­‐centred’	   approach,	   which	   includes	  enhancing	  patient	  expectations,	  involving	  patients	  in	  decision-­‐making	  and	  being	  responsive	   to	   patient	   attitude	   change.	   Other	   social	   factors	   such	   as	   clear	   and	  revisable	   goal	   setting	   and	   reminding	  patients	   of	   goals	   beyond	   the	   therapeutic	  setting	   have	   also	   been	   suggested	   in	   helpful	   in	   increasing	   patient	   motivation,	  (Tupper	  &	  Henley,	  1997).	  Once	   motivated,	   this	   set	   of	   experiments	   has	   shown	   that	   patients	   may	  then	   be	   more	   likely	   to	   respond	   to	   positive	   ‘safety	   signals’	   within	   the	  environment.	  Examples	  of	  such	  ‘safety	  signals’	  may	  be	  found	  in	  the	  literature.	  In	  1984,	  biologist	  Edward	  Wilson	  put	  forward	  his	  “Biophilia	  Hypothesis”,	  in	  which	  he	  claims	  human	  beings	  have	  an	  innate	  attraction	  to	  nature	  resulting	  from	  the	  natural	  selection	  of	  our	  gene	  pool	  on	  the	  African	  Savannahs.	  He	  goes	  further	  to	  suggest	  interaction	  with	  nature	  will	  therefore	  have	  a	  therapeutic	  effect.	  This	   has	   been	   supported	   by	   many	   studies	   investigating	   the	   effect	   of	  viewing	   pastoral	   images	   on	   patient	   recovery,	   whereby	   this	   prediction	   was	  extended	  to	  include	  images	  of	  natural	  scenes.	  Ulrich	  (1984)	  was	  the	  first	  to	  test	  Wilson’s	  claims	  using	  pictures,	  and	  found	  pastoral	  images	  did	  aid	  recovery	  from	  surgery.	   Pastoral	   images	   have	   since	   been	   found	   to	   help	   reduce	   pain	   in	   areas	  such	   as	   burns	   care,	   (Miller	   et	   al.,	   1992);	   paediatric	   care,	   (Rusy	   &	   Weisman,	  2000)	  and	  in	  bronchoscopy	  recovery,	  (Diette	  et	  al.,	  2003;	  Lechtzin	  et	  al.,	  2010).	  However,	   it	   is	   not	   just	   images	   of	   nature	   that	   can	   provide	   a	   positive	  environmental	   signal.	   During	   a	   laboratory	   experiment,	   Aou	   et	   al.,	   (2005),	  demonstrated	  that	  the	  presence	  of	  ‘green’	  odours	  can	  significantly	  reduce	  pain.	  Nature	   sounds	   have	   also	   been	   shown	   to	   be	   effective	   in	   reducing	   pain.	   For	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example,	  Cutshall	  et	  al.,	  (2011),	  found	  that	  nature	  sounds	  reduced	  patient	  pain	  following	  cardiac	  surgery.	  	  Another	   positive	   ‘safety	   signal’	   that	   has	   been	   investigated	   within	   the	  literature	  is	  the	  use	  of	  music.	  Relaxing	  classical	  music	  has	  been	  found	  to	  lower	  heart	   rates	   in	   coronary	   patients,	   (Guzzetta,	   1989);	   reduce	   anxiety	   and	   pain	  during	   dental	   procedures,	   (Anderson	   et	   al.,	   1991),	   and	   following	   abdominal	  surgery,	  (Good	  et	  al.,	  1999).	  However,	  there	  is	  little	  agreement	  as	  to	  a	  definition	  of	   ‘relaxing’	   music.	   It	   may	   therefore	   be	  more	   advantageous	   to	   encourage	   the	  patient	  to	  choose	  the	  music	  they	  find	  the	  most	  relaxing	  on	  an	  individual	  basis,	  (Hanser,	  1985;	  Gerdner,	  1999).	  Our	   sense	   of	   taste	  may	   also	   provide	   positive	   sensory	   information.	   For	  example,	  sweet	  tasting	  substances	  have	  been	  found	  to	  have	  analgesic	  effects	  in	  human	  infants,	  (Johnston	  et	  al.,	  1999;	  Barr	  et	  al.,	  1994)	  and	  adults,	  (Lewkowski	  et	  al.,	  2003).	  However,	  this	  effect	  may	  be	  moderated	  by	  age	  and	  gender,	  (Mercer	  &	  Holder,	  1997).	  This	  effect	  may	  also	  extend	  to	  our	  sense	  of	  smell.	  For	  example,	  Prescott	   and	   Wilkie,	   (2007),	   found	   sweet	   smelling	   caramel	   increased	   pain	  analgesia.	  	  Attending	   to	   patient	   sense	   of	   touch	   may	   also	   provide	   positive	   safety	  signals.	  For	  example,	  massage	  has	  been	  found	  to	  improve	  pain	  levels	  in	  cancer	  patients,	   (Kutner	   et	   al.,	   2008);	   reduce	   labour	   pain,	   (Field	   et	   al.,	   1997),	   and	  improve	  pain	  levels	  in	  Fibromyalgia	  patients,	  (Field	  et	  al.,	  2002).	  	   The	  experiments	  conducted	  for	  this	  Ph.D.	  suggest	  that	  a	  combination	  of	  increasing	   patient	   motivation	   and	   presenting	   these	   physical	   stimuli	   may	   be	  most	   effective	   in	  promoting	  patient	   recovery.	  However,	   this	   research	  has	   also	  shown	   that	   the	   use	   of	   primes	   is	   not	   always	   rational.	   (For	   example,	   the	  subliminal	  illness	  prime	  in	  Chapter	  5	  actually	  decreased	  expected	  pain	  in	  some	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participants).	   As	   such,	   more	   research	   into	   understanding	   how	   various	   inputs	  interact,	   and	   the	   role	   of	  motivation	   in	   attending	   to	   those	   signals,	   is	   crucial	   in	  determining	  an	  effective	  clinical	  role	  for	  positive	  environmental	  cues.	  	   	  7.4	   Limitations	  
	   Subliminal	   priming	   effects	   have	   been	   shown	   to	   last	   up	   to	   2	   minutes,	  (Bargh	  &	  Chartrand,	  2000),	  therefore	  in	  order	  to	  associate	  the	  placebo	  with	  the	  words	   in	   the	   subliminal	   priming	   task,	   the	   placebo	   was	   administered	   directly	  after	   the	   priming	   task	   in	   all	   placebo	   conditions,	   (or	   simultaneously	   as	   in	  Chapters	   5	   and	   6).	   This	   resulted	   in	   the	   expectancy	   questionnaire	   being	  administered	   after	   the	   placebo	   in	   all	   experiments.	   As	   the	   verbal	   placebo	  informed	  participants	  that	  there	  would	  be	  a	  time	  delay	  between	  the	  application	  of	  the	  placebo	  and	  feeling	  its	  effects,	  the	  assumption	  was	  made	  that	  participants	  wouldn’t	   experience	   any	   placebo	   symptoms	   until	   after	   the	   expectancy	  questionnaire	  had	  been	  completed.	  This	  assumption	  may	  have	  been	   incorrect,	  especially	  in	  light	  of	  the	  significant	  effect	  of	  participants	  simply	  being	  informed	  they	  were	   in	   the	  placebo	  condition	  on	  baseline	  caffeine	  symptom	  measures	   in	  Chapter	  2.	   In	   this	   respect,	   the	  positioning	   the	  expectancy	  questionnaire	   in	   the	  procedure	  may	  have	  reduced	  its	  validity	  as	  it	  may	  have	  actually	  been	  measuring	  the	   onset	   of	   the	   experience	   of	   placebo	   related	   symptoms	   instead	   of	   their	  expectancy.	  	   If	  motivation	  is	  important	  in	  determining	  response	  as	  suggested	  here,	  it	  is	   important	   to	   take	   recruitment	   bias	   into	   consideration	   within	   this	   set	   of	  experiments.	  It	  is	  possible	  that	  participants	  who	  are	  highly	  motivated	  not	  to	  feel	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pain	  would	  not	   have	   signed	  up	   for	   this	   experiment.	   These	   participants	  would	  potentially	  have	  been	  the	  most	  responsive	  to	  subliminal	  priming	  effects.	  	   In	   Chapters	   5	   and	   6,	   a	   novel	   placebo	   paradigm	   was	   used	   in	   order	   to	  increase	  uncertainty	   in	   the	  participant.	  This	  uncertainty	   is	   thought	   to	   increase	  the	  use	  of	  environmental	  information,	  (Geers	  et	  al.,	  2014),	  and	  it	  was	  proposed	  that	  this	  would	  include	  strengthening	  the	  use	  of	  the	  subliminal	  prime.	  However,	  increasing	  the	  uncertainty	  of	  the	  context	  to	  this	  extent	  may	  also	  have	  decreased	  the	  credibility	  of	  the	  placebo	  itself,	  resulting	  in	  no	  overall	  main	  placebo	  effect.	  It	  is	   therefore	   difficult	   to	   ascertain	   the	   effects	   of	   subliminal	   primes	   in	   a	   true	  placebo	  context.	  Infornet	  theory	  predicts	  that	  humans	  can	  never	  be	  taken	  out	  of	  context.	  We	  will	  always	  respond	  to	  any	  information	  in	  the	  environment,	  and	  respond	  to	  it	  in	  different	  ways	  depending	  on	  our	  previous	  learning.	  Infornet	  theory	  mainly	  applies	  this	  to	  a	  medical	  context.	  However,	   it	  may	  also	  be	  applicable	  within	  an	  experimental	   setting.	   It	   appears	   that	   even	   in	   a	   controlled	   laboratory,	   human	  beings	  will	  respond	  to	  the	  smallest	  changes	  in	  their	  environment,	  even	  within	  a	  short-­‐term	  context.	   It	  may	  be	   the	  case	   that	  when	  studying	  human	  beings	  only	  the	   responses	   that	   dictate	   the	   highest	   infornet	   priority	   will	   yield	   the	   most	  reliable	  results.	  
	  7.5	   Future	  Research	  
Long-­term	  placebo	  contexts	  This	   research	   looked	   at	   the	   effects	   of	   subliminal	   priming	   in	   short-­‐term,	  laboratory	   based	   placebo	   contexts.	   Motivation	   has	   been	   identified	   as	   an	  important	  factor	  in	  predicting	  longer-­‐term	  placebo	  responses,	  (Hyland,	  2011b).	  If,	  as	  suggested	  here,	  motivation	  is	  a	  potentially	  important	  moderator	  in	  the	  use	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of	   subliminal	   primes	   within	   a	   placebo	   context,	   investigating	   the	   effects	   of	  subliminal	  primes	  may	  be	  more	  fruitful	  within	  a	  long-­‐term	  placebo	  context.	  
	  
Motivation	  and	  Unfamiliarity	  interaction	  Further	   investigation	   into	   a	   possible	   interaction	   between	   motivation	   and	  unfamiliar,	   (or	   novel),	   placebo	  paradigms	  may	  provide	   important	   information	  on	  placebo	  response.	  This	  set	  of	  experiments	  suggest	  that	  it	  is	  possible	  that	  the	  effects	   of	   motivation	   are	   more	   likely	   to	   be	   demonstrated	   in	   more	   unfamiliar	  paradigms	  as	  participants	  have	  fewer	  previously	  learnt	  ‘automatic’	  heuristics	  to	  fall	  back	  on.	  Familiarity	  with	  all	   aspects	  of	   the	  paradigm	  should	  be	   taken	   into	  consideration.	  
	  
Alteration	  of	  Priority	  Infornet	   theory	   predicts	   that,	   in	   a	   short-­‐term	   context,	   verbal	   information	   is	   a	  stronger	   predictor	   of	   response	   than	   conditioned	   information.	   The	   findings	   in	  this	   set	   of	   experiments	   suggest	   that	   verbal	   information	   is	   also	   a	   stronger	  predictor	  of	   response	   than	   subliminal	   information.	  However,	   if	   the	   suggestion	  that	   attention	   is	   an	   output	   of	   the	   infornet	   based	   on	   current	   priority	   were	  correct,	  it	  would	  predict	  that	  altering	  that	  current	  priority	  would	  alter	  response.	  	  This	   could	   be	   investigated	   by	   manipulating	   external	   priority,	   (for	  example,	   introducing	   the	   presence	   of	   unexplained	   loud	   banging	   within	   the	  room),	  or	  internal	  priority,	  (for	  example,	  inducing	  participant	  tiredness,	  hunger	  or	   thirst).	   If	   the	   suggestion	   that	   attention	   towards,	   (and	   response	   to),	  environmental	   cues	   is	   adjusted	   according	   to	   infornet	   priority,	   these	   types	   of	  manipulations	  are	  likely	  to	  alter	  placebo	  response.	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Depleted	  Cognitive	  Resource	  Even	  if	  a	  participant	  were	  motivated,	  they	  would	  be	  less	  able	  to	  divert	  attention	  to	   placebo	   related	   stimuli	   if	   their	   cognitive	   resource	   is	   depleted,	   thereby	  reducing	  the	  placebo	  effect.	  Applying	  Baumeister	  et	  al.’s,	  (1998),	  ego	  depletion	  work	   to	   a	   placebo	   paradigm,	   or	   introducing	   a	   high	   cognitive	  workload	   to	   the	  placebo	   paradigm,	   may	   therefore	   reduce	   the	   placebo	   effect.	   This	   may	  particularly	   apply	   to	   unfamiliar	   paradigms	   where	   motivation	   is	   predicted	   to	  have	  the	  strongest	  effect.	  
	  7.6	   Concluding	  Remarks	  
The	  results	  of	  the	  experiments	  conducted	  for	  this	  Ph.D.	  suggest	  no	  reliable	  effect	  of	   subliminally	   presented	   information	   on	   placebo	   response	   in	   a	   short-­‐term	  placebo	  context.	  The	  use	  of	  subliminal	  information	  within	  this	  context	  appears	  to	  be	  weak	  and	  inconsistent.	  Within	  a	  traditional	  placebo	  paradigm,	  consciously	  presented	   verbal	   information	   remains	   the	   strongest	   predictor	   of	   placebo	  response.	   In	   addition,	   it	   appears	   that	   the	   use	   of	   subliminally	   presented	  information	  is	  highly	  susceptible	  to	  contextual	  factors.	  	   These	  findings	  support	  criticisms	  encountered	  by	  the	  subliminal	  priming	  field	  within	  the	  last	  6	  years,	  whereby	  a	  lack	  of	  successful	  replications	  has	  called	  into	  question	  the	  strength	  of	  subliminal	  priming	  effects.	  However,	  it	  is	  possible	  that	  these	  effects	  may	  be	  strengthened	  by	  use	  within	  a	  long-­‐term	  context.	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Appendix	  A	  
	  Experimental	  Materials	  
	  A.1	   Participant	  Information	  Sheets	  Chapter	  2	  
	  
Aim of research 
 
To identify the effects of caffeine on cognitive reaction times. 
 
Description of procedure 
 
Once seated at a computer screen, you will be asked to fill in a ‘Caffeine 
Usage Questionnaire’. You will then be given a 5 minute rest period, where 
you will be asked to relax and clear your mind. 
 
Following the rest period, your blood pressure readings will be taken using a 
digital arm cuff on your non-dominant arm. 
 
You will then be asked to carry out a computer based cognitive reaction time 
task requiring you to indicate whether a 7-letter ‘X’ string appears on the left 
or right hand side of the computer screen. 
 
You may then be asked to consume a cup of caffeinated black coffee. 
 
Your blood pressure reading will then be taken again using a digital arm cuff 
on your non-dominant arm. 
 
You will then be asked to wait for a period of 5 minutes for the caffeine to 
take effect, during which time you will be asked to complete a brief 
‘Expectancy Questionnaire’. 
 
Your blood pressure readings will then be taken again using a digital arm cuff 
on your non-dominant arm, and you will be asked to fill in a ‘Caffeine 
Response Questionnaire’. 
 
You will then be asked to repeat the cognitive reaction time task. 
 
Following the task, you will be asked to complete a ‘Caffeine Questionnaire’ 
and a ‘Debriefing’ questionnaire. 
 
Description of risks 
  
Increased heart rate and blood pressure due to caffeine consumption. This 
study is not open to participants who are smokers, who are on prescription 
medication or who have any known heart conditions. Please inform the 
experimenter immediately if any of the above apply to you. 
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Benefits of proposed research 
 
To improve cognitive reaction times under pressure in applied settings. For 
example, pilots and medical staff. 
 
Right to withdraw 
 
You have the right to withdraw your data at any time. 
 
If you are dissatisfied with the way the research is conducted, please contact 
the principal investigator in the first instance: telephone number 07875 
816233.  If you feel the problem has not been resolved please contact the 
secretary to the Faculty of Science and Technology Human Ethics 
Committee:  Mrs Paula Simson 01752 584503. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
APPENDIX	  A.	  MATERIALS	  	  
	   158	  




Please indicate below your responses to the following questions: 
You have the right to withdraw your responses at any time. 
 
 
1. What was the purpose of today’s study? 	  
2. Were you aware of any factors within the experiment that could have 
affected your performance on the cognitive reaction time task? (If yes, 
please specify below). 
 
3. Were you aware of anything unusual within the experiment? (If yes, 
please specify below). 
 
4. Did you feel any aspect of the experiment could have impacted on your 
response to any other part of the experiment? (If yes, please specify 
below) 
 
5. Did you notice anything unusual about the blood pressure readings? (If 
yes, please specify below). 
 
6. Did you notice anything unusual about the cognitive reaction time task? (If 
yes, please specify below) 
 
7. Did you notice anything unusual about the Expectancy Questionnaire? (If 
yes, please specify below). 
 
8. If applicable, did you notice anything unusual about the coffee? (If yes, 
please specify below). 
 
9. Did your participation in the cognitive reaction time task influence your 
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A.3	   Baseline	  /	  Self-­‐Report	  Caffeine	  Symptom	  Measure	  Chapter	  2	  
 Instructions	  
To answer the questions in the attached questionnaire, please indicate your 
response to each of the questions by circling the most appropriate part of the 
scale. 
 
For example, the answer below indicates the person strongly disagrees with 
the following statement: 
 
The colour blue is nicer than the colour green.  
 
Strongly -        -        -        -        -        -        -        -        -        -        -  Strongly 
Disagree         Agree 
    
 
Please select your response to the following statements below. 
 
You have the right to withdraw your responses at any time. 
 
 Questionnaire	  Items	  	  
1. How alert do you feel at the moment? 
 
Not At All  -        -        -        -        -        -        -        -        -        -        -  Extremely 
Alert          Alert 
                  
 
2. How anxious do you feel at the moment? 
 
Not At All  -        -        -        -        -        -        -        -        -        -        - Extremely 
Anxious         Anxious
            
 
3. How restless do you feel at the moment? 
 
Not At All   -        -        -        -        -        -        -        -        -        -        - Extremely 
Restless         Restless
           
  
4. Compared to when you are at home watching TV, how fast is your heart 
beating at the moment? 
 
Significantly   -        -        -        -        -        -        -        -        -        -        -        Significantly 
Slower                    Faster 
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5. Compared to when you are at home watching TV, how high do you think 
your blood pressure is at the moment? 
 
Significantly   -        -        -        -        -        -        -        -        -        -        -        Significantly 




6. Overall, how much of an effect do you think the caffeine has had on you? 
 
No Effect   -        -        -        -        -        -        -        -        -        -        -     A Highly 
    At All Significant           
Effect 
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A.4	   Expectancy	  Questionnaire	  Chapter	  2	  
 Instructions	  
To answer the questions in the attached questionnaire, please indicate your 
response to each of the questions by circling the most appropriate part of the 
scale. 
 
For example, the answer below indicates the person strongly disagrees with 
the following statement: 
 
The colour blue is nicer than the colour green.  
 
Strongly -        -        -        -        -        -        -        -        -        -        -  Strongly 
Disagree         Agree 
    
 
We want to find out how caffeine normally affects you. With this in mind, 
please fill in the following questions about how you expect the caffeine to 
alter your physiological responses. 
 
You have the right to withdraw your responses at any time. 
 
 Questionnaire	  Items	  	  
1. How alert do you expect to feel in 10 minutes time? 
 
Not At All  -        -        -        -        -        -        -        -        -        -        -  Extremely 
Alert          Alert 
                  
 
2. How anxious do you expect to feel in 10 minutes time? 
 
Not At All  -        -        -        -        -        -        -        -        -        -        - Extremely 
Anxious         Anxious
            
 
3. How restless do you expect to feel in 10 minutes time? 
 
Not At All   -        -        -        -        -        -        -        -        -        -        - Extremely 
Restless         Restless
           
  
4. Compared to when you are at home watching TV, how fast do you expect 
your heart to be beating in 10 minutes time? 
 
Significantly   -        -        -        -        -        -        -        -        -        -        -        Significantly 
Slower                    Faster 
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5. Compared to when you are at home watching TV, how high do you expect 
your blood pressure to be in 10 minutes time? 
 
 
Significantly   -        -        -        -        -        -        -        -        -        -        -        Significantly 




6. Overall, how much of an effect do you think the caffeine will have on you?  
 
No Effect   -        -        -        -        -        -        -        -        -        -        -     A Highly 
    At All Significant           
Effect 
 Scoring	  All	  items	  were	  scored	  on	  an	  11-­‐point	  scale.	  A	  score	  of	  0	  was	  given	  to	  the	  lowest	  symptom	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  highest	  symptom	  indication	  point.	  Scores	  were	  then	  averaged	  so	  that	  a	  higher	  score	  reflected	  higher	  expected	  caffeine	  symptom	  levels.	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A.5	   Participant	  Information	  Sheets	  Chapters	  3	  &	  4	  	  
Aim of research 
 
To identify the effects of pain on cognitive reaction times. 
 
Description of procedure 
 
Once seated at a computer screen you will be asked to carry out a computer 
based cognitive reaction time task requiring you to indicate whether a 7-letter 
‘X’ string appears on the left or right hand side of the computer screen. 
You will then have an analgesic cream applied to the index finger on one 
hand and be asked to fill out an ‘Expectancy Questionnaire’. Pain will then be 
applied using a Fordyce Finger Crusher simultaneously to the index finger on 
both hands. Following this, you will be asked to fill out a ‘Pain Intensity’ 
questionnaire. 
You will then be asked to repeat the cognitive reaction time task. Following 
the task, you will be asked to complete a ‘Debriefing’ questionnaire. 
 
Description of risks 
  
This study is not open to participants who are on prescription medication or 
who have any known heart conditions. Please inform the experimenter 
immediately if any of the above apply to you. 
 
Benefits of proposed research 
 
To develop our understanding of the impact of pain in applied settings. For 
example, in military settings. 
 
 
Right to withdraw 
 
You have the right to withdraw your data at any time. 
 
If you are dissatisfied with the way the research is conducted, please contact 
the principal investigator in the first instance: telephone number 07875 
816233.  If you feel the problem has not been resolved please contact the 
secretary to the Faculty of Science and Technology Human Ethics 
Committee:  Mrs Paula Simson 01752 584503. 	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Please indicate below your responses to the following questions: 
You have the right to withdraw your responses at any time. 
 
 
1. What was the purpose of today’s study? 	  
2. Were you aware of any factors within the experiment that could have 
affected your rating of the painkiller effectiveness? (If yes, please specify 
below). 
 
3. Were you aware of any factors within the experiment that could have 
affected your choice of painkiller? (If yes, please specify below). 
 
4. Were you aware of anything unusual within the experiment? (If yes, 
please specify below). 
 
5. Did you notice anything unusual about the cognitive reaction time task? 
(If yes, please specify below) 
 
6. Did you notice anything unusual about the Expectancy Questionnaire? (If 
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A.7	   Expectancy	  Questionnaire	  Chapters	  3	  &	  4.	  
	  Instructions	  
To answer the questions in the attached questionnaire, please indicate your 
response to each of the questions by circling the most appropriate part of the 
scale. 
 
For example, the answer below indicates the person strongly disagrees with 
the following statement: 
 
The colour blue is nicer than the colour green.  
 
Strongly -        -        -        -        -        -        -        -        -        -        -  Strongly 
Disagree         Agree 	  	  
Please select your response to the following statements below. 
 
You have the right to withdraw your responses at any time. 
 
 Questionnaire	  Items	  	  
1. How intensely do you think the lever will hurt on the finger with the cream? 
 
 
No Pain   -        -        -        -        -        -        -        -        -        -        -        The Worst  
At All                               Pain You 
                Can Imagine 
 
 




No Pain   -        -        -        -        -        -        -        -        -        -        -        The Worst  
At All                               Pain You 
                Can Imagine Scoring	  All	   items	   were	   scored	   on	   an	   11-­‐point	   scale.	   A	   score	   of	   0	   was	   given	   to	   the	   ‘No	   Pain	   At	   All’	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  ‘The	  Worst	  Pain	  You	  Can	  Imagine’	  indication	  point.	  The	  pain	   intensity	  score	  given	  to	  the	  question	  relating	  to	  the	  finger	  with	  the	  cream	  was	  used	  as	  the	  expected	  pain	  score	  within	  the	  placebo	  condition.	  The	  pain	  intensity	  score	  given	  to	  the	  question	  relating	  to	  the	  finger	  without	  the	  cream	  was	  used	  as	  the	  expected	  pain	  score	  within	  the	  no	  placebo	  condition.	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 A.8	   Pain	  Intensity	  Questionnaire	  Chapters	  3	  &	  4.	  
	  Instructions	  
To answer the questions in the attached questionnaire, please indicate your 
response to each of the questions by circling the most appropriate part of the 
scale. 
 
For example, the answer below indicates the person strongly disagrees with 
the following statement: 
 
The colour blue is nicer than the colour green.  
 
Strongly -        -        -        -        -        -        -        -        -        -        -  Strongly 
Disagree         Agree 	  	  
Please select your response to the following statements below. 
 
You have the right to withdraw your responses at any time. 
 
 Questionnaire	  Items	  	  
1. How intensely did the lever will hurt on the finger with the cream? 
 
 
No Pain   -        -        -        -        -        -        -        -        -        -        -        The Worst  
At All                               Pain You 
                Can Imagine 
 
 
2. How intensely did the lever will hurt on the finger without the cream? 
 
 
No Pain   -        -        -        -        -        -        -        -        -        -        -        The Worst  
At All                               Pain You 
                Can Imagine Scoring	  All	   items	   were	   scored	   on	   an	   11-­‐point	   scale.	   A	   score	   of	   0	   was	   given	   to	   the	   ‘No	   Pain	   At	   All’	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  ‘The	  Worst	  Pain	  You	  Can	  Imagine’	  indication	  point.	  The	  pain	   intensity	  score	  given	  to	  the	  question	  relating	  to	  the	  finger	  with	  the	  cream	  was	  used	  as	  the	  self-­‐report	  pain	  score	  within	  the	  placebo	  condition.	  The	  pain	  intensity	  score	  given	  to	  the	   question	   relating	   to	   the	   finger	  without	   the	   cream	  was	   used	   as	   the	   self-­‐report	   pain	   score	  within	  the	  no	  placebo	  condition.	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A.9	   Positive	  and	  Negative	  Affect	  Schedule	  (PANAS)	  	  	  	  	   Chapters	  3	  &	  4.	  	  Instructions	  
This scale consists of a number of words that describe different feelings and 
emotions. Read each item and then list the number from the scale below next to each 
word. Indicate to what extent you feel this way right now: 
 
 
          1                             2                        3                            4                        5 
 
Very Slightly or           A Little           Moderately            Quite a Bit          Extremely 
   Not At All 
 	  Scale	  Items	  	  
 
__________ 1. Interested    __________ 11. Irritable 
 
 __________ 2. Distressed   __________ 12. Alert 
 
 __________ 3. Excited    __________ 13. Ashamed 
 
 __________ 4. Upset    __________ 14. Inspired 
 
 __________ 5. Strong    __________ 15. Nervous 
 
 __________ 6. Guilty    __________ 16. Determined 
 
 __________ 7. Scared    __________ 17. Attentive 
 
 __________ 8. Hostile    __________ 18. Jittery 
 
 __________ 9. Enthusiastic   __________ 19. Active 
 
 __________ 10. Proud     __________ 20. Afraid	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Scoring	  	  Positive	  Affect	  Score:	  The	  scores	  on	  item	  numbers	  1,	  3,	  5,	  9,	  10,	  12,	  14,	  16,	  17,	  and	  19	  were	  added	  together.	  These	  were	  then	  averaged	  to	  provide	  a	  positive	  affect	  score.	  
 Negative	  Affect	  Score:	  The	  scores	  on	  item	  numbers	  2,	  4,	  6,	  7,	  8,	  11,	  13,	  15,	  18,	  and	  20	  were	  added	  together.	  These	  were	  then	  averaged	  to	  provide	  a	  negative	  affect	  score.	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A.10	  	  Participant	  Information	  Sheet	  Chapter	  5	  	  
Aim of research 
 
To investigate the effects cognitive workload on pain response. 
 
Description of procedure 
 
Once seated at a computer screen you will be asked to carry out a computer 
based cognitive reaction time task requiring you to indicate whether a 7-letter 
‘X’ string appears on the left or right hand side of the computer screen. 
You will then be asked to fill in an Expectancy Questionnaire. Pain will then 
be applied using a Fordyce Finger Crusher simultaneously to the index finger 
on both hands. You will be told to inform the experimenter when the pain 
becomes unbearable and the levers will be removed. Following this, you will 
be asked to fill out a ‘Pain Report’ questionnaire, followed by a ‘Debriefing’ 
questionnaire. 
 
Description of risks 
  
This study is not open to participants who are on prescription medication or 
who have any known heart conditions. Please inform the experimenter 
immediately if any of the above applies to you. 
 
 
Benefits of proposed research 
To develop our understanding of the impact of cognitive load on pain in 
applied settings. For example, in military settings. 
 
 
Right to withdraw 
 
You have the right to withdraw your data at any time. 
 
If you are dissatisfied with the way the research is conducted, please contact 
the principal investigator in the first instance: telephone number 07875 
816233.  If you feel the problem has not been resolved please contact the 
secretary to the Faculty of Science and Technology Human Ethics 








APPENDIX	  A.	  MATERIALS	  	  
	   170	  
A.11	  	  	  	  	  Participant	  Information	  Sheet	  Chapter	  6	  
	  
Aim of research 
 
To investigate how personality and cognitive workload interact in pain 
response. 
 
Description of procedure 
 
Once seated at a computer screen you will be asked to carry out a computer 
based cognitive reaction time task requiring you to indicate whether a 7-letter 
‘X’ string appears on the left or right hand side of the computer screen. 
You will then be asked to fill in an Expectancy Questionnaire. Pain will then 
be applied using a Fordyce Finger Crusher simultaneously to the index finger 
on both hands for 60 seconds.  
Following this, you will be asked to fill out a ‘Pain Report’ questionnaire, 
followed by a ‘Debriefing’ questionnaire. 
 
Description of risks 
  
This study is not open to participants who are epileptic, on prescription 
medication or who have any known heart conditions. Please inform the 
experimenter immediately if any of the above applies to you. 
 
Benefits of proposed research 
 
To develop our understanding of the impact of cognitive load on pain in 
applied settings. For example, in military situations. 
 
 
Right to withdraw 
 
You have the right to withdraw your data at any time. 
 
If you are dissatisfied with the way the research is conducted, please contact 
the principal investigator in the first instance: telephone number 07875 
816233.  If you feel the problem has not been resolved please contact the 
secretary to the Human Ethics Committee:  Ms Sarah Jones. 	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A.12	  	  	  	  	  Participant	  Debrief	  Questionnaire	  	  





Please indicate below your responses to the following questions: 
You have the right to withdraw your responses at any time. 
 
 
1. What was the purpose of today’s study? 	  
2. Were you aware of anything unusual in today’s experiment? (If so, 
please specify below) 
 
3. Were you aware of any factors within the experiment that could have 
altered your pain levels? (If yes, please specify below). 
 
4. Did you notice anything unusual about the cognitive reaction time task? 
(If yes, please specify in detail below anything you identified.) 
 
5. Did you notice anything unusual about the Expectancy Questionnaire? (If 
yes, please specify below) 
 
6. Did you notice anything unusual about the Pain Report Questionnaire? (If 
yes, please specify below). 	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A.13	  	  	  	  Expectancy	  Questionnaire	  Chapters	  5	  &	  6.	  
	  Instructions	  
To answer the questions in the attached questionnaire, please indicate your 
response to each of the questions by circling the most appropriate part of the 
scale. 
 
For example, the answer below indicates the person strongly disagrees with 
the following statement: 
 
The colour blue is nicer than the colour green.  
 
Strongly -        -        -        -        -        -        -        -        -        -        -  Strongly 
Disagree         Agree 	  	  
Please select your response to the following statements below. 
 
You have the right to withdraw your responses at any time. 
 
 Questionnaire	  Items	  	  
1. How intense do you think the pain in your fingers will be? 
 
 
Not At All   -        -        -        -        -        -        -        -        -        -        -        Extremely  
Intense                   Intense             
           
 
2. How unpleasant do you think the pain in your fingers will be? 
 
 
Not At All   -        -        -        -        -        -        -        -        -        -        -        Extremely  
Unpleasant                            Unpleasant 
                 	  Scoring	  All	  items	  were	  scored	  on	  an	  11-­‐point	  scale.	  A	  score	  of	  0	  was	  given	  to	  the	  ‘Not	  At	  
All’	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  ‘Extremely’	  indication	  point.	  Scores	  from	  then	  each	  question	  were	  then	  added	  together	  and	  averaged	  so	  that	  a	  higher	  score	  reflected	  higher	  pain	  levels.	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A.14	  	  	  	  Pain	  Intensity	  Questionnaire	  Chapters	  5	  &	  6.	  	  Instructions	  
To answer the questions in the attached questionnaire, please indicate your 
response to each of the questions by circling the most appropriate part of the 
scale. 
 
For example, the answer below indicates the person strongly disagrees with 
the following statement: 
 
The colour blue is nicer than the colour green.  
 
Strongly -        -        -        -        -        -        -        -        -        -        -  Strongly 
Disagree         Agree 	  	  
Please select your response to the following statements below. 
 
You have the right to withdraw your responses at any time. 
 
 Questionnaire	  Items	  	  
1. How intense was the pain in your fingers? 
 
 
Not At All   -        -        -        -        -        -        -        -        -        -        -        Extremely  
Intense                   Intense             
           
 
2. How unpleasant was the pain in your fingers? 
 
 
Not At All   -        -        -        -        -        -        -        -        -        -        -        Extremely  
Unpleasant                            Unpleasant 
                 	  Scoring	  All	  items	  were	  scored	  on	  an	  11-­‐point	  scale.	  A	  score	  of	  0	  was	  given	  to	  the	  ‘Not	  At	  
All’	  indication	  point	  and	  a	  score	  of	  10	  was	  given	  to	  the	  ‘Extremely’	  indication	  point.	  Scores	  from	  then	  each	  question	  were	  then	  added	  together	  and	  averaged	  so	  that	  a	  higher	  score	  reflected	  higher	  pain	  levels.	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This experiment is studying the effects of two main personality types on the 
experience of pain. A list of the relevant personality characteristics 
associated with each personality type are shown below: 
 
Type A      Type B 
Insecure      Creative 
Irrational      Bright 
Shallow        Intelligent 
Unoriginal      Original 
Discontent      Clever 
Passive      Lively 
Timid       Curious 
Inhibited      Humorous 
Forgetful      Interesting 
Solemn      Clear-headed 
 
 
Previous research has found little, or no, relationship between the amount of 
pain experienced and personality type. 	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A.16	  	  	  	  	  Personality	  Characteristics	  Description	  	   	  	  	  	  	  	  	  -­‐	  Motivated	  Condition	  Chapter	  6	  
 
Experiment Information 	  
This experiment is studying the effects of two main personality types on the 
experience of pain. A list of the relevant personality characteristics 
associated with each personality type are shown below: 
 
Type A      Type B 
Insecure      Creative 
Irrational      Bright 
Shallow        Intelligent 
Unoriginal      Original 
Discontent      Clever 
Passive      Lively 
Timid       Curious 
Inhibited      Humorous 
Forgetful      Interesting 
Solemn      Clear-headed 
 
Research has found a strong relationship between the amount of pain 
experienced from the Fordyce levers and personality type. 
 
It has been reliably found that if you experience less pain from the levers, 
this is indicative of a Type B personality, whereas more pain is indicative of 
a Type A personality. 
 
It is thought this is because the characteristics of a Type B personality allow 
the person to employ more effective coping strategies, such as the ability to 
mentally disengage from the pain. 
 
How much pain you experience from the levers will therefore help the 
experimenter determine your personality type. 	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